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Chapter 1 
Introduction
This chapter is adapted and extended from: 
de Geus, E.J.C, van Lien, R., Neijts, M., & Willemsen, G. (2015). 
Genetics of Autonomic Nervous System Activity (pp. 357-390). 
In: Canli, T. (ed), The Oxford Handbook of Molecular Psychology, 
Oxford University Press: London.
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Cardiovascular disease (CVD) is one of the main causes of death in Westernized countries. 
The etiology of CVD is complex, with many different factors (demographical, lifestyle, 
psychological, and genetic) contributing to an increased risk of CVD development (Brotman, 
Golden, & Wittstein, 2007; Brotman, Walker, Lauer, & O’Brien, 2005). The physiological 
risk factors that form the final common pathway to CVD include the metabolic syndrome, 
with hypertension, hyperlipidemia, hyperglycemia, and android obesity as core features 
(Bayturan et al., 2010); inflammation (Danesh et al., 2008); coagulation/fibrinolysis 
imbalance (Libby & Theroux, 2005); reduced heart rate variability (Dekker et al., 1997; 
Dekker et al., 2000); and increased heart rate (Fox et al., 2007). Strikingly, activity of the 
autonomic nervous system (ANS) is associated with all of these physiological risk factors 
(Charkoudian & Rabbitts, 2009; Lambert & Lambert, 2011; Malpas, 2010; Straub, Wiest, 
Strauch, Harle, & Scholmerich, 2006; Task Force of the European Society of Cardiology 
and the North American Society of Pacing and Electrophysiology, 1996; Tracey, 2009; 
von Kanel R., Mills, Fainman, & Dimsdale, 2001). Because the ANS is very sensitive to 
psychosocial stress, it plays a key role in almost all models in biobehavioral medicine 
that try to account for the well-known role of social (Karasek et al., 1988; Rosengren et 
al., 2004; Siegrist, Peter, Junge, Cremer, & Seidel, 1990) and psychological (Nicholson, 
Kuper, & Hemingway, 2006) sources of chronic stress in hypertension, diabetes, and 
cardiac disease.
There are large individual differences in the activity of the ANS in the basal resting 
state (Berntson, Cacioppo, & Quigley, 1994; Berntson, Norman, Hawkley, & Cacioppo, 
2008; Cacioppo et al., 1994; Grossman & Kollai, 1993; Light, Kothandapani, & Allen, 1998; 
Salomon, Matthews, & Allen, 2000). These differences in ANS activity are further amplified 
in response to brief laboratory stressors (de Geus, Kupper, Boomsma, & Snieder, 2007; 
Houtveen, Rietveld, & de Geus, 2002; Lucini, Norbiato, Clerici, & Pagani, 2002; Wang 
et al., 2009) as well as prolonged psychosocial stress (Riese, van Doornen, Houtman, 
& de Geus, 2000; Vrijkotte, van Doornen, & de Geus, 2004). This chapter reviews the 
contribution of genetic factors to the individual differences in ANS activity at rest and 
during stress. We first present a short overview of the ANS and of the measurement 
strategies used to study it, with a focus on (ambulatory) noninvasive measures that can 
be used in population-based samples that are sufficiently large to allow genetic analyses. 
Next, we review the twin studies on the heritability of these ANS measures and present a 
list of candidate genes that have already been found to influence ANS activity.
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The autonomic nervous system 
The ANS can be divided in two branches; the sympathetic nervous system (SNS) and the 
parasympathetic nervous system (PNS). The SNS is best known for its key role in the ‘fight-
or-flight’ response. Activity of the SNS causes, among other things, an increase in heart 
rate, contractility, blood pressure, breathing rate, bronchodilation, sweat production, 
epinephrine secretion, and a redistribution of blood flow favoring the muscles. The PNS, 
on the other hand, promotes the maintenance of the body by acquiring energy from food 
and getting rid of wastes. The PNS is therefore often labeled as the “rest and digest” 
branch of the ANS. Its activity causes slowing of the heart, constriction of the pupils, 
stimulation of the gut and salivary glands, and other responses that help restore energy. 
Many organs are innervated by both the sympathetic and the parasympathetic branches 
of the ANS, and an increase in the activity of these branches typically exerts opposing 
actions. However, some organs are not dually innervated (e.g., sweat glands) and, even 
for dually innervated organs, the autonomic branches may have synergistic rather than 
opposing effects (e.g., salivary glands).
The main function of the ANS is to coordinate bodily functions to ensure homeostasis 
and performing adaptive responses when faced with changes in the external and internal 
environment, such as those due to physical activity, posture change, food consumption, 
or hemorrhage. In addition, the ANS is capable of substantial heterostatic action; it can 
prepare the body for anticipated threats to homeostasis even in the absence of actual 
changes in bodily activity. The best known example is the anticipatory response that 
prepares the body for physical activity in response to a vast range of stressors that can 
be purely symbolic in nature and are often not followed by actual physical activity (fight-
or-flight) or changes in internal environment (e.g., through blood loss or infection). This 
response is called the physiological stress response.
In humans, subjective experience of stress can be sufficient to trigger the physio-
logical stress response. Subjective experience of stress typically occurs when there is 
an imbalance between perceived threats/demands and perceived abilities/resources. In 
the brain, the perception of internal (thoughts) or external (environmental events) threats 
by neocortical areas leads to the activation of limbic areas, in particular the amygdala 
(Lovallo, 2005). The amygdala, in turn, projects to paraventricular and other hypothalamic 
nuclei as well as to a network of neurons in the rostral ventrolateral medulla (RVLM) and 
the nucleus of the solitary tract (NTS) that initiates changes in the activity of sympathetic 
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neurons in the intermediolateral (IML) column and in activity of the parasympathetic 
neurons in the n. ambiguus.
Parasympathetic nervous system activity
The preganglionic fibers of the PNS leave from the cell bodies of the motor nuclei of 
cranial nerves (CN) III, VII, IX, and X in the brainstem and from the second, third, and 
fourth sacral segments of the spinal cord. The vagus nerve (CN X) carries fibers to the 
heart and lungs (as well as to other organs) and is the primary source of parasympathetic 
innervation of these organs. Many efferent fibers in the vagus originate in the n. ambiguus. 
The preganglionic axons terminate in parasympathetic ganglia, which lie within or very 
close to the organs innervated by the short postganglionic neurons. The preganglionic 
neurons employ acetylcholine (ACh) as the primary neurotransmitter, which binds to a 
nicotinic receptor subtype on the postganglionic neurons in the ganglia. Postganglionic 
parasympathetic fibers also employ ACh as a primary neurotransmitter, but the receptor 
subtypes on the target organ are commonly muscarinic. For instance, the parasympathetic 
postganglionic receptors in the sinoatrial (SA) node of the heart are type 2 muscarinic 
(M2) and their activation reduces heart rate.
Sympathetic nervous system activity
The preganglionic fibers from neurons in the IML column leave the central nervous system 
from the thoracic and lumbar regions of the spinal cord. They synapse onto a chain of 
sympathetic ganglia that lie close to the spinal cord, known as the sympathetic trunk. 
The preganglionic neurons from the IML column to the sympathetic ganglia employ 
ACh as the primary neurotransmitter. The postganglionic neurons from the sympathetic 
ganglia to the organs employ norepinephrine as the primary neurotransmitter, which 
can act on α1-adrenergic (e.g., in arterioles) or β1- and β2-adrenergic receptors (e.g., on 
the heart). Stimulation of the α1-adrenergic receptors causes vasoconstriction by acting 
on the smooth muscles in the medial layer of the blood vessels. Stimulation of the 
cardiac β-adrenergic receptors by norepinephrine released from the cardiac sympathetic 
nerves (nn. accelerantes) increases the pacemaker frequency of the SA node (i.e., heart 
rate), as well as contractility of the ventricles. Together, vasoconstriction and increased 
cardiac performance account for the increase in blood pressure seen during increased 
sympathetic activity.
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A first exception to the use of norepinephrine as the final effector in the SNS is found 
in the sympathetic innervation of eccrine sweat glands, which is cholinergic rather than 
adrenergic. A second exception is a set of preganglionic neurons that end in a special 
ganglion, namely the adrenal medulla. On activation by preganglionic neurons, the 
adrenal medulla releases a small amount of norepinephrine into the bloodstream, but 
most of the released norepinephrine is converted to epinephrine, which is excreted in 
much larger amounts than norepinephrine (5:1). Circulating epinephrine preferentially 
binds to β2-receptors in the vessels and on the heart, causing vasodilatation (mostly in 
muscle tissue) and increases in heart rate and contractility.
Measurements of autonomic nervous system activity
Many studies of the ANS have focused on the fight-or-flight response, which is often 
characterized by reciprocal increases in SNS activity and decreases in PNS activity. Such a 
pattern gives rise to increases in heart rate and blood pressure, and heart rate and blood 
pressure reactivity are still among the most used variables to indicate changes in ANS 
activity. However, a disadvantage of these variables is that they represent an unknown 
mix of sympathetic and parasympathetic effects. It has been shown that the classical 
reciprocal pattern of sympathetic activation with parasympathetic deactivation describes 
only a limited part of the total autonomic space (Berntson, Cacioppo, & Quigley, 1991). 
Different patterns of co-activation, reciprocal activation and co-inhibition are found across 
individuals performing the same task or within individuals performing different tasks. For 
example, dental phobia patients engaged in a stressful mental arithmetic task showed an 
increase in their SNS activity with decreased PNS activity; but, when exposed to phobic 
stimuli, the same subjects showed increased SNS activity with increased PNS activity 
(Bosch, de Geus, Veerman, Hoogstraten, & Nieuw Amerongen, 2003). Most important, 
health outcomes of sympathetic hyperreactivity need not be the same as those of 
parasympathetic hyperreactivity. Hyperactivity of the SNS has been mostly associated 
with an increased risk for hypertension, the metabolic syndrome, and left ventricular 
failure (Brotman et al., 2007; Esler, 2010; Esler et al., 2008; Lambert, Straznicky, Lambert, 
Dixon, & Schlaich, 2010), whereas loss of PNS activity causes a reduction in the electrical 
stability of the heart (Schwartz et al., 2003; Vanoli et al., 1991) and may play a key role in 
the pro-inflammatory state (Rosas-Ballina & Tracey, 2009; Tracey, 2009).
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Because heart rate and blood pressure do not reveal the underlying pattern of ANS 
activity, studies in the past two decades began indexing sympathetic and parasympathetic 
activity separately. Parasympathetic nervous system activity can be assessed invasively by 
parasympathetic microneurography, microdialysis, or pharmacological blockade (Berntson 
et al., 1994; Cacioppo et al., 1994; Cerati & Schwartz, 1991; Jewett, 1964; Kunze, 1972; 
Martinmaki, Rusko, Kooistra, Kettunen, & Saalasti, 2006; Shimizu et al., 2009), but also 
less invasively by measuring baroreflex sensitivity (BRS), or noninvasively by measuring 
heart rate variability (HRV), particularly HRV in the respiratory frequency range or RSA 
(Akselrod et al., 1981; Cerutti, Bianchi, & Mainardi, 2001; DiRienzo, Parati, Radaelli, & 
Castiglioni, 2009; Katona & Jih, 1975; La Rovere, Pinna, & Raczak, 2008; Sztajzel, 2004; 
Task Force of the European Society of Cardiology and the North American Society of 
Pacing and Electrophysiology, 1996). There are different ways to quantify HRV and several 
commonly used time- and frequency domain indices of HRV are summarized in Table 1.1. 
As is the case for PNS activity, SNS activity can also be measured invasively by means 
of sympathetic microneurography, regional norepinephrine spillover, or pharmacological 
blockade (Berntson et al., 1994; Cacioppo et al., 1994; Eisenhofer, 2005; Esler et al., 
1988; Esler & Kaye, 2000; Grassi & Esler, 1999; Hagbarth & Vallbo, 1968; Julius, Pascual, 
& London, 1971; Wallin, 1984; Wallin, 2004). Other commonly used measurements of 
the SNS are plasma or urinary catecholamines, salivary α-amylase activity, or the LF/HF 
ratio (Esler et al., 1990; Hjemdahl, 1990; Goldstein, Eisenhofer, & Kopin, 2003; Nater & 
Rohleder, 2009; Pagani & Malliani, 2000). However, together with electrodermal activity 
(Boucsein, 1992; Dawson, Schell, & Filion, 2000; Fowles, 1986) measurement of cardiac 
contractility is currently the preferred noninvasive method to measure SNS activity. 
Contractility is reflected in a larger ejection fraction which can be measured, e.g. by 
echocardiography, as the fraction of the end-diastolic volume ejected as stroke volume. 
Contractility is also reflected in a more rapid start of the ejection phase after the onset 
of ventricular depolarization, a time interval referred to as the pre-ejection period (PEP) 
(Sherwood et al., 1990). The different ways to quantify SNS activity non-invasively are 
summarized in Table 1.2.
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Table 1.1. Several commonly used noninvasive measures of heart rate variability (HRV).
Time domain measures
SDNN Standard deviation of all valid interbeat intervals
SDANN Standard deviation of the average interbeat intervals across all 5-minute 
segments of the entire recording 
RMSSD Root mean square of differences between valid, successive interbeat intervals
pvRSA Respiratoy Sinus Arrhythmia derived by peak-valley estimation. In the time 
domain, estimates of pvRSA are obtained by subtracting the shortest IBI 
during heart rate acceleration in the inspiration phase from the longest IBI 
during heart rate deceleration in the expiration phase 
BRS Baroreflex Sensitivity derived by the sequence method in combined 
continuous blood pressure and ECG recordings (can also be derived in the 
frequency domain as the cross time-series coherence)
Frequency domain measures
HF power Power in the respiratory frequency range of 0.15-0.40 Hz
LF power Power in the low frequency range (0.04-0.15 Hz)
VLF power Power at very low frequencies (0.003-0.04 Hz) 
ULF power Power in the ultra low frequency band (< 0.003 Hz)
Total power (TP) ULF + VLF + LF + HF
Table 1.2. Several commonly used noninvasive measures of sympathetic nervous system activity.
Plasma NE/E Measurements of concentrations of norepinephrine (NE) or epinephrine (E)  
in venous (or arterial) blood using liquid chromatography
Urinary NE/E Measurement of (24-h) urinary excretion of NE or E (relative to creatinine)
LF/HF The LF/HF ratio spectral power of the heart rate in the lower frequencies centered 
around 0.1 Hz (LF) divided by the power in the higher frequencies centered 
around the respiratory frequency (HF)
PEP The Pre-Ejection Period is the time interval between the onset of ventricular 
depolarization (the QRST complex, or Qonset) and the opening of the semilunar 
valves (sharp upstroke in the dZ/dt, or the B point in the impedance cardiogram)
EF Ejection Fraction is the fraction of the end-diastolic volume that is ejected with 
each heart beat. 
SCL The Skin Conductance Level representing slow tonic shifts in electrodermal activity 
nsSCR Skin Conductance Responses (SCRs) are more rapid transient events. nsSCR is 
the count or frequency of these nonspecific responses (also called electrodermal 
lability)
SVR Systemic Vascular Resistance is the resistance to blood flow that must be 
overcome to push blood into the peripheral circulation
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Genetics of autonomic nervous system activity
To determine the genetic contribution to the individual differences in ANS measures, we 
can resort to family studies. The essence of all family studies is that they relate the degree of 
genetic resemblance to the degree of trait resemblance. From basic biometrical principles, 
we can compute the estimated genetic covariance between two individuals based on the 
degree of their genetic relatedness (Falconer & Mackay, 1996; Lynch & Walsh, 1997). If 
two individuals are genetically unrelated, their expected genetic covariance is zero. It is 
important to note that this does not mean that they cannot show trait resemblance, but 
that such resemblance must be due to factors other than genetic ones (i.e., environmental 
factors). Things change when the covariance is computed between individuals who do 
have a genetic relationship. Relatives, for instance, parent and offspring, will more often 
have identical variants at a DNA locus than will unrelated individuals. If genetic factors 
contribute to the trait, the covariance between family members will vary systematically 
with the degree of genetic relatedness.
A general formula for the genetic part of the covariance between a trait measured 
in two relatives is:
Covariance (P1,P2) = u * VA + r * VD
where P1 is a trait measured in relative 1, P2 the same trait measured in relative 
2, VA the additive genetic variance caused by all loci contributing to the trait, VD the 
dominant genetic variance caused by all loci contributing to the trait, u the coefficient 
of relationship representing the correlation between the relatives for loci acting additive, 
and r the coefficient of dominance. 
A locus acts additively if both variants at a locus contribute equally to trait variance, 
whereas in dominance, one variant exerts a (much) stronger effect than the other variant. 
For parent–offspring pairs, u= ½ and r =0, for full siblings u = ½ and r = ¼, for uncles (aunts) 
with the nephews (nieces) u = ¼ and r = 0, for grandparent and grandchild u = ¼ and r = 0, 
and for single first cousins u = 1/8 and r = 0. When the covariance between family members 
in a trait is measured across many different family relationships (e.g., different values for 
u and r), this yields a set of equations that can be algebraically solved to estimate VA and 
VD. This is the essence of the use of pedigrees (parent–offspring, grandparent–grandchild, 
uncle–niece, siblings, etc.) studies to estimate the broad heritability of a trait, which is simply 
the genetic variance (VA and VD) in the trait divided by the total variance (VP) in the trait.
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Studying family resemblance is a powerful tool to detect genetic contribution to a trait 
but, as already noted by Sir Francis Galton (Galton, 1869), a major shortcoming of this 
type of family studies is that the degree of genetic relatedness can be confounded 
with the degree of shared family environment. Full siblings, for instance, do not only 
share more genes than nieces and nephews, they are also typically reared in the same 
household. The shared family environment includes potentially important factors like 
parental socioeconomic status (SES), neighborhood, school, sports club, family diet, and 
parental attitudes and general rearing style. The solution to separating the genetic and 
shared environmental effects on the trait resemblance of family members has been found 
in what Galton called “a unique experiment of nature”: monozygotic (MZ) and dizygotic 
(DZ) twin pregnancies.
Monozygotic twinning occurs when, for reasons that are still incompletely 
understood, a fertilized egg divides before it nestles in the uterus. Monozygotic twins 
are usually said to inherit identical genetic material. This is not entirely correct. Genetic 
imprinting patterns can be found to differ in MZ twins as is illustrated, for instance, in an 
MZ twin pair discordant for Beckwith-Wiedemann syndrome due to differential imprinting 
(Martin, Boomsma, & Machin, 1997). A number of other occurrences can make the 
genetic identity of MZ twins less than 100 percent. Since these occurrences are all rare, 
the assumption that MZs have 100 percent genetic identity is quite defensible, particularly 
since deviation from perfect identity will lead to an underestimation of genetic effects 
(i.e., the assumption is a conservative one).
If more than one egg is released from the ovaries during a menstrual cycle, and 
each egg is fertilized by a separate sperm, the result is a nonidentical twin also known 
as a DZ or fraternal twin. Dizygotic twinning rates have risen in the last decades in most 
countries because of artificial reproduction techniques and the higher age at which 
mothers get their first child, which may be paired to higher levels of follicle stimulating 
hormone. Genetically, DZ twins do not differ from singleton brother–brother, sister–sister, 
or brother–sister pairs; that is, they share on average 50 percent of their genetic material 
(Hoekstra et al., 2004). Opposite-sex (DOS) twins are always DZ twins.
In a twin study, four possible factors and their interactions and correlations are 
assumed to contribute to the total variance in a trait: unique environmental factors (E), 
shared environmental factors (C), additive genetic factors (A), and dominant genetic 
factors (D). Shared environmental factors and additive and dominant genetic factors can 
cause twin resemblance, whereas the extent to which twins do not resemble each other 
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is ascribed to the unique (or nonshared) environmental factors. These include all unique 
experiences such as differential jobs or lifestyle, accidents, or other life events, and, in 
childhood, differential treatment by the parents and nonshared peers. Twin researchers 
typically use structural equation modeling (SEM) to estimate the relative contribution of 
the A, D, C, and E factors to the individual differences in the trait. In SEM, the relationships 
between several latent unobserved variables (e.g., genetic and environmental factors) 
and observed variables (e.g., ANS measures) are summarized by a series of equations. 
Additional equations can specify the correlation between the latent genetic and 
environmental factors based on the known genetic relationship. For instance, the latent 
additive and dominant genetic factors influencing an ANS measure are correlated unity in 
MZ twins, but only 0.5 and 0.25, respectively, in DZ twins.
It is possible to derive the expected variance-covariance matrix implied by the 
total set of equations through the use of covariance algebra. Using maximum likelihood 
estimation, the fit of the expected covariance/variance matrix to the actual observed 
covariance/variance matrix is iteratively tested in a sample of hundreds or thousands of 
twins over a range of possible values for the path coefficients. From the best fitting model, 
the estimates for the path coefficients (e.g., a, c, d, and e) are used to estimate the relative 
contribution of the latent factors A, C, D, and E to the total variance in, for instance, an 
ANS measure. Heritability of the ANS measure, defined as the relative proportion of the 
total variance explained by genetic factors, is obtained as the ratio of a² + d²/(a² + d² + 
e² + c²). The heritability can also be expressed as a percentage by multiplying this ratio 
by 100.
Using the classic twin design, we can only estimate three components of variance 
at the same time (either A, C, and E, or A, D, and E). One solution is to add parents or 
offspring of twins to create an extended twin-family design (Keller et al., 2009). If such 
family data are not available, one needs to make the assumption that either C or D is 
absent. This can be inferred in twin studies by first inspecting the MZ and DZ correlations 
to see whether dominance or shared environmental effects are actually likely to play a 
role. The presence of dominance can be recognized because it yields DZ correlations 
that are much lower than half the MZ correlation. In contrast, the presence of shared 
environmental effects yields DZ correlations that are much higher than half the MZ 
correlations. If the MZ correlation is about twice as high as the DZ correlation an AE 
model will fit best.
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Twin studies of Indicators of Autonomic Nervous System Activity
Tables 1.3 and 1.4 summarize the results from twin studies on the heritability of various 
measures of ANS activity. Only studies with at least 50 twin pairs were included. Table 
1.3 focuses on studies that have estimated the heritability of cardiac vagal activity using 
the different measures of RSA. The table excludes a study on HF power in 5-month-old 
infants, in which HF power was only weakly influenced by genetic factors (11 percent), 
and unique environmental factors explained most of the HF variance, particularly in boys 
(Dubreuil et al., 2003). Because myelinization of vagal fibers is still incomplete up until 
age 2 (Loeliger, Tolcos, Leditschke, Campbell, & Rees, 2000), it is uncertain whether the 
relation between vagal activity and RSA in such young children is comparable to that 
in adolescents and adults. For completeness, Table 1.3 also includes the heritability 
estimates for the BRS and total heart rate variability, either measured as the standard 
deviation of all IBIs (SDNN) or the TP of the IBI spectrum, and for the VLF and ULF power. 
These HRV measures also reflect PNS effects on the heart but are less ‘purely’ PNS than 
RSA. Table 1.4 focuses on studies that have estimated the heritability of measures of 
SNS activity that, to date, only include muscle sympathetic nerve activity (MSNA), plasma 
catecholamines, SCL/nsSCRs, and PEP. The table excludes a study on nine MZ twin pairs 
that used the golden standard MSNA approach (Wallin, Kunimoto, & Sellgren, 1993). 
This study reported that the MZ twin resemblance was as good as the average test–retest 
reliability of the method.
Heritability of Measures of Cardiac Vagal Activity
In laboratory twin studies that record RSA in quiet resting conditions, a significant but 
modest genetic contribution has been systematically reported (Busjahn et al., 1998; de 
Geus et al., 2007; Kupper et al., 2004; Kupper et al., 2005; Riese et al., 2006; Riese et 
al., 2007; Su et al., 2010; Tank et al., 2001; Tuvblad et al., 2010; Uusitalo et al., 2007; 
Wang, Thayer, Treiber, & Snieder, 2005; Wang et al., 2009; Zhang et al., 2007). Heritability 
estimates at rest for pvRSA range from 25 to 55 percent, for RMSSD from 36 to 71 
percent, and for HF from 37 to 63 percent. Heritability estimates for BRS ranged from 
22 to 55 percent. Osztovits et al. (2011) were the only exception to this as heritability of 
RSA in their study was not significant. Heritability estimates for European Americans and 
African Americans were very similar (Wang et al., 2005), and none of the studies reported a 
sex difference in heritability or evidence for different genes being expressed in males and 
females.
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The difference in heritability estimates across studies and measures probably does not 
reflect a truly different genetic architecture. Instead, it may simply reflect the large age 
range across the studies (mean age 9 to mean age 55) and the different duration of 
the resting condition and the posture of the subject (sitting, supine). One study that 
used multiple measures in the same set of subjects found a very high correlation among 
SDNN, RMSSD, and HF, indicating that these three RSA measures may reflect the same 
underlying genetic factor (Wang et al., 2005).
Strikingly, heritability of ambulatory values of RSA tends to be higher than the values 
at rest. Three studies that measured pvRSA, HF, or BRS at rest and during a series of mental 
stressors reported increased genetic variance in these measures under stress (de Geus et 
al., 2007; Riese et al., 2006; Wang et al., 2009). This suggests that genetic influences 
on cardiac vagal activity become more pronounced when the subject is challenged by 
mentally and emotionally “engaging” conditions.
Table 1.3. Studies reporting heritability of cardiac parasympathetic nervous system activity.
Reference
Number  
of subjects
 
Age Sex Protocol Measure Heritability (%)
Best 
fitting 
model
Boomsma, 
et al., 1990
MZ = 140
DZ = 180
16.7 m/f Laboratory 
(8-minute rest - 
quiet sitting)
pvRSA 25 AE
Snieder,  
et al., 1997
MZ = 182
DZ = 234
44.2 m/f Laboratory 
(8-minute rest - 
quiet sitting)
pvRSA 31 AE
Busjahn  
et al., 1998
MZ = 190
DZ = 92
33 Ambulatory 
30-minute 
recording
SDNN 60 ADE
RMSSD 65 ADE
HF 39 AE
Tank  
et al., 2001
MZ = 176
DZ =122
33 m/f Laboratory 
(10-minute rest –
semi-supine)
BRS 43 AE
Kupper  
et al., 2004
MZ = 218
DZ = 301
Sibs = 253
31 m/f Ambulatory 24-hour 
recor ding, analysis 
restricted to sitting 
activities and sleep
SDNN
SDNN
SDNN
SDNN
35 (morning)
36 (afternoon)
47 (evening)
43 (night)
AE
AE
AE
AE
RMSSD
RMSSD
RMSSD
RMSSD
41 (morning)
48 (afternoon)
48 (evening)
40 (night)
AE
AE
AE
AE
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Reference
Number  
of subjects
 
Age Sex Protocol Measure Heritability (%)
Best 
fitting 
model
Kupper  
et al., 2005
MZ = 222
DZ = 305
Sibs = 253
31 m/f Ambulatory  
24-hour recording, 
analysis restricted 
to sitting activities 
and sleep
pvRSA
pvRSA
pvRSA
pvRSA
40 (morning)
49 (afternoon)
55 (evening)
54 (night)
AE
AE
AE
AE
Wang  
et al., 2005
MZ = 104
DZ = 102
15.2 m/f Laboratory 
(10-minute rest – 
supine)
SDNN 66 AE
RMSSD 71 AE
HF 63 AE
LF 45 AE
de Geus  
et al., 2007
Re-analysis  
of 
Boomsma 
1990 
dataset
16.7 m/f Laboratory 
(8-minute rest - 
quiet sitting)
Laboratory  
(mental stress)
Laboratory 
(reactivity)
pvRSA
pvRSA
pVRSA
31
54
ns
AE
AE
Re-analysis 
of Snieder 
1997 
dataset
44.2 m/f Laboratory 
(3-minute rest - 
quiet sitting)
Laboratory  
(mental stress)
Laboratory 
(reactivity)
pvRSA
pvRSA
pvRSA
32
44
ns
AE
AE
Riese  
et al., 2006
MZ =148
DZ = 102
23.2 f Laboratory 
(5-minute rest - 
quiet sitting)
Laboratory  
(mental stress)
BRS
BRS
22
42
AE
AE
Riese  
et al., 2007
MZ = 115
DZ = 91
22.8 f Laboratory  
(rest + stress in a 
single latent factor)
BRS 53 AE
TP 51 AE
Zhang  
et al., 2007
MZ = 336
DZ = 106
15-
84
m/f Laboratory 
(5-minute rest – 
sitting)
BRS 55 AE
TP 23 AE
Uusitalo  
et al., 2007
MZ = 208  
(104 chronic 
diseased)
DZ = 296  
(173 chronic 
diseased)
51.5 m Laboratory 
(5-minute rest – 
supine)
RMSSD 36 ADE
LF 28 AE
HF 37 ADE
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Reference
Number  
of subjects
 
Age Sex Protocol Measure Heritability (%)
Best 
fitting 
model
Wang  
et al., 2009
MZ = 282
DZ = 372
Singleton 
twins = 81
17.8 m/f Laboratory 
(15-minute  
rest – supine)
Laboratory  
(mental stress)
Laboratory 
(reactivity)
RMSSD
RMSSD
RMSSD
48
58
18
AE
AE
AE
Laboratory  
(15 minute  
rest – supine)
Laboratory  
(mental stress)
Laboratory 
(reactivity)
HF
HF
HF
50
58
49
AE
AE
AE
Su et al., 
2010
198
MZ = 121
DZ = 77
55.0 m Ambulatory  
24-hour recording, 
physical activity 
restricted to light 
walking
TP 63 AE
ULF 59 AE
VLF 57 AE
LF 43 AE
HF 56 AE
Tuvblad  
et al., 2010
MZ = 482
DZ = 361
9.6 m/f Laboratory 
(3-minute rest – 
quiet sitting)
pvRSA 39 AE
Osztovits 
et al., 2011
MZ = 126 
DZ = 76
44.3 m/f Laboratory 
(15-minute rest – 
supine)
RMSSD ns CE
pNN50 ns CE
LF ns CE
HF ns CE 
BRS ns CE
Hightower 
et al., 2013
MZ = 350 
DZ = 198
38.6 m/f Laboratory 
(5-minute rest – 
sitting)
BRS 25/37 a -
MZ, monozygotic; DZ, dizygotic, Sibs, singleton siblings of the twins added in an extended twin design.
aDifferent estimate for upward/downward deflection
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Heritability of Measures of Sympathetic Nervous System Activity
Table 1.4 summarizes the twin studies that have estimated the heritability of (putative) 
measures of SNS activity. The studies on plasma and urinary norepinephrine levels 
reported heritability estimates of 42 to 70 percent for plasma and 46 to 76 percent for 
urinary levels. For epinephrine, heritability estimates of 64 to 74 percent were found for 
plasma and 65 to 78 percent for urinary levels (Jedrusik et al., 2004; Rao et al., 2007; 
Williams, Puddey, Beilin, & Vandongen, 1993; Hightower et al., 2013).
For electrodermal lability, heritability estimates between 30 and 43 percent have been 
found (Crider et al., 2004; Lykken, Iacono, Haroian, McGue, & Bouchard, Jr., 1988), and, 
for skin conductance level, heritability was 26 percent in males and 34 percent in females 
(Tuvblad et al., 2010). An echocardiographic study computing the sibling correlations 
in the ejection fraction estimated the familial variance in left ventricular contractility at 
40 percent (Fox et al., 2010). These familial factors appear to be of a genetic nature as 
shown by a more recent twin study estimating the heritability of contractility at 40 percent 
(Hightower et al., 2013). In our own studies in the Netherlands Twin Registry, we used 
the PEP to index left ventricular contractility (de Geus et al., 2007; Kupper, Willemsen, 
Boomsma, & de Geus, 2006). We found substantial heritability of the PEP in laboratory 
and ambulatory settings, which varied from 48 percent in nighttime recordings to 74 
percent during mental stress. In an adolescent sample, PEP reactivity to a mental stressor 
was also heritable (54 percent). This converges with the finding of significant genetic 
contribution to the stress reactivity of heart rate and blood pressure, the variables that 
strongly depend on cardiac SNS reactivity. Mental stress-induced increases in heart rate 
and systolic and diastolic blood pressure ranged between 26 percent and 43 percent 
(Wu, Snieder, & de Geus, 2010), respectively.
In the middle-aged groups, but not in the adolescents, the DOS correlation for PEP was 
lower than the correlation in same-sex DZ pairs (de Geus et al., 2007; Kupper et al., 2006). 
This indicates that different genes play a role in individual differences in cardiac sympathetic 
activity in adult men and women. The most likely explanation for this sex difference is an 
interaction between adrenoceptor signaling and the male and female sex hormones. 
Several studies have shown the presence of such interaction. Testosterone regulates 
gene expression of the major calcium regulatory proteins in isolated ventricular myocytes 
(Golden, Marsh, & Jiang, 2004; Golden, Marsh, Jiang, & Moulden, 2005). A role for female 
sex hormones is supported by several studies showing that estrogen inhibits β1-adrenergic 
receptor activation on the heart (Thawornkaiwong, Preawnim, & Wattanapermpool, 2003).
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Table 1.4. Studies reporting heritability of measures of sympathetic nervous system activity.
Authors
Number  
of subjects Age Sex Protocol Measure
Heritability 
(%)
Best 
fitting 
model
Williams  
et al., 1993
MZ + DZ = 
196
17–65 m/f Venipuncture in 
supine rest
Plasma 
[NE]
57 AE
Plasma 
[E]
74/64a AE
Crider  
et al., 2004
MZ = 325
DZ = 291
47.8 m 4 + 3 minutes  
rest – quiet sitting
nsSCR 43 AE
Jedrusik  
et al., 2004
MZ = 78
DZ = 74
34.5 m/f Venipuncture  
in rest
Plasma 
[NE]
42 AE
Urinary 
[NE]
76 AE
Plasma 
[E]
69 AE
Urinary 
[E]
65 AE
O’ Connor 
group 
(data re-
published 
in multiple 
papers; 
here (Rao 
et al., 
2007) was 
used
MZ = 238
DZ = 106
15–84 m/f Venipuncture  
in rest
Plasma 
[NE]
70 AE
Urinary 
[NE]
46 AE
Plasma 
[E]
67 AE
Urinary 
[E]
68 AE
Wang  
et al., 2005
MZ = 104
DZ = 102
15.2 m/f Laboratory 
(10-minute  
rest – supine)
LF /HF 32 AE
Kupper  
et al., 2006
MZ = 218
DZ = 301
Sibs = 253
31 m/f 24 hour recording, 
analysis restricted 
to sitting activities 
& sleep
PEP
PEP
PEP
PEP
62 
(morning)
62 
(afternoon)
55 
(evening)
48 (sleep)
AE
AE
AE
AE
de Geus  
et al., 2007
MZ = 140
DZ = 180
16.7 m/f Laboratory  
(8 minute rest - 
quiet sitting)
Laboratory  
(mental stress)
Laboratory 
(reactivity)
PEP
PEP
PEP
70
74
54
AE
AE
AE
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Authors
Number  
of subjects Age Sex Protocol Measure
Heritability 
(%)
Best 
fitting 
model
de Geus  
et al., 2007
MZ = 182
DZ = 234
44.2 m/f Laboratory  
(3 minute rest - 
quiet sitting)
Laboratory  
(mental stress)
Laboratory 
(reactivity)
PEP
PEP
PEP
64
56
ns
AE
AE
Uusitalo  
et al., 2007
MZ = 208 
(104 chronic 
diseased)
DZ = 296 
(173 chronic 
diseased)
51.5 m Laboratory 
(5-minute rest – 
supine)
LF/HF 28 AE
Tuvblad  
et al., 2010
MZ = 512
DZ = 484
9.6 m/f Laboratory  
(3 minute rest – 
quiet sitting)
SCL 26/34a AE
nsSCR 30 AE
Bosker  
et al., 
(2012)
MZ = 94
DZ = 74
Singleton 
twins = 24
18 m/f Overnight urine Urinary 
[NE]
Urinary 
[E]
68
74
AE
Hightower 
et al., 2013
MZ = 350 
DZ = 198
38.6 m/f Venipuncture  
in rest
Plasma 
[NE]
65 -
Urinary 
[NE]
49 -
Plasma 
[E]
67 -
Urinary 
[E]
78 -
Laboratory 
(5-minute rest – 
sitting) 
LV con-
tractility 
(dP/dT 
max)
40 -
Stroke 
volume
73 -
Stroke 
volume 
index
58 -
Systemic 
vascular 
compli-
ance
53 -
Systemic 
vascular 
resistan-
ce (SVR)
57 -
24 Chapter 1
Authors
Number  
of subjects Age Sex Protocol Measure
Heritability 
(%)
Best 
fitting 
model
Wu, 
Treiber, & 
Snieder, 
2013
MZ = 540 
DZ = 522
14.7 m/f Laboratory  
(15-min rest – 
supine)
Laboratory  
(15-min mental 
stress)
Laboratory 
(reactivity)
Stroke 
volume 
(SV)
SVR 
Index 
SV
SVR 
Index
SV
SVR 
Index
51/58a
49/44a
53/58a
55/39a
ns/6a
8/10a
AE
AE
AE
AE
AE
Noh et al., 
2015
MZ = 596 
DZ = 124 
Sibs = 567 
Parents = 
354
42.5 
(parents 
= 65.7)
m/f Laboratory 
echocardiography
Left Ven-
tricular 
Ejection 
Fraction
27 -
NE, norepinephrine; E, epinephrine; MZ, monozygotic; DZ, dizygotic; Sibs, singleton siblings of the 
twins added in an extended twin design.
aDifferent estimate in males/females
Which Genetic Variants Cause the Heritability of SNS and PNS Activity?
Although twin studies show that individual differences in basal ANS activity and its 
responses to stress are significantly influenced by genetic factors, these factors are 
modeled as latent factors, and the actual gene networks that harbor the DNA variants 
underlying the heritability of the ANS are left unspecified. Identification of these genes 
and their functional variants is an important next step because they could help elucidate 
the biological pathways through which ANS activity contributes to CVD risk.
One of the main gene finding strategies is a candidate gene association study. 
Such a study tests whether a particular variant in a candidate gene and a trait co-occur 
above chance level, given the frequency of the variant and the distribution of the trait 
in the population (McCaffery, Snieder, Dong, & de, 2007). The selection of genes is 
often based on the known biological pathways involved in the trait of interest. For the 
PNS, genes involved in biosynthesis, transport, and breakdown of ACh seem obvious 
candidates, as are the genes for the muscarinic receptors. For the SNS, likely candidates 
are genes controlling catecholamine synthesis and metabolism, neuronal norepinephrine 
reuptake, and adrenergic receptor function. The variants to be typed within the candidate 
gene – for example, single nucleotide polymorphisms (SNPs), repeat polymorphisms, 
or insertion/deletion polymorphisms – are prioritized by their location within coding, 
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promoter, or splice regions, or, if known, their functional effects on the gene product or 
on gene expression.
Table 1.5 presents a sample of the genetic variants that have been found, at least 
once, to be significantly associated with an ANS measure in human subjects (Adam et 
al., 2014; Baccarelli et al., 2008; Beetz et al. (2009); Boccardi et al., 2010; Busjahn et al., 
1998; Chang, Chang, Chen, Fang, & Huang, 2014; Chang, Fang, Chang, Chen, & Huang, 
2014; Huntgeburth et al., 2011; Ellis, Beevers, Hixon, & McGeary, 2011; Kurnik et al., 
2007; Masuo et al., 2005; Matsunaga et al., 2005; Matsunaga et al., 2007; Matsunaga et 
al., 2009; Matsunaga et al., 2010; Milan et al., 2005; Nagai, Sakane, Tsuzaki, & Moritani, 
2011; Neumann, Lawrence, Jennings, Ferrell, & Manuck, 2005; Neumann et al., 2006; 
Neumann et al., 2009; Neumeister et al., 2005; Newton-Cheh et al., 2007; Nishikino et 
al., 2006; Park et al., 2006; Probst-Hensch et al., 2008; Rao et al., 2008; Seppala et al., 
2014; Shihara et al., 1999; Shihara et al., 2001; Stolarz et al., 2004; Su et al., 2009a; Suzuki 
et al., 2003; Thayer et al., 2003; Tingley et al., 2007; Viola, James, Archer, & Dijk, 2008; 
Yang et al., 2010; Yasuda et al., 2004; Ylitalo et al., 2000; Zhang et al., 2010). Such a list is, 
by its nature, unfinished, because ongoing progress in the understanding of the biology 
of the ANS will increase the list, whereas failure to replicate typically does not lead to 
removal of the gene as a “candidate” (because it still meets the criterion “associated at 
least once”). If the more rigorous demands were made that (1) an association needs to be 
detected in a sample that was a priori sufficiently powered and (2) the association needs 
to be replicated exactly (same SNP, same variant, same direction of effect, same ANS 
variable) in independent samples (Sullivan, 2007), then none of the candidates on the list 
would survive. This is probably too rigid, and at least two genes are very likely to be truly 
involved in ANS activity based on experimental confirmation in animal studies; namely, 
the genes encoding the G-protein-regulated phosducin and the dual-specific A kinase-
anchoring protein 2 (Beetz et al., 2009; Tingley et al., 2007, respectively).
Mice with a targeted deletion of Pdc displayed elevated catecholamine turnover, and 
their postganglionic sympathetic neurons showed prolonged action potential firing after 
stimulation with Ach and increased firing frequencies during membrane depolarization 
(Beetz et al., 2009). Interestingly, Pdc –/– mice displayed exaggerated increases in blood 
pressure in response to stress, and in two different human populations several SNPs in the 
PDC gene were associated with stress-induced blood pressure reactivity. These findings 
suggest that phosducin is an important modulator of sympathetic activity. For the PNS, 
subjects with a variant in the dual-specific A kinase-anchoring protein 2 (AKAP10) gene 
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were found to have lower SDNN in a small patient sample (Tingley et al., 2007). In a 
much larger sample of healthy middle-aged adults, the same variant was again found 
to be associated with SDNN and also with RMSSD. The importance of this gene for 
cardiac vagal activity was further confirmed by experimental disruption of the gene in 
mouse embryonic stem cells that were differentiated into cardiac cells (Tingley et al., 
2007). Mutation of mouse AKAP10 increased the sensitivity of cultured cardiac cells to 
cholinergic signals, and this result was reproduced in living mice.
In a very recent study by Riese et al. (2014) data of seven cohorts were used in a large 
candidate gene study including 443 genotyped and imputed common genetic variants 
in eight key genes (CHAT, SLCI8A3, SLC5A7, CHRNB4, CHRNA3, CHRNA, and ACHE) of 
the acetylcholinergic pathway. It was tested whether these variants were associated with 
the RMSSD. Results showed that none of the variants were significantly associated with 
RMSSD after correction for multiple testing. 
A fair summary of the current state of the art is that the yield of the candidate gene 
approach has been modest. This may reflect a general disadvantage of an approach 
that capitalizes entirely on existing biological disease models. Many of the hundreds or 
thousands of genes relevant to the disease may not have been properly annotated, or 
they may reside in pathways that have not been linked to the disease before. Increasingly, 
gene finding attempts in large-scale samples have used the more agnostic strategy of 
a genome-wide association study (GWAS) that makes no a priori assumptions on the 
biological pathways involved (Manolio et al., 2009). Genome-wide association studies 
exploit the availability of the human genome sequence and the rapid development 
across the past decades of affordable, high-accuracy, high-throughput technologies to 
genotype from SNPs scattered across the entire genome. Although a single subject will 
deviate in around 4 million SNPs from the major variant in the base population, a subset 
of 500,000 to 1 million well-chosen tagging SNPs can capture the whole genome of that 
subject. Single-nucleotide polymorphisms that lie in proximity on the same chromosome 
are often transmitted together across generations as a block of SNP genotypes (also called 
a haplotype block). Recombination among the SNPs in the haplotype block is infrequent, 
and combining the tagSNPs with the detailed inventory of the haplotype structure of the 
world’s main populations in the HapMap/1000 genomes projects allows the imputation 
of the unmeasured SNPs with high precision. The final set of (imputed) SNPs can be used 
to test genetic association to ANS parameters on a genome-wide scale.
At the time of writing, two GWA studies had been published that focused specifically on 
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the ANS (Fox et al., 2013; Newton-Cheh et al., 2007). In the Framingham Heart Study, 
548 subjects were typed on the Affymetrix 100K SNP chip (Newton-Cheh et al., 2007). 
No genome-wide association test results for SDNN/TP nor for the LF/HF ratio met the 
stern p-value criterion of 5 × 10e-8 commonly applied in GWAS to deal with the huge 
multiple testing burden when half a million SNPs are tested. Taken the current experience 
of the GWA field, this study was a priori underpowered to detect a significant effect of a 
single SNP, which will typically contribute no more than 0.1–0.01 percent to the genetic 
variance in the trait. To detect significant SNP contribution in GWAS, analyses on tens 
to hundreds of thousands of subjects are needed for which whole-genome SNP data 
and ANS traits are available. No single research group can mount such numbers, and 
large GWA consortia have been formed worldwide that exchange their association results 
in an across-study meta-analysis. These meta-analyses have been hugely successful 
(http://www.genome.gov/gwastudies/) for many traits, including cardiovascular risk 
factors (Demirkan et al., 2011; Dehghan et al., 2011; Eijgelsheim et al., 2010; Dupuis et 
al., 2010; Wain et al., 2011).
For this reason, Fox et al. (2013) joined data of nine cohorts on several variables 
related to cardiac structure and systolic function, including ejection fraction, as measured 
by fractional shortening on two-dimensional echocardiography. A genome-wide signi-
ficant hit on chromosome 13 for rs9530176 in KLF5 was found. This locus contains two 
genes that are associated with left ventricular systolic dysfunction and ejection fraction, 
Chromogranin B (CHGB) and forkhead box A2 (FOXA2), respectively. CHGB is involved 
in catecholamine secretion and may contribute to beta-adrenergic effects on contractility. 
FOXA2 controls multiple genes implicated in metabolism-secretion coupling of glucose-
induced insulin release and hyperinsulinemia may ultimately affect ejection fraction 
because of an increase in mitogen-activated protein kinase activity that influences 
myocyte hypertrophy (Fox et al., 2013). 
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Table 1.5. Studies reporting association of candidate genes with measures of autonomic nervous 
system activity.
Reference
ANS 
measure Genetic variant Finding Remarks
Busjahn  
et al., 1998
HF
RMSSD
SDNN
Angiotensin-
converting enzyme 
(ACE)
The DD variant of an insertion
deletion polymorphism was 
associated with increased 
RSA at rest.
Association 
opposite to that 
found in African 
Americans by 
Thayer et al.
Ylitalo  
et al., 2000
BRS Aldosterone 
synthase gene 
(CYP11B2)
BRS became incrementally 
lower with more C-alleles in 
the promoter C-344T SNP.
Findings were 
stronger in women 
than in men.
Shihara  
et al., 2001
VLF Uncoupling 
protein 1 (UCP1)
β3 adrenergic 
receptor (β3AR)
GG homozygotes of the 
UCP1 promoter A-3826G 
SNP had lower VLF at supine 
rest.
The inhibitory 
effect of UCP1 
on VLF was 
observed only with 
occurrence of the 
Trp64Arg variant of 
the β3AR gene.
Suzuki  
et al., 2003
LF
VLF
α-adrenergic 
receptor type 2B 
(ADRA2B)
Short/Short homozygotes 
of a three-amino acid 
deletion polymorphism 
had significantly greater LF 
and VLF than Long/Long 
homozygotes.
Thayer  
et al., 2003
HF Angiotensin-
converting enzyme 
(ACE)
The II variant of an insertion
deletion polymorphism was 
associated with increased 
RSA at rest.
Association 
opposite to that 
found in European 
Americans by 
Busjahn et al.
Stolarz  
et al., 2004
LF/HF
LF
HF
Aldosterone 
synthase 
(CYP11B2)
Supine LF and LF/HF 
increased whereas HF 
decreased with the number 
of T-alleles at the CYP11B2 
C-344T promoter SNP.
Association only 
seen in subjects 
with sodium 
excretion > 190 
mmol.
Stolarz  
et al., 2004
LF/HF
LF
HF
Type-1-angiotensin 
receptor (AT1R)
Orthostatic changes in LF, HF, 
and LF/HF were blunted in 
C-allele carriers of the AT1R 
A1166C SNP.
Association only 
seen in subjects 
with sodium 
excretion > 190 
mmol.
Yasuda  
et al., 2004
HF α-Subunit Gs-
protein (GNAS1)
T-allele carriers at the GNAS1 
T393C SNP had lower supine 
HF, but not standing HF.
Zhang  
et al., 2004
Plasma [E]
Urinary 
[NE]
Tyrosine 
Hydroxylase (TH)
Increased number of the 
(TCAT)10i allele of a repeat 
polymorphism was associated 
with higher levels of plasma E 
and urinary NE.
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Reference
ANS 
measure Genetic variant Finding Remarks
Matsunaga 
et al., 2005
LF/HF G-Protein β3 
Subunit (GNB3)
CC homozygotes for the 
GNB3 C825T SNP had lower 
LF/HF and higher HF/TP 
ratio’s than CT/TT genotypes 
while standing.
Milan et 
al., 2005
BRS Bradykinin β2 
receptor gene 
(B2R)
The BRS increased with the 
number of T-alleles at the B2R 
C258T SNP.
B2R genotype 
was a strong 
independent 
predictor of BRS, 
accounting for 12% 
of its variation.
Neumann 
et al., 
2005, 
2006.
HF
LF
LF/HF
Acetylcholine 
transporter (CHT1, 
SLC5A7)
G-allele homozygotes for a 
CHT1 non-coding 3′ UTR 
SNP (rs333229) had lower HF 
power and higher LF power 
and higher LF/HF ratio.
Same SNP is also 
associated to 
depressed mood 
and brain activity 
in regions of the 
“central autonomic 
network.”
Neumeister 
et al., 2005
Total 
body NE 
spillover
α-Adrenergic 
receptor type 2C 
(ADRA2C)
At rest, homozygotes for the 
Del322-325 polymorphism 
had higher total body NE 
spillover than heterozygotes 
or noncarriers.
The same In-
frame deletion 
of ADRA2C 
increases the risk 
of congestive heart 
failure.
Kurnik et 
al., 2006
plasma 
[NE]
α-Adrenergic 
receptor type 2A 
(ADRA2A)
Two uncommon variants 
(G>C at -1903 and C>G at 
-1607, identified in 3 black 
subjects) were associated 
with higher plasma NE levels.
Nishikino 
et al.,2006
LF Type-1-angiotensin 
receptor (AT1R)
Higher LF in C-allele carriers 
of the AT1R A1166C SNP.
Park et al., 
2006
HF Hemochromatosis 
gene (HFE)
C282Y(rs1800562) and H63D 
(rs1799945) major alleles 
were associated with lower 
HF.
Association was 
conditional on high 
level of particulate 
air pollution.
Matsunaga 
et al., 2007
HF
LF/HF
LF
β-Adrenergic 
receptor type 1 
(ADRB1)
β-Adrenergic 
receptor type 2 
(ADRB2)
At supine rest, ADRB1 Arg16 
homozygotes had lower 
LF/HF and higher HF than 
the Gly16 allele carriers. 
ADRB2 Glu27 allele carriers 
had higher LF than Gln27 
homozygotes.
Newton-
Cheh et 
al., 2007
SDNN α-Adrenergic 
receptor type 1A 
(ADRA1A)
6 SNPs in the gene reached 
significance at classical p <.05
As the SNPs were 
part of a genome-
wide association 
scan, the 
significance level 
may have been too 
liberal.
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Reference
ANS 
measure Genetic variant Finding Remarks
SDNN/TP α-Adrenergic 
receptor type 1B 
(ADRA1B)
1 SNP(rs2195926) in the 
gene reached significance at 
classical p <.05
As the SNP was 
part of a genome-
wide association 
scan, the 
significance level 
may have been too 
liberal.
TP α-Adrenergic 
receptor type 2B 
(ADRA2B)
1 SNP(rs9325124) in the 
gene reached significance at 
classical p <.05
As the SNP was 
part of a genome-
wide association 
scan, the 
significance level 
may have been too 
liberal.
Tingley et 
al., 2007
SDNN Alpha-kinase 
anchoring protein 
10 (AKAP10)
Homozygotes for the G-allele 
(Val) at the AKAP10 I646V 
SNP (rs203462) have lower 
SDNN.
In mice AKAP10 
was shown to 
modulate the 
sensitivity of 
cardiac cells 
to cholinergic 
stimulation.
Baccarelli 
et al., 2008
SDNN  Methylene-
tetrahydrofolate 
reductase (MTHFR)
T-allele carriers of the MTHFR 
C677T SNP (rs1801133) 
had lower SDNN than CC 
homozygotes.
Rao et al., 
2008
plasma 
[NE]
Tyrosine 
hydroxylase (TH)
TH promoter haplotype 
#2 (TGGG) increased NE 
excretion during stress.
Beetz et 
al., 2009
Plasma 
[NE]
G-protein 
regulated 
phosducin (PDC)
Compared with Pdc +/+ 
mice, Pdc -/- mice showed 
elevated catecholamine 
turnover, their post-
ganglionic neurons showed 
prolonged action potential 
firing after stimulation 
with Ach and increased 
firing frequencies during 
membrane depolarisation 
Pdc -/- mice also 
showed greater 
increases in BP 
in response to 
stress compared 
with Pdc +/+ 
mice. And in two 
different human 
populations, 
several SNPs in the 
PDC gene were 
associated with 
stress-induced BP 
reactivity
Matsunaga 
et al., 2009
HF
LF/HF
Uncoupling 
proteins 2 & 3 
(UCP2, UCP3)
At supine rest the II variant 
of the UCP2 45-bp insertion/
deletion polymorphism was 
associated higher LF/HF ratio.
Carriers of the T-allele of the 
UCP3 S55 C/T SNP had lower 
LF/HF ratio and higher HF 
than CC homozygotes.
The II variant 
of the UCP2 
insertion/deletion 
polymorphism was 
also associated 
with higher blood 
pressure.
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ANS 
measure Genetic variant Finding Remarks
Neumann 
et al., 2009
SDNN
RMSSD
Alpha-kinase 
anchoring protein 
10 (AKAP10)
G-allele (Val) carriers at 
the AKAP10 I646V SNP 
(rs203462) have lower SDNN 
and RMSSD.
SDNN exactly 
replicates Tingley 
et al., 2007
Rana et al., 
2009
plasma [E] Nicotinic 
acetylcholine 
receptor (CHRNA)
CHRNA3 K95K (G) allele 
(rs3743075) was associated 
with higher E levels.
Su et al., 
2009a
ULF C-reactive protein 
(CRP)
Subjects homozygous for the 
T-allele at CRP SNP rs1205 
had higher ULF than CC 
homozygotes.
The SNP was 
significantly 
associated with 
both CRP and ULF 
and explained 11% 
of their genetic 
covariance.
Viola et al., 
2009
SDNN
LFnu
Circadian clock 
gene PERIOD3
(PER3)
Homozygotes for the longer 
allele (5/5) in a variable 
number tandem repeat 
polymorphism in the coding 
region of PER3 had higher 
LFnu and lower SDNN
compared to 4/4 
homozygotes, in particular 
during baseline sleep.
The PER3 VNTR 
polymorphism also 
affected slow wave 
sleep duration.
Boccardi 
et al., 2010
Transcription factor 
7-like 2 (TCF7L2)
TT homozygotes of a TCF7L2 
G/T SNP (rs12233572) had 
higher LF/HF ratio during 
glucose ingestion compared 
to heterozygotes and CC 
homozygotes.
No effects of the 
TCF7L2 SNP were 
found on baseline 
LF/HF.
Ellis et al., 
2010
HF Serotonin 
transporter  
(5-HTT) repeat 
polymorphism
The short variant of the 
5-HTTLPR was associated 
with lower HF at rest.
Matsunaga 
et al., 2010
HF
LF
VLF
TP
Estrogen receptor 
α gene (ESR1)
Haplotype analysis based 
on the PvuII and XbaI 
polymorphisms showed that 
ESR1 haplotype 2 (PvuII C 
allele and XbaI A allele) had 
lower TP, VLF, LF, and HF at 
supine rest.
Carriers of the 
ESR1 haplotype 2 
also had a higher 
systolic and mean 
arterial blood 
pressure.
Probst-
Hensch et 
al., 2010
TP
LF
Glutathione 
S-transferase (GST)
Participants missing both 
copies of the GSTT1 gene 
had lower TP and LF.
Yang et al., 
2010
HF
RMSSD
LF/HF
Brain-derived 
neurotrophic
factor (BDNF)
Met/Met homozygotes 
at the BDNF Val66Met 
polymorphism had lower HF, 
RMSSD and higher LF/HF 
ratio compared to the Val/Val 
homozygotes.
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Reference
ANS 
measure Genetic variant Finding Remarks
Hunt-
geburth  
et al., 2011
Fractional  
shortening 
(FS) Rate-
corrected 
velocity  
of circum-
ferential 
fiber 
shortening 
(Vcfc)
Arg389Gly β1-
adrenoreceptor 
gene 
polymorphism
Homozygous Arg389 carriers 
showed significant higher FS 
at baseline. In response to 
dobutamine treatment both 
FS and Vcfc were higher in 
the homozygous Arg389 
carriers. Pre-treatment with 
metropolol decreased the 
levels of the Arg/Arg carriers 
to the levels of the Gly-
carriers. 
In Arg/Gly or Gly/
Gly participants, 
modest effects 
of dobutamine-
induced increase 
in FS only at low 
not at higher 
concentrations of 
dobutamine was 
found after pre-
treatment with 
metropolol 
Nagai  
et al., 2011
VLF
LF
HF
TP
Uncoupling 
protein 1 (UCP1)-
3826 A/G
G/G carriers showed lower 
VLF
Adam  
et al., 2014
SDNN
TP
ULF
VLF
LF
HF
LF/HF
Functional 
IL-6-174 G/C 
polymorphism
Compared with IL6-174 
GG genotypes, participants 
with one or no G-risk allele 
showed higher SDNN, TP, 
and lower LF/HF.
An inverse 
association 
between traffic-
related particulate 
matter exposure 
and the IL6-
174 G/C on 
change in HRV 
was found with 
higher exposure 
being related to 
lower SDNN and 
LF for -174 GG 
genotypes. 
Chang  
et al., 2014
RMSSD
TP
VLF
LF
HF
LF/HF
BDNF Males bearing the Val/Val 
genotype had higher LF 
and LF/HF ratio, compared 
to Met/Met homozygotes 
at the BDNFVal66Met 
polymorphism.
Females showed 
the opposite 
association, but 
nonsignificant 
Chang  
et al., 2014
HF
RMSSD
Functional 
nerve growth 
factor (NGF) 
polymorphism
Males with any T-allele 
showed lower HF and RMSSD 
compared to men with the 
C/C genotype.
Females showed 
the opposite 
association, but 
nonsignificant 
Seppälä  
et al., 2014
LF
HF
LF/HF
Alanine-glyoxylate 
aminotransferase 2 
(AGXT2)
Both rs37369 and rs16899974 
were associated with LF/
HF and rs16899974 was 
additionally associated with 
the HF component alone.
This finding was 
part of a GWAS in 
which symmetric 
dimethylarginine 
(SDMA) levels 
were significantly 
associated with 
both AGXT2 
variants. 
NE, norepinephrine; E, epinephrine
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Conclusion
Although the molecular genetics of ANS activity remains to be elucidated in full, twin 
studies demonstrate significant genetic contributions to the main indices of the SNS and 
PNS. For the main indicator of cardiac vagal activity, RSA, heritability estimates range 
between 25 and 71 percent and for a second indicator, BRS, heritability estimates range 
between 22 and 53 percent. For the SNS, diverse indicators of activity to different organs 
converge on an even more substantial contribution of genetic factors. Heritability of 
plasma and urinary norepinephrine varied between 42 and 76 percent, heritability of 
epinephrine levels between 64 and 74 percent, heritability of nsSCR/SCL between 26 and 
43 percent, and heritability of PEP between 48 and 74 percent. 
This thesis
A weakness of the research conducted so far is that the majority of studies on the genetics 
of ANS activity have focused on laboratory recordings. Laboratory studies generally 
involve the measurement of ANS activity during one or more rest periods and during 
mental and physical challenges, with each period often lasting no more than 5–15 
minutes. Such studies have been instrumental in establishing the existence of stable 
individual differences in basal ANS activity and its responses to stress. However, these 
individual differences in ANS (re)activity may not transfer well to actual real-life situations 
because the association between laboratory and ambulatory measurements has been 
shown to be moderate at best (Gerin, Rosofsky, Pieper, & Pickering, 1994; Johnston, 
Tuomisto, & Patching, 2008; Kamarck, Debski, & Manuck, 2000; Kamarck & Lovallo, 2003; 
van Doornen, Knol, Willemsen, & de Geus, 1994). It is possible that the psychological and 
physiological processes induced by laboratory conditions are only a poor reflection of the 
actual processes in everyday real-life situations. Perhaps as a consequence, the predictive 
value of cardiovascular reactivity to laboratory challenges for future CVD is low, with the 
response to a challenge hardly contributing to the prediction of disease when basal levels 
have been taken into account (Barnett, Spence, Manuck, & Jennings, 1997; Carroll et 
al., 1998; Coresh, Klag, Mead, Liang, & Whelton, 1992). As an alternative to bringing 
“everyday situations to the laboratory,” researchers have increasingly tried to bring the 
“laboratory to everyday situations.” This is done by using miniaturized versions of the 
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recording equipment to perform prolonged ambulatory monitoring in naturalistic settings 
(Fahrenberg, Myrtek, Pawlik, & Perrez, 2007; Houtveen & de Geus, 2009; Wilhelm & 
Grossman, 2010). The expectation is that ambulatory measurement of physiological levels 
and reactivity in the natural environment will lead to better prediction of morbidity and 
mortality. For blood pressure, the added value of the ambulatory approach has already 
been amply demonstrated (Mallion, Baguet, Siche, Tremel, & De, 1999; Palatini & Julius, 
2004; Verdecchia, 2000; Verdecchia, Schillaci, Reboldi, Franklin, & Porcellati, 2001).
For the research project described in this thesis, an already existing dataset of 816 
adult participants with 24-h ANS activity measurements collected between August 1998 
and June 2003 (ANS Study 1, [Kupper et al., 2006; Kupper et al., 2005]) was further 
expanded with a new data collection round in 592 adult participants between November 
2010 and June 2012 (ANS Study 2). This led to a unique dataset large enough to allow 
extensive genetic analyses. Data from these two studies was used to investigate the 
role of genetic and environmental factors in individual differences in ambulatory levels 
and reactivity (calculated as the absolute difference between ambulatory rest and stress 
levels) of the two main indicators of ANS activity, PEP and RSA. Between these two 
ANS studies, the NTR undertook a large biobank study, assessing biodata from blood 
samples in over 9000 twins and their family members between January 2004 and July 
2008 (Willemsen et al., 2010). Data of all three studies was combined to investigate the 
prospective bi-directional association between ambulatory PEP/RSA level and reactivity 
and pro-inflammatory and metabolic risk factors. In chapter 2, an overview of the data 
and variables that were used for the current research project is provided. The main focus 
is on the data collection procedures for ANS Study 2, as this data was collected within the 
current PhD project. 
In the research described in chapter 3, data of the two large 24-h ambulatory ANS 
studies was combined to explore heritability of the three most commonly used HRV 
measures in the largest ambulatory dataset to date. Because previous research has shown 
that ceiling effects may strongly impact HRV at low heart rates - a result that was recently 
confirmed by our group (van Lien et al., 2011), a secondary goal of this research was to 
test whether these effects confounded heritability estimates, at different levels of physical 
activity. 
Chapter 4 focuses on the quantification of ambulatory ANS reactivity to real-life 
situations. ANS activity during real life stress is typically measured during a concrete event 
or stressor taking place in the daily life of the subject. In this chapter, we systematically 
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explored the possibilities of capturing real life stress in unstructured settings without 
preset (stressful) events. Several resting baseline and periods of stress were quantified 
and the temporal stability and heritability of these measures was inventoried. We further 
tested whether we could replicate the increase in genetic variance when going from rest 
to stress, as previously observed in a laboratory setting (de Geus et al., 2007). 
In chapter 5, several clinically relevant cardiac repolarization and depolarization 
parameters were extracted from the continuous ECG registrations that were assessed in 
the second 24-hour ambulatory ANS study. The reliability of this approach was inventoried 
by researching the heritability of these parameters and by comparing the heritability 
estimates to those of the same parameters obtained from a typical 10 sec resting ECG 
as commonly used in clinical practice. Among the repolarization parameters studied was 
the T-wave amplitude (TWA). Because of its alleged link to sympathetic influences on 
cardiac repolarization, the TWA was recently coined as a valuable addition to the PEP 
in characterizing cardiac sympathetic activity (van Lien, Neijts, Willemsen, & de Geus, 
2015). As heart rate was a major co-determinant of TWA, we specifically tested whether 
the same or different genetic factors operated on repolarization at different heart rates. 
Furthermore, it was tested whether the same or different genetic factors were at the basis 
of the different repolarization parameters. 
In chapter 6, focus temporarily shifted from ANS functioning to inflammation 
processes, more specifically to pro-inflammatory activity which forms yet another impor-
tant correlate of cardiovascular disease risk. The heritability of the plasma levels of two 
important cytokines and two acute phase reactants was assessed in an extended twin 
design which included not only twins and their siblings, but also the mothers and fathers 
of the twins. Various sources of noise were taken into account (batch effects, oral contra-
ception-induced or cyclic variation in estrogen, and seasonal variation) after which the 
heritability of these parameters was established. These data were then used in chapter 7 
to research the prospective association between ambulatory ANS level and reactivity, 
and pro-inflammatory and metabolic risk in two independent tests. In the first test ANS 
functioning was linked to inflammatory and metabolic risk factors measured 4.9 years 
later. In the second test the reverse association was researched linking inflammatory and 
metabolic risk to ANS functioning measured 5.4 years later.
Chapter 8 summarizes the main results of this thesis and provides new hypotheses 
for future cardiovascular research regarding the causes and consequences of ANS 
regulation in daily life.

Chapter 2 
Research design and data collection
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All data used in this project was collected in participants who were registered with the 
(adult) Netherlands Twin Register (NTR). Since 1991, ongoing large-scale longitudinal data 
is being collected by means of surveys on health, lifestyle and personality and through 
experimental projects in which data on biological, psychological and/or behavioral 
processes are actively collected. For an overview of the data that is collected in adults by 
the NTR, see Willemsen et al. (2013). For this project we used data from a large biobank 
study conducted by the NTR and two large 24-hour ambulatory ANS studies. The first 
ambulatory ANS study took place between August 1998 and June 2003 (ANS Study 1) 
and biobank data was collected between January 2004 and July 2008. As part of this 
PhD project, additional ambulatory 24-hour ANS data was collected between November 
2010 and June 2012 (ANS Study 2). Figure 2.1 gives an overview of these three studies. A 
total of 465 participants who took part in the first ambulatory ANS study, also took part in 
the biobank study and all participants participating in the second ambulatory ANS study, 
were selected based on participation in the biobank study.
Figure 2.1. Overview of the data(structure) used for this thesis.
1998 -2003  
ANS Study 1 - wave 1 & 2 
 
Ambulatory ANS  
Recordings 
 
Cortisol 
 
Demographic, lifestyle, and 
physical and mental health 
assessment 
 
N = 797 
2004 – 2008 
Biobank Study 
 
 
DNA and Biomarker 
Assessment 
 
 
Demographic, lifestyle, and 
physical and mental health 
assessment 
 
N = 9 530 
2010 – 2012 
ANS Study 2 – wave 3 
 
Ambulatory ANS  
Recordings 
 
Cortisol 
 
Demographic, lifestyle, and 
physical and mental health 
assessment 
 
N = 592 
Follow-up 
 
 N = 592 
Follow-up 
 
 N = 465 
ANS Study 1 - wave 2 
 
Retest study 
 
Demographic, lifestyle, 
and physical and 
mental health 
assessment 
 
N = 62 
The study protocol and the data collection for the two ambulatory studies was essentially 
the same. The main differences between the first ANS data collection round and the second 
one, is that software and hardware improvements have been made over time. The ANS 
assessments in Study 2 were performed with an improved version of the VU Ambulatory 
Monitoring System (VU-AMS) and, compared with Study 1, the protocol of Study 2 was 
complemented by several (subscales of) questionnaires concerning physical health and 
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psychological wellbeing. We also made some changes in the protocol concerning the 
cortisol data collection. For more detailed information on the previous ANS study, you 
are referred to the dissertations of Mireille van den Berg who was involved in the first 
wave of data collection of Study 1 (van den Berg, 2002), Nina Kupper who was involved 
in the data collection of wave 2 of Study 1 (Kupper, 2005), and Annebet Goedhart who 
was mainly involved in the retest part of this study (Goedhart, 2008). Below, a detailed 
description of the research set up and protocol for the current 24-hour ambulatory ANS 
study is provided, followed by a brief overview of the biobank study.
Figure 2.2. Overview of the subject selection for the current ambulatory ANS recording study.
N = 107 
Reached by phone? 
N = 873 
no 
N = 766 
yes 
-  Not reached at all (82) 
-  Not reached anymore  
   after first contact (17) 
-  Living abroad (8) 
Met inclusion criteria? 
N = 136 N = 592 
N = 38 N = 728 
no yes 
-  Pregnant (17) 
-  Cardiovascular disease (6) 
-  Other disabling disease (5) 
-  Not able to conform to  
   protocol because of work (10) 
Interested in participation? 
no yes 
-  Too demanding (14) 
-  Too busy/not interested (68) 
-  No participation because family did not participate (11) 
-  Reason not specified (43) 
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Ambulatory ANS Study 2
Participants
Healthy twins aged between 21 and 50, and non-twin siblings within an age range of 
three years of the twins were considered eligible. Additional requirements were that they 
had also participated in the biobank study and that they had not participated in the first 
ambulatory ANS study. Furthermore, only participants with DNA data for at least two 
multiples within the family were selected for participation. The resulting sample was then 
pre-screened for known cardiovascular disease or other disease related states that could 
compromise the ambulatory recordings (i.e. multiple sclerosis). This screening was based 
on their health status as assessed during the biobank study. A total of 873 participants 
that met the inclusion criteria were contacted for participation in the current ANS Study. 
Ultimately, 592 (81.3%) of the 728 participants who were reached by phone and who met 
the inclusion criteria as verified by telephone interview participated in the current study 
(see figure 2.2 for an overview).
Testing procedure
All participants that were eligible for participation received a letter by mail informing 
them about the study and providing them with background information. The invitation 
letter and brochure are in Appendix I. About one to two weeks after the invitations 
were sent, participants received a phone call and were asked if they were interested in 
participating in the current study. During the phone call their health status was shortly 
screened. A priori reasons for exclusion were pregnancy (until half a year after delivering 
the baby), heart transplantation, presence of a pacemaker, known ischemic heart disease 
or congestive heart failure or other physical complaints that could compromise the 
ambulatory assessment (i.e. severe illness, broken leg). When the inclusion criteria were 
met, an appointment was made on a representative weekday, preferably a working day. 
The appointment was then confirmed in a letter (Appendix II) which was accompanied by 
the informed consent form (Appendix III), three Salivettes, instructions for saliva collection 
(Appendix IV) and a survey. Included in the survey were a questionnaire on sleep quality 
(Pittsburgh Sleep Quality Index, Buysse, Reynolds III, Monk, Berman, & Kupfer, 1989), life 
events, and neuroticism and extraversion were assessed by means of the Amsterdamse 
Biografische Vragenlijst which is a personality questionnaire similar in content to the 
Eysenck Personality Questionnaire (Eysenck & Eysenck, 1975). Participants were asked 
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to fill out the survey the day(s) prior to the ambulatory recording. They were asked to 
refrain from excessive physical exertion the day prior to the ambulatory recording and 
on the recording day itself. On the first morning of the testing day, participants collected 
two fasting saliva samples; the first one was collected immediately after awakening. The 
second was collected 30 minutes later. They were then visited by the researcher and the 
research assistant in the morning, between 6 am and 12 pm at home, or when preferred 
at work. Figure 2.3 shows an overview of the testing day. 
During the visit, the procedure was explained, the informed consent was signed 
and the Salivettes that were used prior to the visit were collected. The researcher then 
conducted an interview on socioeconomic status, lifestyle and health status, including an 
inventory of medication use, current health complaints and adherence to the protocol. 
Meanwhile participants were asked about their height, weight was measured with a 
calibrated scale, and waist and hip circumference were assessed using measuring tape, 
and consecutively the VU-AMS was attached by the research assistant (see Appendix V 
for the interview/protocol of the visit). After this, participants were asked to sit down in a 
secluded part of the house/work area, they were attached with a blood pressure monitor 
and asked to fill out a second survey about their perceived quality of life (Cantril, 1965), 
life satisfaction (Satisfaction with Life Scale, Diener, Emmons, Larsen, & Griffin, 1985), 
anxiety by means of the Young Adult Self Report (Verhulst, Van der Ende, & Koot, 1997) 
and the State Trait Anxiety Inventory (Van der Ploeg, Defares, & Spielberger, 1979), and 
a questionnaire assessing self-esteem (Rosenberg Self-Esteem Scale, Rosenberg, 1965). 
Consecutively, two 2-min cognitive performance (mental stress) tasks were completed 
(the Stroop Colour/Word Test and the Serial Substraction Task). Blood pressure was 
assessed twice during the resting period while the participant filled out the survey, and 
twice during the stress period, once during each task. The total protocol took about 
45 minutes. Finally, participants received a diary (Appendix VI), that also included the 
shortened Dutch version of the Profile of Mood States (POMS) that contains 32 items (Wald 
& Mellenberg, 1990), and a questionnaire on their perceived sleep quality concerning the 
night of the ambulatory recording (GSKL, Groningse Slaap Kwaliteit Lijst Meijman, de 
Vries-Griever, de Vries, & Kampman, 1988). They were additionally provided with three 
more Salivettes, and instructions for the rest of the day, the following night and the next 
morning. 
During waking hours, participants were asked to chronologically report about their 
activities, social situation, location and posture every 60-min in the diary to relate to the 
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continuously recorded tri-axial accelerometer and ECG signals of the VU-AMS device. At 
11.30 pm, or earlier if participants wanted to go to bed earlier, participants were asked to 
collect one saliva sample after a 30-min period of fasting. At the end of the day, before 
going to bed, they were asked to fill out the POMS. The next morning, participants 
collected two fasting saliva samples again, the first one immediately after awakening 
and the second one half an hour later. They additionally filled out the GSKL. After having 
worn the ambulatory recording device for 24 hours, participants detached the VU-AMS 
themselves. The VU-AMS, the diary and the saliva samples were then sent back by mail 
to the VU University Amsterdam. 
Figure 2.3. Overview of the testing day.
       0                           6                       12                     18            24 
T -1 Awakening 
Cortisol 1 
T -0.5 Awakening + 30 
Cortisol 2 
T 0 Home visit 
Interview 
Body measurements  
Blood pressure 
Connecting VU-AMS device 
Questionnaire 2 
Stroop Colour/Word Test 
Serial Subtraction Task 
T 15 Sleep 
Cortisol 3 
POMS 
T 23 Awakening 
Cortisol 4 
Sleep Quality Questionnaire (GSKL) 
T 23.5 Awakening + 30 
Cortisol 5 
T 24 End of testing day 
Disconnecting  VU-AMS 
Time 
The Salivettes were stored immediately at -20˚C upon arrival at the VU. They were sent 
to the laboratory in Dresden for cortisol determination in two waves, once after the first 
year of data collection (fall 2011) and once after the second year, at the end of the data 
collection (fall 2012). 
The ANS data was visually inspected immediately after delivery of the device by 
mail. The ECG signal was checked and scored, and generally within two weeks, the 
participants received a report on their blood pressure and their heart rate during the 24-
hour ambulatory recording (see Appendix VII for an example). The respiration, RSA, and 
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impedance signals were scored at the end of the data collection. Methods on how the 
ECG and ICG signals were derived with the VU-AMS and details on how this data was 
scored is outlined in the chapters specifically focusing on these measures. Table 2.1 gives 
an overview of the variables we extracted from the 24-h ECG and ICG for this research 
project. 
Table 2.1. The ANS variables extracted from the ECG and ICG that were used in this research project.
Measures From Comment
Heart rate,
Heart Rate Variability (SDNN, RMSSD, 
HF-IBI power, LF IBI-power, VLF-IBI power, 
peak-valley RSA), Respiration Rate
Ambulatory ECG & 
respiration signal;  
24-hour recording
HF, RSA, and RMSSD 
assess relatively pure 
cardiac vagal control.
Pre-ejection period (PEP) Ambulatory ECG & 
ICG signal; 24-hour 
recording
PEP assesses relatively 
pure cardiac sympathetic 
control.
T-Wave Amplitude (TWA) Ambulatory ECG signal TWA is associated more 
strongly with PEP than 
with RSA
 
Data loss
Of the 592 participants who wore the VU-AMS device, VU-AMS data of 16 participants 
were discarded for the following reasons: Data of one participant were missing because 
we never received back the device. ECG and ICG data of four participants were lost 
due to equipment failure, data of eight participants were discarded because their ECG 
showed many arrhythmias or preventricular contractions, and data of three participants 
were excluded because we did not receive back the diary. The resulting sample 
comprised 297 families with 576 family members, of which 3 participants were triplets 
and 518 participants were twins: 282 MZ twins (128 complete pairs) and 236 DZ twins (98 
complete pairs). Furthermore, 55 non-twin siblings, 21 brothers and 34 sisters, of twins 
participated (see Table 2.2). 
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Biobank study 
For the biobank study, a total of 9 530 adult twins and their family members were visited 
between 7 am and 10 am at home or, when preferred, at work, to collect fasting blood 
and urine samples. They were instructed to abstain from physical exertion and, if possible, 
not to take medication at the day of the home visit, and to refrain from smoking one hour 
before the home visit. Fertile women were visited on the 2nd-4th day of their menstrual 
cycle or, if they took oral contraceptives, in their pill-free week. During the home visit, a 
brief interview was conducted on health status, including an inventory of medication use, 
illness (last time occurrence, duration and type of illness), and adherence to the protocol. 
Also, height, weight and waist circumference were assessed. Blood tubes were collected 
in the following order; 2 × 9 ml EDTA, 2 × 9 ml heparin, 1 × 4.5 ml CTAD, 1 × 2 ml EDTA, 
1 x 4.5 ml serum. From these samples, the levels of several biomarkers were determined, 
including inflammatory and metabolic parameters. Table 2.3 provides an overview of the 
biomarkers that were used in this project. For more details about this study, you are 
referred to the paper of Willemsen et al. (2010), which gives an overview of the data that 
was collected during this study.
Table 2.2. Family composition ANS Study 2.
Number of additional non-twin siblings
0 1 2 3 Total
MZ Twin pair 112 13 3 - 128
Single twin 23 3 - - 26
DZ Twin pair 84 10 2 2 98
Single twin 33 5 2 - 40
Triplet 1 - - - 1
No twin - 4 - - 4
Total number of families 253 35 7 2 297
 Research design and data collection 45
2
Table 2.3. Variables that were collected in the biobank study and used in this thesis.
Measures From
Pro-inflammatory markers
Tumor Necrosis Factor (TNF)-
alpha, Interleukin-6 (IL-6)
EDTA plasma, using an UltraSensitive ELISA (R&D systems, 
Minneapolis, USA, Quantikine HS HSTA00C)
C-Reactive protein (CRP) CRP was measured in heparin plasma, using Immulite 1000 
CRP assay (Diagnosic Product Corporation, USA)
Fibrinogen Fibrinogen levels were measured in citrate plasma, on a STA 
Compact Analyzer (Diagnostica Stago, France), using STA 
Fibrinogen (Diagnostica Stago, France)
Metabolic markers
Fasting glucose Glucose was measured using the Vitros 250 Glucose assay 
(Johnson & Johnson, Rochester, USA)
Total Cholesterol (TC), High 
Density Lipoprotein Cholesterol 
(HDL-C), Triglycerides (Trig)
TC, HDL-C, and triglycerides were measured in heparin 
plasma, using Vitros 250 direct HDL cholesterol and Vitros 250 
Triglycerides assays (Johnson & Johnson, Rochester, USA)
Low Density Lipoprotein 
Cholesterol (LDL-C)
LDL-C was calculated using the Friedewald Equation 
(Friedewald, 1972)

Chapter 3 
Heritability of cardiac vagal control in 
24-hour heart rate variability recordings: 
Influence of ceiling effects 
at low heart rates 
This chapter is published as:
Neijts, M. van Lien, R., Kupper, N., Boomsma, D. I., Willemsen, G., 
& de Geus, E. J. C. (2014). Heritability of cardiac vagal control in 24-hour 
heart rate variability recordings: Influence of ceiling effects at low heart rates. 
Psychophysiology, 51, 1023-1036.
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Abstract
This study estimated the heritability of 24-h heart rate variability (HRV) measures, 
while considering ceiling effects on HRV at low heart rates during the night. HRV 
was indexed by the standard deviation of all valid interbeat intervals (SDNN), the 
root mean square of differences between valid, successive interbeat intervals 
(RMSSD), and peak-valley respiratory sinus arrhythmia (pvRSA). Sleep and waking 
levels of cardiac vagal control were assessed in 1,003 twins and 285 of their non-
twin siblings. Comparable heritability estimates were found for SDNN (46%-53%), 
RMSSD (49%-54%), and pvRSA (48%-57%) during the day and night. A nighttime 
ceiling effect was revealed in 10.7% of participants by a quadratic relationship 
between mean pvRSA and the interbeat interval. Excluding these participants did 
not change the heritability estimates. The genetic factors influencing ambulatory 
pvRSA, RMSSD, and SDNN largely overlap. These results suggest that gene 
finding studies may pool the different cardiac vagal indices and that exclusion of 
participants with low heart rates is not required. 
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Introduction
Reduced heart rate variability (HRV) is a predictor for all-cause mortality and adverse car dio-
vascular events, including atrial fibrillation, myocardial infarction, congestive heart failure, 
and coronary artery disease in pre-morbid populations and samples of cardiac patients 
(Bigger, Jr., Fleiss, Rolnitzky, & Steinman, 1993; Bigger, Jr. et al., 1992; Bigger, Jr., Hoover, 
Steinman, Rolnitzky, & Fleiss, 1990; Buccelletti et al., 2009; Dekker et al., 1997; Dekker et al., 
2000; Kleiger, Miller, Bigger, Jr., & Moss, 1987; Singer et al., 1988; Tsuji et al., 1996; Vikman 
et al., 2003). A proposed mechanism that can explain the risk conveyed by low HRV is that it 
reflects a decrease in cardiac vagal activity which increases the chance of arrhythmic events 
(La Rovere et al., 2001; Schwartz, Billman, & Stone, 1984; Schwartz et al., 1988). 
A useful noninvasive measure of vagal activity is the HRV in the respiratory frequency 
range (0.15-0.4 Hz), also called respiratory sinus arrhythmia (RSA). RSA is generated when 
tonic firing of motor neurons in the nucleus ambiguus is modulated by phasic inhibition 
and excitation coupled to the respiratory cycle (Berntson, Cacioppo, & Quigley, 1993). 
This modulation is caused by connections between the nuclei that control the respiratory 
generator in the pre-Bötzinger and Bötzinger complexes and the vagal motor neurons, 
which lie in close proximity in the brainstem (Rekling & Feldman, 1998) and is further 
influenced by input from baro-, mechano-, and chemoreceptors. Respiration-autonomic 
nervous system (ANS) coupling yields an oscillatory pattern in the release of acetylcholine 
in the sinoatrial (SA) node, such that acetylcholine levels increase during expiration and 
decrease during inspiration. The effect of this respiratory ‘gating’ (Eckberg, 2003) is that 
heart rate increases during inspiration and decreases during expiration. The effect of 
the respiratory-related changes in vagal gating on RSA shows relatively little sensitivity 
to sympathetic blockade but is affected in a dose-response way by muscarinic blockers 
in humans (Martinmaki et al., 2006) and vagal cooling in animals (Katona & Jih, 1975). 
This has led to the use of RSA as a proxy for individual differences in cardiac vagal 
activity (Berntson et al., 1997; Task Force of the European Society of Cardiology and 
the North American Society of Pacing and Electrophysiology, 1996), although it must 
be acknowledged that differences in the sensitivity of the muscarinic receptor signaling 
pathway and differences in respiratory behavior can influence RSA independently of true 
differences in cardiac vagal activity (Grossman & Kollai, 1993; Grossman, Wilhelm, & 
Spoerle, 2004; Ritz & Dahme, 2006). RSA, therefore, is more appropriately considered a 
measure of cardiac vagal control, rather than of vagal activity.
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RSA can be measured directly from the combined ECG and respiration signal as peak 
valley RSA (pvRSA), but two HRV measures derived only from the interbeat interval (IBI) 
time series are also often used to index vagal control over the heart, namely the standard 
deviation of all valid IBIs (SDNN) and the root mean square of differences between valid, 
successive IBIs (RMSSD). Age is a major source of interindividual differences in cardiac 
vagal control, with younger participants having higher RSA levels than older participants 
across the entire adolescent/adult age range (de Geus et al., 2007; De Meersman & 
Stein, 2007; Quilliot, Fluckiger, Zannad, Drouin, & Ziegler, 2001; Vallejo, Marquez, Borja-
Aburto, Cardenas, & Hermosillo, 2005). Sex, BMI and lifestyle variables like smoking and 
regular exercise have also been shown to affect RSA, although these effects are generally 
modest (de Geus et al., 2007; De Meersman & Stein, 2007; McNarry & Lewis, 2012; 
Sacknoff, Gleim, Stachenfeld, & Coplan, 1994; Umetani, Singer, McCraty, & Atkinson, 
1998; Valentini & Parati, 2009; van Lien et al., 2011). 
In contrast, a substantial portion of the interindividual variance in RSA appears to 
be due to genetic variation. Twin studies that record RSA in quiet resting conditions in the 
laboratory systematically reported a significant genetic contribution to RSA (Boomsma et 
al., 1990; de Geus et al., 2007; Riese et al., 2006; Riese et al., 2007; Snieder et al., 1997; 
Tank et al., 2001; Tuvblad et al., 2010; Uusitalo et al., 2007; Wang et al., 2009; Wang 
et al., 2005; Zhang et al., 2007). Heritability estimates at rest range from 25% to 71%. 
Ambulatory studies report heritabilities ranging from 35% to 65% (Busjahn et al., 1998; 
Kupper et al., 2004; Kupper et al., 2005) and from 35% to 55% when confined to sleeping 
or sitting conditions only (Kupper et al., 2004; Kupper et al., 2005). Estimates were very 
similar for European and African Americans (Wang et al., 2005), across the three different 
measures used (Goedhart, van der Sluis, Houtveen, Willemsen, & de Geus, 2007; Kupper 
et al., 2004), and none of these twin studies reported a sex difference in heritability or 
evidence for different genes being expressed in males and females. 
Interestingly, three independent studies that measured cardiac vagal control at rest 
during a series of mental stressors all reported increased genetic variance in these measures 
under stress (Riese et al., 2006; de Geus et al., 2007; Wang et al., 2009). Compared to the 
heritability of resting baseline levels, the genetic contribution to the variance in measures 
of vagal control increased on average up to 10-20% when participants were exposed to 
various stress tasks. These findings have been taken to suggest that genetic influences 
on cardiac vagal control become more pronounced when the participant is challenged 
by mentally and emotionally ‘engaging’ conditions, i.e. they seem to provide evidence 
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of Gene x Stress interaction (de Geus et al., 2007). This would lead to the prediction that 
RSA heritability estimates might vary across an ambulatory recording day, for instance 
by being higher during daytime than at night. In addition, physical stressors may also 
give rise to higher genetic variance, as vagal withdrawal may not be as strong in each 
individual. Therefore, across the daytime, heritability of RSA measures may be lower 
during sitting conditions than during more physically active conditions.
Previous ambulatory twin studies have only indirectly addressed these questions and, 
importantly, failed to take into account the key observation that RSA can be paradoxically 
lowered at very low heart rates due to ceiling effects (Malik & Camm, 1993; van Lien 
et al., 2011). Normally, respiratory gating will result in a larger difference between the 
shortest IBI in inspiration and the longest IBI in expiration if tonic levels of vagal control 
over the heart are larger (Berntson et al., 1993; Eckberg, 2003). However, when cardiac 
vagal control is very high, a ceiling effect may prevent the lengthening of the IBI during 
expiration more than during inspiration (Malik & Camm, 1993). The biological basis of this 
ceiling effect is that high cardiac vagal control causes a large occupancy of the available 
muscarinic receptors on the SA node, and at this level of saturation any further increases 
in acetylcholine may no longer linearly increase the IBI as it would at low to moderate 
levels of cardiac vagal control (illustrated in Figure 3.1). As expiration is characterized by 
higher vagal control than inspiration the beats during expiration suffer more strongly from 
the ceiling effect than beats during inspiration. 
Figure 3.1. Graphical representation of the occurrence of a ceiling effect, showing that there is little 
room left for RSA at very long inter beat intervals (IBIs).
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This ceiling effect is expected to cause a quadratic relationship between IBI and RSA at 
low heart rates. This quadratic shape of the IBI-RSA relationship has indeed been found in 
laboratory studies inducing variance in vagal control by phenylephrine and nitroprusside 
infusion (Goldberger, Challapalli, Tung, Parker, & Kadish, 2001). More recently, the 
occurrence of the quadratic shape was shown under naturalistic settings in 24-hour 
recordings (van Lien et al., 2011). In a subset of 13 out of 52 participants, with half of them 
selected as being engaged in regular vigorous exercise, a ceiling effect on RSA was found 
during the nighttime. Based on these findings it was hypothesized that cardiac vagal 
control in conditions of low heart rate levels will be underestimated by RSA in participants 
with a quadratic shape of the IBI-RSA relationship compared to participants with a linear 
shape of the IBI-RSA relationship (van Lien et al., 2011). Here, we further hypothesize that 
the variation in the shape of the IBI-RSA curve may lead to an underestimation of the 
heritability of nighttime cardiac vagal control when it is based on RSA measures.
In this study we aim to test whether heritability of RSA at night differs from that of 
daytime RSA during sitting and physically active conditions. For this, we use the largest 
sample with 24-h ambulatory cardiac recordings to date. We assessed the shape of the 
IBI-RSA relationship in 24-h ambulatory recordings of 486 monozygotic (MZ) twins, 517 
dizygotic (DZ) twins, and 285 of their singleton siblings. Based on the scatter plots of 
the mean of RSA and IBI in 10-min bins we made a qualitative distinction between linear 
IBI-RSA shapes showing no evidence of ceiling/saturation effects and quadratic IBI-RSA 
shapes suggesting reduction of RSA at long IBIs through ceiling/saturation effects. First, 
heritability of three often used RSA measures were computed during sleep and daytime by 
comparing MZ and DZ/sibling resemblance using the established twin methodology (Neale 
& Cardon, 1992). Next, heritability estimates of these RSA measures were re-estimated 
after removing the participants with evidence of ceiling effects. Furthermore, heritability 
of pvRSA was estimated after replacing the nighttime pvRSA values by (a) the maximal 
observed pvRSA at the peak of their quadratic IBI-RSA curve, and (b) by the pvRSA value 
at the longest nighttime IBI obtained from extrapolating from the linear part of their IBI-
RSA curve. Although these virtual maxima may still underestimate the true level of cardiac 
vagal control, they preserve all the participants for the analysis and may better capture the 
total genetic variance. The rationale behind this approach is akin to the correction of blood 
pressure in medicated participants by adding the average effect of the antihypertensive 
medication to the observed blood pressure. This was shown to preserve genetic variance 
compared to removing participants with medication (Cui, Hopper, & Harrap, 2003). 
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Our foremost goal was to establish the heritability of RSA measures across the 24-h 
period while accounting for ceiling effects on RSA at low heart rate levels during the 
night. We expected the heritability estimates for the nighttime RSA measures to be 
significantly moderated by the IBI-RSA shape, such that heritability of cardiac vagal 
control is underestimated unless the ceiling effect is taken into account. As a secondary 
goal we tested the degree of overlap in the genetic factors influencing pvRSA, RMSSD 
and SDNN, and their potential sensitivity to the ceiling effects. As these measures are all 
used to capture individual differences in cardiac vagal control, the expectation is that the 
genetic factors influencing them are highly correlated.
Method
Participants
Participants were all registered in the Netherlands Twin Register and took part in a 
large cardiac ambulatory monitoring project in which 24-h recordings were collected 
in three data collection waves. A priori reasons for exclusion were pregnancy, heart 
transplantation, presence of a pacemaker and known ischemic heart disease, congestive 
heart failure, or diabetic neuropathy. We excluded data of 8 participants showing much 
arrhythmias. Valid ambulatory HRV recordings were available for 1,373 participants, of 
which 797 participated in the first two waves between 1998 and 2003. Sixty-seven of 
these participants took part in both waves, as part of a study on temporal stability of the 
ambulatory recordings (Goedhart, Kupper, Willemsen, Boomsma, & de Geus, 2006). In 
Wave 3, running between 2010 to 2012, the sample was further expanded with 576 new 
participants. 
Data for 71 participants (75 recordings) were excluded due to the use of cardio vascular 
medication (beta blockers, ATC C07, cardiac therapy, ATC C01), or antidepressants (ATC 
N06A) at the time of the ambulatory assessment. Of the remaining 1,302 participants, 
63 had duplicate ambulatory recordings from which we selected a single recording only. 
When the difference in the duration between the duplicate recordings was greater than 
or equal to 200 min, the shorter recording was excluded (12 recordings). Next, preference 
was given to the recordings of the data collection wave in which both twins participated, 
by excluding the recordings for the wave when only one of the twins participated (25 
recordings excluded). For the remaining duplicate recordings, the recording of the wave 
in which most family members participated was retained (26 recordings excluded). 
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To simplify genetic modeling, we excluded the third member of triplets and included a 
maximum of two singleton brothers and two singleton sisters per family. Therefore, eleven 
participants from larger families were additionally excluded: the third member of a triplet 
(N = 1), nine siblings when more than two brothers and two sisters participated, and one 
twin who belonged to a second twin pair in the family. For the latter, we selected the 
siblings who were closest in age to the twins. We additionally excluded three participants 
who took part in the first two waves while all other family members participated in the 
third wave. 
 The final sample comprised 1,288 participants belonging to 624 families, with 486 
MZ twins (210 complete pairs), 517 DZ twins (205 complete pairs), and 285 non-twin 
siblings. Mean age was 33.5 years (SD = 9.2 years), and 61.6% of the sample was female. 
Zygosity of the twins was determined by DNA typing for 97.9% of the same-sex twin pairs. 
For the remaining same-sex pairs, zygosity was based on survey questions on physical 
similarity and the frequency of confusion of the twins by parents, other family members, 
and strangers. Agreement between zygosity based on these items and zygosity based on 
DNA is 96.1% (Willemsen et al., 2013). The Medical Ethics Committee of the VU University 
Medical Center approved of the study protocol and all participants gave written consent 
before entering the study.
Ambulatory Measurements of Heart Rate and Heart Rate Variability
For the first two data collection waves, the VU University Ambulatory Monitoring System 
(VU-AMS) version 4.6 was used (VU University, Amsterdam, The Netherlands, www.vu-ams.
nl). This version of the VU-AMS continuously recorded the ECG and changes in thoracic 
impedance (dZ) from a six-electrode configuration (de Geus & van Doornen, 1996; de 
Geus, Willemsen, Klaver, & van Doornen, 1995; Riese et al., 2003). The device automatically 
detects each R wave in the ECG signal, at which it reads out and resets a millisecond 
counter to obtain the heart period time series. The thoracic impedance (Z), assessed against 
a constant current of 50 KHz, 350 microamperes, was amplified and led to a precision 
rectifier. The rectified signal was filtered at 72 Hz (low pass) to give basal impedance Z. 
Filtering Z at 0.1 Hz (high pass) supplied the dZ signal, which was band pass filtered with 0.1 
and 0.4 Hz cutoffs, after tapering with (sin(x))2, to yield the respiration signal. 
The IBI time series was obtained from the ECG by an online automated R-wave 
peak detector, where IBI is the interval in milliseconds between two adjacent R waves of 
the ECG. Artifact processing was performed on the IBI data offline. When the IBI deviated 
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more than 3 SD from the moving mean of a particular period it was automatically coded 
as an artifact and the IBI was either rejected during visual inspection or new IBIs were 
created by summing too short IBIs or too long IBIs were split in two IBIs of equal length.
For the third wave, the 5fs version of the VU-AMS was used, which improved on 
the 4.6 version in that it stores the entire ECG for offline analysis rather than online 
R-wave peak-detection (van Dijk et al., 2013). The ECG signal was imported into the VU-
DAMS software (version 3.2, VU University Amsterdam, www.vu-ams.nl). After automated 
detection of bad ECG signal fragments (artifacts), R-wave peak detection was done using 
a modified version of the algorithm by Christov (Christov, 2004). From the R-wave peaks, 
the IBI time series was again constructed and visually displayed for interactive correction 
of missed or incorrect R-wave peaks. In addition to the ECG, the 5fs version also stores 
the entire dZ at 1000 Hz to obtain the respiration signal. The dZ signal is filtered using 
a second order band pass filter that passes all frequencies in the range of 0.1 to 0.4 
Hz. An Exponential Smoothing Average technique is then applied on the filtered DZ 
signal, which acts as an additional low pass filter. The output of this filter is a weighted 
combination of previous smoothed value and the newest measured data, or in formula: 
St = α* St −1 + (1 − α) *xt
where St is the smoothed average, α is the tunable smoothing factor (which is in the range 
of 0 to 1), xt is the observation at time t, and St−1 is the previous smoothed value.
Computation of the RSA measures was done in the same way for all three waves. 
Combining the IBI time interval series with the respiration signal extracted from the thorax 
impedance signal (dZ), the ‘peak–valley’ RSA method was used to asses pvRSA (de Geus 
et al., 1995; Grossman, van Beek, & Wientjes, 1990; Grossman & Wientjes, 1986). In this 
method, RSA is scored from the combined respiration and IBI time series by detecting the 
shortest IBI during inspiration and the longest IBI during expiration on a breath-to-breath 
basis according to the procedures detailed elsewhere (de Geus et al., 1995; Houtveen, 
Groot, & de Geus, 2005; van Lien et al., 2011). Breathing cycles that showed irregularities 
like gasps, breath holding and coughing, were considered invalid and were removed 
from further processing. If no shortest or longest IBI could be detected in inspiration and 
expiration respectively, the breath was either set to missing or to zero when computing the 
average per condition for pvRSA. Similar results were found for pvRSA computed either 
way and we employed only one (breaths set to missing) in further statistical analyses. The 
two other measures of RSA were derived from the IBI time series by taking the standard 
deviation of all valid IBIs (SDNN) and the root mean square of differences between valid, 
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successive IBIs (RMSSD):
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Procedure
Participants were visited at home, before starting their normal daily activities. During a 
short interview, information on health status and current medication use was obtained. 
The VU-AMS was attached and its operation explained. Participants were instructed to 
wear the device the entire day and night up until awakening the next morning. Instructions 
were supplied that explained how to respond to potential alarm beeps (e.g., on loose 
electrode contacts), and telephone assistance was available during waking hours. 
Participants were requested to keep a diary and to write down a chronological account of 
activity, posture, location, and social situation over the time period. For Wave 1 and 2 this 
was done every 30 min, for Wave 3 every 60 min. Participants were instructed to refrain 
from vigorous exercise during the ambulatory recording day.
Data Reduction
Using the activity diary entries in combination with a visual display of the output of an 
inbuilt accelerometer (measuring movement), the entire 24-h recording was divided into 
fixed periods. These periods were coded for posture (supine, sitting, standing, walking, 
bicycling), activity (e.g. desk work, dinner, meetings, watching TV), and physical load 
(no load, light, intermediate and heavy). Minimum duration of periods was 5 min and 
maximum duration was 1 h. If periods with similar activity and posture lasted more than 
1 h (e.g., during sleep), they were divided into multiple periods of maximally 1 h. All 
periods were classified into three main ambulatory conditions: (1) lying asleep, (2) sitting 
during the day, or (3) mild physical activity (e.g. standing/walking) based on the dominant 
posture/ activity reported in that period; the exact timing of changes in posture/activity 
was verified using the accelerometer signal from the ambulatory device. 
To determine the shape of the relationship between IBI and pvRSA we divided 
the entire 24-h recording into bins no longer than 10 min, thereby making a distinction 
between waking and sleeping periods. For the majority of the bins (83%), condition within 
the bin was uniform. The other bins did not fall within a single condition because it was 
not always determined for the entire bin, or the bin covered more than one condition. 
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The mean IBI and pvRSA were determined per bin and the correlation across these IBI 
and pvRSA means was depicted in a separate scatter plot for each of the participants 
in the study. Four examples of the IBI-RSA relationship are shown in Figure 3.2 (full set 
of scatter plots available upon request from the corresponding author). Significance of 
the regression weights (β1 and β2) in the linear and quadratic terms was tested by the 
SPSS CURVEFIT procedure. First automated classification of the shape was used. To be 
classified as quadratic, the β2 parameters had to be significantly different from zero, the 
quadratic solution had to explain 20% of the variance in RSA, and the quadratic solution 
had to improve on the linear solution by at least 10% additional explained variance. Two 
human raters (MN and GW) independently verified this algorithmic classification of the 
scatter plots by visual inspection; a third rater (EG) resolved remaining discrepancies. For 
all participants, the intercept and standardized beta (daytime_slope) of the IBI-RSA curve 
was assessed in the waking part of the data, where it was found to be non-quadratic in 
all participants. 
Figure 3.2. Representative IBI-RSA curves of three participants without ceiling effects (panel a,b,c) 
and one participant with ceiling effects (panel d). The lines represent the best fitting linear and  
quadratic function for each participant.
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For IBI, respiration rate and the three HRV measures (SDNN, RMSSD, pvRSA) a mean 
value was computed across the sleep, sitting and physically active periods in the 
recordings. In addition two separate measures were computed to index maximal cardiac 
vagal control during the night. First, the median value of the six 10-min bins with the 
highest pvRSA value during the night (pvRSAmax) was obtained. For participants without 
ceiling effects these bins occurred mostly around the end of the night. For participants 
with a ceiling effect, the highest pvRSA values were obtained in an earlier phase of the 
night, corresponding to the moment of occurrence of the peak in the quadratic IBI-RSA 
curve. Second, a virtual pvRSAmax (pvRSAmax_virtual) was calculated on the basis of 
the intercept and slope of the daytime IBI-RSA association during sitting activities, by 
extrapolating the pvRSA to the value that would have been obtained at the nighttime 
10-min bin with the longest IBI value (IBImax in seconds) by the following formula:
pvRSAmax_virtual = intercept + (daytime_slope * IBImax)
The rationale behind this virtual value is that by extrapolating the observed daytime IBI-
RSA relationship to nighttime RSA, an RSA value may be obtained that may prove a valid 
alternative to excluding data of participants showing ceiling effects. 
Statistical Analyses
SDNN and IBImax showed a continuous normal distribution. A LogN (LN) transformation 
(for pvRSAmax, pvRSAmax_virtual, pvRSA, and RMSSD) or a squared transformation (for 
daytime_slope) was applied to obtain a normal distribution. 
Group and Condition effects
We used a mixed model ANOVA (IBM SPSS 20.0) and included age, sex, and respiration 
rate (the latter for pvRSA and RMSSD only) as covariates and family as a random factor. 
Respiration rate was only included as a covariate in the analyses for pvRSA and RMSSD, 
because SDNN does not specifically capture HRV related to cadiorespiratory coupling. 
We tested the fixed effects of group (ceiling vs no ceiling), ambulatory condition 
(sleep, sitting, active) and the Group x Condition interaction. Significant interaction was 
followed by post-hoc tests of the ceiling effect within each of the ambulatory conditions. 
Mixed model ANOVA was also used to test the effects of group on the two alternative 
measures of maximal pvRSA at nighttime, pvRSAmax and pvRSAmax_virtual. Effects were 
considered significant when p < .01.
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Genetic Analyses 
In a twin study, the observed variance can be decomposed into four possible sources 
of variance: variance due to additive genetic effects (A), non-additive genetic effects 
(D), common environment (C) shared by family members, and nonshared or unique 
environment (E) (Boomsma & Gabrielli, Jr., 1985). However, in a design that includes 
identical twins, fraternal twins, and sibling pairs, estimates of C and D are confounded 
and the observed variances and covariances only provide sufficient information to model 
either an ACE model or an ADE model, but not both. Based on the pattern of twin and 
sibling correlations we chose to model A, C, and E. For identical twins, fraternal twins, 
and sibling pairs alike, common environmental factors are correlated 1. Genetic factors 
are correlated 0.5 in siblings and DZ twins and 1.0 in MZ twins. By definition, nonshared, 
or unique, environmental factors are uncorrelated in family members.
To answer the question to what extent A, C, and E factors contribute to the variance 
in the RSA measures, biometrical genetic models were fitted to the observed data using 
the structural equation modeling program Mx (Neale, Boker, Xie, & Maes, 2006). First, 
fully saturated models were fitted for each variable separately. In these fully parameterized 
models, means, and variances were estimated freely for both sexes. Then, we tested for 
sex differences in means and variances by constraining these to be equal for males and 
females and tested whether these more constrained models led to a significant worse 
fit to the data. Next, we tested for heterogeneity of correlations of males versus females 
and of fraternal twins versus singletons. The resulting most parsimonious saturated model 
indicated to what extent we could limit the specification of the variance components 
models. 
As the individual differences in the ambulatory RSA measures were expected to be 
sensitive to three main confounding variables: differences in age, sex, and respiration rate 
(de Geus et al., 2007; De Meersman & Stein, 2007; Eckberg, 2003; Quilliot et al., 2001; 
Umetani et al., 1998; Vallejo et al., 2005), the above models specifically regressed the 
effects of sex and age on RSA. Respiration rate was additionally included as a covariate 
for pvRSA and RMSSD. 
Furthermore, we tested for effects of the version of the ambulatory recording device 
by comparing the means and variances of the three waves. In keeping with the highly 
similar strategies used to obtain the RSA measures, no device version effect was found 
so that all three waves were pooled during all genetic modeling. To examine whether the 
genetic architecture of the RSA measures changed from nighttime to daytime and, within 
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the daytime, from sitting only to more physical active activities, full trivariate genetic 
ACE models in Cholesky decomposition were fitted to the mean values for the three 
RSA measures separately for the nighttime sleep, daytime sitting and daytime physically 
active periods. Because the MZ twin correlations were always at least twice as high as the 
DZ and non-twin sibling correlations, it is more likely that familial resemblance derives 
from genetic factors rather than from shared environmental influences. The ACE model 
was therefore tested against the nested AE model only. The resulting most parsimonious 
model was used to further test the source of the observed covariance in the different 
HRV measures. Figure 3.3 depicts a schematic representation of the full trivariate genetic 
model that was fitted to the data. 
Figure 3.3. Example of a path model decomposing trait variance into additive genetic (A), and 
shared (C) and unique environmental (E) factors in one twin pair. Unique A, C and E factors load on 
all three HRV measures. Additionally, A, C and E factors can be shared between the phenotypes. 
This is depicted by the ‘a’, ‘c’ and ‘e’ paths running from the former A, C and E factors of a HRV 
phenotype to the next (a21, a31, a32, c21, c31, c32, and e21, e31, and e32). With these paths, the 
genetic and environmental covariance can be studied. Finally, MZ twins correlate 1.0 regarding the 
A factor scores because they are assumed to share all of their genetic material, whereas DZ or  
sibling pairs correlate 0.5. 
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The significance of A, C, and E factors was tested by comparing the fit of the more 
parsimonious nested models to the fit of the full model using the likelihood-ratio (χ²) 
test in which the difference in minus twice the logarithm of the likelihood (-2LL) was 
calculated. When the χ² test was significant (p < .01), the more parsimonious model was 
considered to fit significantly worse to the data than the fuller model it was tested against. 
In addition, Akaike’s Information Criterion (AIC = χ² - 2df) (Akaike, 1987) was calculated for 
each model, which offers a quick approach to judging the fit of nested models. Those with 
lower values fit better than models with higher values. For more background information 
on the heritability estimation procedures, see (de Geus, 2010). 
To test whether the heritability estimates were significantly affected by participants 
whose data showed ceiling effects, the trivariate genetic analyses were repeated excluding 
those participants. As an alternative to correct for a potential underestimation of the 
heritability of nighttime vagal control two additional genetic analyses were performed 
on pvRSAmax and pvRSAmax_virtual and it was tested whether the heritability estimates 
for these alternative measures were higher compared to the estimates obtained for 
uncorrected nighttime pvRSA.
Results
In 52 participants no valid nighttime recording of the RSA measures was obtained for at 
least five 10-min bins. Analyses of the scatter plots of mean RSA and IBI across the 24-h 
period in the remaining 1,236 participants, showed a significant quadratic relationship 
in 132 participants (10.7%). From Table 3.1 it can be seen that the nighttime pvRSA 
and RMSSD may be underestimated in these participants. Mixed ANOVA analysis with 
correction for family relatedness showed a significant Group x Condition interaction for 
pvRSA, F(2,3061) = 36.20, R2 = 0.64, p < .01; and RMSSD, F(2,3063) = 17.30, R2 = 0.30, p 
< .01; but not for SDNN, F(2,3056) = 3.08, R2 = 0.04, p = .046. Whereas participants with 
a ceiling effect due to a quadratic IBI-RSA curve have a significantly longer IBI throughout 
the entire recording (hinting at higher cardiac vagal control) compared to the participants 
without a ceiling effect, their pvRSA and RMSSD are only higher during the two daytime 
conditions but not at night. Nighttime SDNN appears less affected by the ceiling effect, 
although the group differences in HRV values during the night were also less pronounced 
compared to the daytime conditions. Previously, a similar pattern was observed by our 
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group (van Lien et al., 2011). 
Using the maximal observed pvRSA at night still suggests that the participants with 
a ceiling effect have comparable cardiac vagal control (Fgroup = 0.29, R2 = 0.10, p = .588) 
in spite of their longer nighttime IBI. Only when the linear relationship between RSA and 
IBI was extrapolated to the maximal IBI (pvRSAmax_virtual) was a higher value found in 
the ceiling group (Fgroup = 10.47, R2 = 0.84, p < .01). Daytime_slope for the participants 
with a ceiling effect was steeper compared to the daytime_slope of the participants 
without a ceiling effect (Fgroup = 12.19, R2 = 0.73, p < .01).
Table 3.1. Means and (standard deviation) for IBI, pvRSA, RMSSD, SDNN, daytime_slope, pvRS-
Amax and pvRSAmax_virtual by ceiling status (yes/no) and ambulatory condition.
No ceiling effects Ceiling effects Group difference 
Variable (1100 < N < 1104) (N=132)
IBI (ms)
Sleep 975.34 (125.42) 1053.08 (165.02) 77.74*
Sitting 804.93 (102.13) 844.62 (115.90) 39.69*
Active 712.60 (87.53) 741.08 (100.49) 28.48*
pvRSA (ms)
Sleep 56.10 (24.43) 54.05 (26.32) -2.05
Sitting 44.49 (17.22) 58.18 (21.98) 13.69*
Active 35.24 (12.63) 44.96 (14.72) 9.72*
RMSSD (ms)
Sleep 53.08 (25.58) 60.31 (31.88) 7.23
Sitting 36.03 (16.61) 51.24 (24.83) 15.21*
Active 29.54 (12.85) 40.24 (18.65) 10.70*
SDNN (ms)
Sleep 91.49 (26.90) 104.21 (31.37) 12.72*
Sitting 68.92 (19.80) 86.82 (25.01) 17.90*
Active 81.73 (21.34) 98.26 (24.89) 16.53*
daytime_slope 108.50 (64.17) 110.84 (65.86) 2.34* 
pvRSAmax (ms) 86.03 (34.83) 89.21 (33.42) 3.18
pvRSAmax_virtual (ms) 73.31 (32.45) 89.62 (39.92) 16.31*
All variables were corrected for family relatedness, age and sex. pvRSA, RMSSD, 
pvRSAmax, and pvRSAmax_virtual values were additionally corrected for respiration rate.
**= significant main effect of ceiling (within ambulatory condition) (p < .01)
Note. Abbreviations: IBI = inter beat interval; pvRSA = peak valley respiratory sinus arrhythmia; 
RMSSD = root mean square of differences between valid successive IBIs; SDNN = standard deviation 
of all valid IBIs. 
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Table 3.2. Twin and sibling correlations as estimated from the full saturated model.
MZ 
twins
DZ/sibs 
male
DZ/sibs 
female
Opp. 
sex sibs
MZM MZF DZM twin/
sib-sib
DZF twin/
sib-sib
DOS twin/sib-
OS sib
SDNN / sleep¹ 0.70 0.56 0.17 0.09 0.17 0.21 0.45 0.19
SDNN / sitting¹ 0.64 0.55 -0.07 0.24 0.49 0.30 0.27 0.38
SDNN / active¹ 0.65 0.56 0.01 0.31 0.46 0.36 0.35 0.32
RMSSD / sleep ² 0.74 0.60 0.15 0.31 0.17 0.27 0.43 0.29
RMSSD / sitting² 0.58 0.61 0.01 0.34 0.40 0.32 0.26 0.31
RMSSD / active² 0.57 0.50 0.10 0.40 0.27 0.31 0.28 0.30
pvRSA / sleep ² 0.69 0.56 0.22 0.26 0.31 0.34 0.34 0.29
pvRSA / sitting² 0.60 0.65 0.07 0.35 0.44 0.33 0.28 0.23
pvRSA / active² 0.68 0.63 0.07 0.46 0.37 0.40 0.35 0.19
pvRSAmax² 0.64 0.64 0.25 0.24 0.30 0.35 0.25 0.28
pvRSAmax_
virtual²
0.63 0.72 0.19 0.32 0.44 0.29 0.33 0.34
IBImax¹ 0.53 0.55 0.17 0.27 0.38 0.27 0.31 0.27
daytime_slope¹ 0.46 0.48 -0.06 0.21 0.26 0.25 0.20 0.24
¹ = corrected for age, sex
² = corrected for age, sex, respiration rate
 Note. Abbreviations: SDNN = standard deviation of all valid inter beat intervals (IBIs); RMSSD = 
root mean square of differences between valid successive IBIs; pvRSA = peak valley respiratory sinus 
arrhythmia; pvRSAmax = the median value of the six 10-minute bins with the highest pvRSA value 
during the night; IBImax = the nighttime 10-minute bin with the longest IBI value;daytime_slope = 
the slope of the IBI-RSA curve in the waking part of the data; pvRSAmax_virtual = a non-observed 
experimental variable that extrapolates the pvRSA from the intercept and slope of the daytime IBI-
RSA association during sitting activities to the value that would have been obtained at the longest IBI 
value (IBImax); MZM = monozygotic male, MZF = monozygotic female; DZM = dizygotic male, DZF 
= dizygotic female, DOS = dizygotic opposite sex, sib = non-twin sibling.
Twin-Sibling Resemblance and Heritability
Table 3.2 shows the twin and sibling correlations for all measures. From the pattern of 
the correlations it is clear that there is a substantial genetic contribution to all measures. 
The overarching pattern seen is that DZ and sibling correlations are about half of the MZ 
correlations, with the exception of the male DZ correlations which are low and suggestive 
of nonadditivity. Formal testing, however, showed that the DZ twin and non-twin sibling 
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correlations were homogeneous (all p’s > .01) and could be equalized in further model 
fitting. Correlations of MZ males and MZ females also did not differ significantly, nor did 
the same-sex DZ and opposite-sex DZ twin and non-twin sibling correlations (all p’s > .01) 
so no quantitative or qualitative sex differences were modeled. 
Table 3.3.a shows the best trivariate models for pvRSA, RMSSD and SDNN 
separately for the sleep, sitting, and physically active conditions. An AE model provided 
the best fit. Heritability of pvRSA was lower at night than during the day, but as can 
be seen from the confidence intervals, the heritability estimates were not significantly 
different during sleep, sitting and active periods. For RMSSD and SDNN, heritability was 
also very comparable across all periods. 
Genetic and Unique Environmental Correlations
Table 3.4.a shows significant phenotypic correlations between the various HRV measures 
in all three periods. Generally, the phenotypic, the genetic, and the unique environmental 
correlations between pvRSA and RMSSD and RMSSD and SDNN were higher compared 
to the phenotypic, genetic, and unique environmental correlations between pvRSA and 
SDNN for the entire recording time. A single genetic and unique environmental factor 
influenced all three RSA measures, but RMSSD and SDNN were also influenced by 
independent genetic and unique environmental factors that did not affect pvRSA. The 
observed correlation between the three possible dyads of the RSA measures was for 51% 
to 56% attributable to shared genetic factors, and for 44% to 49% attributable to shared 
unique environmental factors. 
Correcting for Ceiling Effects on Nighttime RSA
To test the impact of the ceiling effects on the RSA measures on the heritability of cardiac 
vagal control, we repeated the above trivariate analysis after excluding participants 
with the ceiling effects. Results are depicted in Table 3.3.b. No significant changes in 
heritability estimates were noticeable after excluding participants with ceiling effects. 
Likewise, excluding the participants with ceiling effects did not significantly change 
the phenotypic, the genetic, and the unique environmental associations between the 
RSA measures, nor was a meaningful change observed in the genetic and unique 
environmental contribution to their covariance (see Table 3.4.b).
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Alternative Measures of Nighttime Cardiac Vagal Control
As an alternative measure of nighttime cardiac vagal control, that might be less sensitive 
to the impact of ceiling effects, we used the median value of the six 10-min bins with the 
highest RSA value in all participants (Table 3.5.a). This led to heritability estimates that 
were higher (5%), but not significantly different from those for the pvRSA during the entire 
sleep period (Table 3.3.a).
A second alternative replaced the nighttime pvRSA values by the estimated 
pvRSAmax (pvRSAmax_virtual) value based on the daytime linear association of RSA and 
IBI and extrapolating to the bin with the longest IBI at night (Table 3.5.b). The heritability 
estimate now increased 7% compared to the uncorrected nighttime pvRSA measure, 
but this increase was again not significant as confidence intervals still overlapped. For 
completeness, Table 3.5.c and 3.5.d also present the heritability of the daytime_slope 
and (nighttime) IBImax.
Discussion
Using a twin family design this paper shows that genetic factors explain around half of the 
individual differences in ambulatory cardiac vagal control as measured by pvRSA, RMSSD 
or SDNN. Our expectation that the heritability estimates for the nighttime RSA measures 
would be significantly affected by the IBI-RSA shape, such that heritability of cardiac vagal 
control is underestimated at low heart rates at nighttime, was not supported by the data. 
In spite of significant changes in mean RSA values across the 24-h period, there was no 
evidence for differences in heritability of cardiac vagal control at night compared to daytime 
conditions and, during daytime conditions, heritability was very comparable between 
sitting-only conditions and conditions in which participants were physically active. The 
genetic factors influencing ambulatory pvRSA, RMSSD, and SDNN largely overlapped, 
providing support for the idea that pvRSA, RMSSD and SDNN capture the same biological 
phenomenon. Nonetheless, the overlap in genetic factors influencing pvRSA and RMSSD 
was higher than the overlap in the genetic factors shared between pvRSA and SDNN. 
Earlier twin studies on the heritability of HRV were mainly based on laboratory 
recordings and the heritability estimates that were found varied substantially between 
conditions and across the different HRV measures that were used. Laboratory studies 
reported heritability estimates of pvRSA in resting conditions between 25% to 39% 
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(Boomsma et al., 1990; de Geus et al., 2007; Snieder et al., 1997; Tuvblad et al., 2010). 
Estimates for resting RMSSD values in the laboratory ranged from 36% to 71% (Uusitalo 
et al., 2007; Wang et al., 2005; Wang et al., 2009). Only one laboratory study researched 
resting SDNN and estimated heritability to be 66% (Wang et al., 2005). These resting 
laboratory levels can be best approximated by the sitting-only condition in our sample. 
Heritability of sitting-only pvRSA was estimated at 53%, RMSSD at 54% and SDNN at 48%. 
During (mental) stress, laboratory studies reported increases in heritability of pvRSA 
and RMSSD of 8% to 23% when compared to heritability estimates of resting levels (de 
Geus et al., 2007; Wang et al., 2009), suggesting that more genetic variance is expressed 
under conditions in which participants were aroused. This Gene x Stress interaction that 
was observed in controlled laboratory situations was not recaptured by a nighttime – 
daytime effect. Instead the genetic variance was rather stable across the 24-h period. 
This finding was supported by previous analyses within a subset of the present sample, in 
which we did not observe significant differences in heritability estimates across different 
times of day (Kupper et al., 2004; Kupper et al., 2005). This raises the important but 
possibly misleading question of which of these two paradigms ‘is right’. The ambulatory 
situation is by definition a less standardized setting compared to the laboratory setting 
in which physical activity and postures can be carefully controlled. On the other hand, 
ambulatory 24-h measurements in real life may give a better reflection of the actual day-
to-day situation of participants and thereby capture daily life better. Cardiac recordings 
in an ambulatory setting presumably also contribute more reliably to risk prediction 
compared to a recording in the laboratory, which is generally shorter and more sensitive 
to momentary or lab-specific influences (e.g. the white coat effect) (Zanstra & Johnston, 
2011). Although not tested here, it would be interesting to elaborate on this topic and 
explore different operationalizations of real life reactivity in future research.
Previous research has already shown that RSA can be reliably measured under 
naturalistic conditions with the use of ambulatory monitoring (de Geus et al., 1995; 
Wilhelm, Roth, & Sackner, 2003). Such recordings yield large individual differences in RSA 
that appear to reflect stable trait characteristics. For the average 24-h levels of RSA, high 
test-retest correlations (.63 < r < .90) have been found after 3 to 65 days in both healthy 
individuals and cardiac patients (Bigger, Jr. et al., 1992; Hohnloser, Klingenheben, Zabel, 
Schroder, & Just, 1992; Kleiger et al., 1991; Sinnreich, Kark, Friedlander, Sapoznikov, 
& Luria, 1998; Stein, Rich, Rottman, & Kleiger, 1995) and moderate to high long-term 
temporal stability (.58 < r < .76) has been shown over periods of 7 months to 3.4 years 
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(Goedhart et al., 2007; Pitzalis et al., 1996). Our results corroborate the stability of these 
individual differences and suggest that they have a genetic basis. 
In keeping with the substantial genetic contribution found across different samples 
and the proven reliability of the assessment of RSA over time, several studies have tried 
to identify the actual genetic variants underlying RSA heritability. These mainly concerned 
candidate gene studies, in which a few genes were selected based on their known 
involvement in processes leading to differences in HRV levels. Candidate gene studies 
have found the angiotensin converting enzyme (ACE) (Busjahn et al., 1998), alpha-kinase 
anchoring protein 10 (AKAP 10) (Neumann et al., 2009; Tingley et al., 2007), methylene-
tetrahydrofolate reductase (MTHFR) (Baccarelli et al., 2008), the circadian clock gene 
PERIOD3 (PER3) (Viola et al., 2008), and the brain-derived neurotrophic factor (BDNF) 
(Yang et al., 2010) to be associated with RMSSD and/or SDNN levels. Candidate gene 
studies do, however, need to be interpreted with caution before they have been confirmed 
in independent replication (Sullivan, 2007) and, ideally, functional studies exist that confirm 
a plausible pathway through which the genetic variant can influence RSA. In that sense, of 
all candidates found, the evidence of AKAP10 to be involved in HRV levels is strongest as 
its involvement was confirmed in animal research as well (Tingley et al., 2007). Candidate 
gene studies are by definition confined to current knowledge, and are selected from 
the biological mechanisms already expected to be involved in heart rate regulation. In 
genome wide association studies (GWAS), no a priori assumptions concerning biological 
mechanisms are made and the entire genome is considered to be ‘candidate’ (Tabor, 
Risch, & Myers, 2002; Manolio et al., 2009). To our knowledge, the Framingham Heart 
Study is the only group that has performed a GWAS on HRV thus far, but none of the 
associations reached genome-wide significance (Newton-Cheh et al., 2007). The sample 
studied was however small (N = 548). In a secondary analysis, this group did find significant 
candidate gene associations between the alpha-adrenergic receptor type 1A (ADDRA1A) 
and the alpha-adrenergic receptor type 1B (ADRA1B) genes and SDNN at p < .05. 
However, to be able to find genome wide significant hits, analyses on tens of thousands 
of participants are needed for which whole genome single nucleotide polymorphism and 
HRV data is available. Because no single research group can mount such numbers, the 
Genetic Variability in Heart Rate Variability (VgHRV) consortium was set up with the aim 
to share association results between different research groups and perform across-study 
meta-analyses on HRV (Nolte et al., 2011). This solves the problem of small sample sizes 
but may introduce yet another pitfall, namely the lack of unity regarding the HRV measures 
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that are used across different studies. With this study, we show that the genetic overlap 
between pvRSA and RMSSD, and RMSSD and SDNN, is high (genetic correlations are 
estimated at .94 and .89 in resting ambulatory sitting conditions) while the genetic overlap 
between pvRSA and SDNN, albeit lower, was still .74. From this it follows, that HRV studies 
that assessed pvRSA and RMSSD, or RMSSD and SDNN, can be safely pooled as the 
genetic architecture is expected to be highly similar.
A major limitation of this study is that exercise status was not obtained for all 
participants at the time of testing. Therefore, we cannot rule out that exercise status may 
explain part of the heritability that is found for HRV since previous work has shown that 
exercise behavior and RSA are genetically correlated (de Geus, Boomsma, & Snieder, 2003). 
A second limitation is that we used a crude approach in pooling all 24-hour HRV data in 
only three ambulatory conditions (sleep, sitting, or physically active) thereby potentially 
introducing heterogeneity within conditions, considering the wide range of activities that 
meet these criteria. This may be particularly pertinent for physical activity, where the range 
of variety is largest. On the other hand, ambulatory activities need to be generalized to 
some extent to make data of different participants comparable. Finally, as nighttime HRV 
recordings in twins and siblings, to our knowledge, have only been performed by our 
group we cannot compare our results to those of independent twin studies.
The major strength of this study is that this is the largest 24-h ambulatory cardiac 
monitoring sample to date in which the heritability of three widely accepted HRV 
measures is studied, including pvRSA, which is taken to be the most ‘pure’ HRV measure. 
Additionally, for the first time, within-participant IBI-RSA associations were inventoried to 
assess ceiling status and the impact of this potential confounding factor on the heritability 
estimates has now been thoroughly tested.
We conclude that about half of the variation that is seen in the levels of the three HRV 
measures that are currently used most in the fields of cardiology and psychophysiology, 
is genetically determined in the healthy adult population. The heritability estimates were 
robust against confounding by IBI-RSA ceiling effects that were observed in a subgroup 
of participants that took part in the study. There is no pressing need to exclude these 
participants, who may be overrepresented among healthy exercisers, in genetic studies of 
HRV. The genetic overlap between the three RSA measures studied is large, especially for 
pvRSA and RMSSD and RMSSD and SDNN, thereby implicating that these measures can 
be pooled in future GWASs to obtain larger sample sizes and increase power to find the 
actual genetic variants being responsible for individual differences in cardiac vagal control. 

Chapter 4
Heritability and temporal stability of 
ambulatory autonomic stress reactivity in 
unstructured 24-h recordings 
This chapter is accepted for publication: 
Neijts, M., van Lien, R., Kupper, N., Boomsma, D., Willemsen, G., 
& de Geus, E. J. C. Heritability and temporal stability of ambulatory 
autonomic stress reactivity in unstructured 24-h recordings. 
Psychosomatic Medicine.
76 Chapter 4
Abstract
Measurement of ambulatory autonomic reactivity can help understand the long 
term health consequences of exposure to psychosocial stress in real-life settings. 
In this study, unstructured 24-h ambulatory recordings of cardiac parasympathetic 
and sympathetic control were obtained in 1288 twins and siblings, spanning 
both work time and leisure time. These data were used to define two ambulatory 
baseline (sleep, leisure) and four stress conditions (wake, work, work_sitting, work_
peak) from which six ambulatory stress reactivity measures were derived. The use 
of twin families allowed estimation of heritability and testing for the amplification 
of existing or emergence of new genetic variance during stress compared to 
baseline conditions. Temporal stability of ambulatory reactivity was assessed in 
62 participants and was moderate to high over a three-year period (0.36 < r < 
0.91). Depending on the definition of ambulatory reactivity employed, significant 
heritability was found, ranging from 29 to 40% for heart rate, 34 to 47% for cardiac 
parasympathetic control (indexed as respiratory sinus arrhythmia), and 10 to 19% 
for cardiac sympathetic control (indexed as the pre-ejection period). Heritability of 
ambulatory reactivity was largely due to newly emerging genetic variance during 
stress compared to periods of rest. Interestingly, reactivity to short standardized 
stressors was poorly correlated to the ambulatory reactivity measures implying 
poor lab-real-life correspondence. We conclude that ambulatory autonomic reac-
tivity extracted from an unstructured real-life setting shows reliable, stable and 
heritable individual differences. Real-life situations uncover new and different ge-
netic variation compared to that seen in resting baseline conditions, including sleep.
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Introduction
Exaggerated cardiovascular responses to stress have been associated with an increased 
risk for cardiovascular disease (CVD) (Chida & Steptoe, 2010; Treiber et al., 2003), 
although the effects will be modulated by genetic sensitivity and the frequency of stress 
exposure in daily life (Light, 2001; Steptoe & Kivimaki, 2012). To assess the propensity 
towards exaggerated reactivity, many studies have used standard mental stressors under 
controlled laboratory conditions. The individual differences in stress reactivity detected 
by such procedures are substantial, have proven to be reliable and may be associated 
with long term adverse cardiovascular outcome (Kamarck et al., 1992; Kamarck, Jennings, 
Stewart, & Eddy, 1993; Matthews et al., 2004). Nonetheless, there is valid concern 
about the extent to which laboratory tasks actually translate to stress situations in real-
life (Johnston et al., 2008; Kamarck et al., 2000; Kamarck, Schwartz, Janicki, Shiffman, 
& Raynor, 2003; Schwerdtfeger, Schienle, Leutgeb, & Rathner, 2014). The laboratory 
setting, although important for inventorying the stress response in all its facets, cannot 
adequately capture prolonged activation and subsequent recovery processes (McEwen, 
1998; Steptoe, Cropley, & Joekes, 1999; Schwartz et al., 2003). 
Cardiovascular stress research has therefore shifted from using mental stress 
tasks (e.g. mental arithmetic, reaction time tasks) to also using tasks with a more social 
evaluative character (e.g. public speaking), see Chida & Hamer (2008) for an overview 
of the studies conducted in this area). Since the past two decades, cardiovascular stress 
research has also increasingly moved from the laboratory to the real-life situation of the 
participants. The rationale behind the ambulatory approach is that the daily life situation 
can give a more accurate and ecological valid reflection of the psychophysiological state 
of the participant and might therefore serve as a better indicator or predictor of disease 
risk (Zanstra & Johnston, 2011). This comes at a price. Compared to the laboratory 
setting, the ambulatory situation is per definition a much less controlled environment 
in which confounding factors like physical activity, posture, and time of day come into 
play (Steptoe, Cropley, & Joekes, 2000). Moreover, there is no standard baseline and 
there are no standard stressors to which all participants are exposed. Two strategies have 
been used to deal with this. First, ambulatory recordings have been scheduled during a 
concrete and relatively comparable stressful event like a school exam (Lucini et al., 2002; 
van Doornen, 1986; van Doornen et al., 1994) or an oral presentation (Houtman & Bakker, 
1991a; Houtman & Bakker, 1991b; Johnston et al., 2008). The second strategy is to use 
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prolonged ambulatory recordings that span periods at work and in leisure time. Reactivity 
is then defined by comparing work levels to leisure time levels, under the assumption that 
the working day will be enriched for mentally and emotionally engaging events compared 
to leisure time (Riese, van Doornen, Houtman, & de Geus, 2004; Steptoe et al., 1999; 
Steptoe et al., 2000; Steptoe & Cropley, 2000; Vrijkotte, van Doornen, & de Geus, 2000; 
Vrijkotte et al., 2004). 
A further challenge in ambulatory recording is that it does not allow the same in-
depth assessment of physiology as is possible within a laboratory setting. Ambulatory 
recording has been typically confined to measurements of blood pressure and heart rate, 
whereas decrease in vagal tone and increased sympathetic nervous system (SNS) activity 
are the key drivers of stress-induced increases in blood pressure and heart rate (HR). 
Fortunately, two non-invasive key measures of cardiac sympathetic and vagal control can 
also be recorded with high fidelity in ambulatory settings: the pre-ejection period (PEP) 
and respiratory sinus arrhythmia (RSA) (de Geus, van Lien, Neijts, & Willemsen, 2015). 
When ambulatory HR, PEP and RSA are assessed in a 24-hour recording across a working 
day, followed by leisure time and sleep recording, there are various ways to define cardiac 
autonomic reactivity, for instance by defining either sleep or leisure time sitting as the 
baseline, or using periods of peak reactivity while sitting at work or the entire work period. 
Until now very little systematic study of the reliability and stability of individual differences 
in such ambulatory autonomic reactivity has been performed. 
In the present study, we recorded 24-h ambulatory HR, RSA and PEP in over 1300 
participants. During waking hours, participants filled out detailed activity diaries that 
were used to divide the entire signal of every participant into fixed periods of distinctive 
activities and postures. The periods were used to define two different resting (baseline) 
conditions and four conditions reflecting more mentally and/or emotionally engaging 
episodes (referred to as ‘stress’ from this point forward). Mean sleep levels were used as 
the ultimate resting baseline condition for each participant. As it is not always possible to 
measure during sleep, we also used an alternative baseline condition by selecting a period 
in leisure time during sitting activities which were relaxing in nature (internet, watching TV, 
reading). As a first stress level we used the entire waking period. Since participants were 
visited on a weekday and more than half of the participants were measured on a working 
day at the working location, we also extracted the mean working day level including all 
postures and the mean working day level for sitting activities only as alternative stress 
levels. We also extracted the most (psychological) arousing activities at work for each 
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participant by searching for periods with low physical activity but accompanied by high 
heart rates. 
Two to five year retest data were available for 62 participants which allowed 
estimation of the temporal stability of these ambulatory reactivity measures. In 576 
participants we also embedded a standard stress testing protocol assessing autonomic 
reactivity to two mental stress tasks. This allowed for a comparison of ambulatory reactivity 
to classical short-term stress reactivity. Measurements were done in monozygotic (MZ) and 
dizygotic (DZ) twins and their family members to be able to estimate the reliability and 
heritability of the various ambulatory reactivity measures. Significant heritability indicates 
that a measure is reliable and taps into stable biological differences. It was further tested 
whether there is amplification of existing or emergence of new genetic variance during 
the ambulatory stress conditions compared to ambulatory baselines as has previously 
been observed for laboratory stressors (de Geus et al., 2007; Riese et al., 2006; Wang et 
al., 2009). The overarching aim was to identify ambulatory autonomic reactivity measures 
from unstructured 24-h recordings for use in stress research that have good temporal 
stability, significant heritability, and the ability to detect stress-specific genetic variance.
Methods
Participants
Participants were all registered in the Netherlands Twin Register (NTR). The NTR has been 
collecting survey and biological data for over 25 years. In the biennial surveys, data on 
health, lifestyle, and personality is assessed (Willemsen et al., 2013). A subset of these 
participants were included in a large cardiac ambulatory monitoring project in which 24-
hour recordings were collected in two separate studies (Kupper et al., 2005; Kupper et 
al., 2006; Neijts et al., 2014). Study 1 was conducted between August 1998 and June 
2003 and included two waves of data collection with partial retest data. This sample was 
further expanded with a new data collection round, Study 2, that took place between 
November 2010 and June 2012. In the latter study, data was collected in a single wave. 
For both studies, adult twins and siblings without known CVD or other relevant health 
complaints were selected and informed about the study by mail. This was followed by 
a short telephone interview in which the health status of the participants was verified. A 
priori reasons for exclusion for all studies/waves were pregnancy, heart transplantation, 
presence of a pacemaker and known ischemic heart disease, congestive heart failure, 
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or diabetic neuropathy. We excluded data of 8 participants showing many arrhythmias or 
preventricular contractions. Of the remaining sample (N=1373), data of participants that 
were on cardiovascular medication, cardiac therapy, or antidepressant medication were 
excluded (N=71). To simplify genetic modeling, we excluded the third member of triplets 
(N=1) and used only one pair from families with multiple twins. We further restricted the 
number of siblings to a maximum of two singleton brothers and two singleton sisters per 
family, selecting the siblings who were closest in age to the twins and removing data for nine 
siblings. Three more participants were excluded because the rest of their family members 
participated in a different wave. 
Table 4.1. Sample characteristics for Study 1, the retest study, which was part of Study 1, and Study 
2. All twins and siblings that participated in Study 2 also participated in the laboratory protocol as 
this was embedded within the same 24-h ambulatory measurement. 
Ambulatory 
Study 1
Ambulatory 
Study 2
Wave 1  
(1998 – 2000)
Wave 2  
(2001 – 2003)
Wave 3  
(2010 – 2012)
New New Retest New
N individuals 367 380 62 541
MZ (N belonging to complete pair) 103 (86) 117 (104) 12 (0) 266 (230)
% MZ females 66.0 62.4 50.0 64.3
DZ (N belonging to complete pair) 144 (110) 120 (147) 29 (4) 180 (226)
% DZ females 75.9 76.3 65.5 72.9
Siblings (% female) 120 (57.5) 116 (61.2) 21 (57.7) 49 (59.2)
Age (SD) 28.5 (9.6) 32.9 (10.7) 33.6 (9.6) 37.2 (5.4)
 
In the end, recordings of 1288 participants were available with 486 monozygotic (MZ) twins 
(210 complete pairs), 517 dizygotic (DZ) twins (205 complete pairs), and 285 non-twin 
siblings. The data of participants belonging to an incomplete twin pair were included 
because they could still be paired to their non-twin sibling and/or contribute to the 
estimates of the means and variances. Incomplete pairs occurred because only one of the 
two participated or because data of the other twin was excluded for reasons mentioned 
earlier. Mean age was 33.5 years (SD = 9.2 years), and 61.6% of the sample was female. 
Zygosity of the twins was determined by DNA typing for 97.9% of the same-sex twin 
pairs. For 2.1% of the same-sex pairs, zygosity was based on survey questions on physical 
similarity and the frequency of confusion of the twins by parents, other family members, and 
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strangers. Agreement between zygosity based on these items and zygosity based on DNA 
is 96.1% (Willemsen et al., 2013). For 62 participants in wave 1 of Study 1, measurements 
were repeated in a wave 2 of that study after an average period of 3.3 years (range 
2.1 to 4.7 years). For more detailed characteristics of the Study 1, Study 2, and the retest 
sample separately, see Table 4.1. The study protocol was approved by the Medical Ethics 
Committee of the VU University Medical Center Amsterdam and all participants gave written 
consent before entering the study. 
Procedure
Participants were visited at home, before starting their normal daily activities. During a 
short interview, information on health status and current medication use was obtained. 
They were fitted with the VU University Ambulatory Monitoring System (VU-AMS) that 
records the electrocardiogram (ECG) and impedance cardiogram (ICG) continuously. For 
participants taking part in wave 1 and wave 2 of Study 1 the VU University Ambulatory 
Monitoring System (VU-AMS) version 4.6 was used. For Study 2, the 5fs version of the 
VU-AMS was used. A standard laboratory protocol was embedded within the ambulatory 
recording protocol of this study. During the home visit two typical laboratory tasks, each 
lasting two minutes, were executed by the participants in a fixed order. For this we used 
the computerized Stroop Color-Word conflict task and a Serial Subtraction task, because 
both cognitive tasks have proven capable of eliciting a psychophysiological stress 
response (Boutcher & Boutcher, 2006; Renaud & Blondin, 1997; Sung, Izzo, Jr., Dandona, 
& Wilson, 1999; Tulen, Moleman, van Steenis, & Boomsma, 1989). For the Stroop task, 
stimuli consisted of one of four color names that were printed in incongruent colors. In 
total, 99 presentations of 12 combinations of incongruent stimuli were presented in a 
random order for 2 minutes. As we only included a 2 min Stroop conflict task and none 
of the non-conflicting control tasks, the test was preceded by a 45 sec practice session. 
Participants verbally responded to the stimuli. In the Serial Subtraction task, participants 
were asked to sequentially subtract backward by 7 aloud as quickly as possible for 2 min. 
Each participant began with the number 1256. When an error was made, the participant 
was corrected and instructed to continue from that point on. The cognitive tasks were 
preceded by four minutes of quiet sitting in a secluded part of the house/work area. 
Subsequently, participants were instructed to wear the VU-AMS device the 
entire day and night up until the next day, after having worn the device for 24 hours. 
Instructions were supplied that explained how to respond to potential alarm beeps (e.g., 
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on loose electrode contacts), and telephone assistance was available during waking 
hours. Participants were requested to keep a paper-and-pencil diary and to write down a 
chronological account of their activity, posture, location, and social situation over the past 
time period (free recall). For wave 1 and 2 in Study 1 participants were prompted by an 
alarm beep to do so every 30 minutes, for Study 2 the diary was filled every 60 minutes. 
In addition, participants were instructed to write down at which time they had breakfast, 
lunch, and dinner and they were asked to refrain from vigorous exercise during the 
ambulatory recording day. The next day, the VU-AMS device was detached and collected 
by the researcher or returned by mail.
RSA and PEP measurement
RSA is considered a reliable index of parasympathetic control over the heart, whereas PEP is 
considered a reliable index of sympathetic control over the heart (de Geus et al., 2015). The 
assessment and quantification of respiration and RSA from VU-AMS recordings has been 
described previously (Neijts et al., 2014). Briefly, the dZ signal at the respiration frequency 
(0.1 to 0.4 Hz), combined with the inter-beat interval (IBI) series was used to compute 
‘peak–valley’ RSA (pvRSA). In this method, RSA is scored by detecting the shortest IBI during 
inspiration and the longest IBI during expiration on a breath-to-breath basis according to 
procedures detailed elsewhere (de Geus et al., 1995; Houtveen et al., 2005). If no shortest 
or longest IBI could be detected in inspiration and expiration respectively, pvRSA was set 
to zero.
For the assessment of the PEP, a measure of cardiac contractility, both the ECG and 
the ICG are used. The ICG signal was ensemble averaged across the diary-coded activity 
periods (described in the section on Ambulatory data reduction), time-locking the signal to 
the R-wave peaks (Riese et al., 2003). The PEP is defined as the time interval between the 
Q-wave onset of the ECG and the B-point of the dZ/dt signal. The Q-wave reflects the 
onset of left ventricular activity and the B-point reflects the opening of the aortic valves. 
In both VU-AMS versions, the R and B points are scored automatically by the software. In 
the newer 5fs version of the VU-AMS, the entire ECG signal is stored, so the Q-onset time 
was available as well. All automated scoring was visually checked by the experimenter. 
For the calculation of PEP in the two waves of Study 1, a fixed Q-R interval of 48 msec 
was added to the duration of the R-B interval (Willemsen, de Geus, Klaver, van Doornen, 
& Carroll, 1996). For Study 2, the true Q-onset point was used when present; otherwise 
the grand average of the Q-R interval was summed to the R-B interval of the individual 
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participant. If R-onset was additionally missing, we subtracted the grand average Q-onset 
time from the individual participants’ B-point (van Lien, Schutte, Meijer, & de Geus, 2013).
Ambulatory data reduction
Using the activity diary entries in combination with a visual inspection of the output of an 
inbuilt accelerometer (measuring movement), the entire 24-h recording was divided into 
fixed periods. These periods were coded for posture (supine, sitting, standing, walking, 
bicycling), activity (e.g. desk work, dinner, meetings, watching TV), physical load (no load, 
light, intermediate and heavy) and location of the participant (e.g. at home, at work, 
public space). Minimum duration of periods was 5 min and maximum duration was 1 
hour. If periods with similar activity and posture lasted more than 1 hour (e.g. during 
sleep), they were divided into multiple periods of maximally 1 hour. For each of the coded 
periods the mean IBI, RSA and PEP was calculated. The periods belonging to the standard 
baseline and stress conditions were additionally coded for the participants that took part 
in Study 2 with one period representing the resting baseline (‘standardized_baseline’) 
condition and one period representing the stress condition, averaged over the two tasks 
(‘standardized_stress’). 
From the ambulatory autonomic nervous system (ANS) recording, two ambulatory 
baseline and four ambulatory stress conditions were defined. For the first ambulatory 
baseline condition, the mean IBI, pvRSA and PEP value across all sleeping periods was 
calculated (‘sleep’). A period was classified as a sleeping period based on the reported 
bedtime in the diary and physical activity was verified by accelerometry. For the second 
ambulatory baseline, per participant the mean of periods spent sitting while being 
engaged in recreational activities in the evening, from 6 pm till bedtime, was determined 
to represent the alternative baseline condition (‘leisure’). Periods summed to at least half 
an hour. For the first ambulatory stress condition, the mean waking level of IBI, pvRSA, 
and PEP was used, including both sitting and light physical (non-sitting) activities (‘wake’). 
As participants were explicitly instructed not to engage in vigorous exercise during the 
recording day, these periods did not include high physical activity. Periods of light physical 
activity were classified as such based on the activity information obtained from the diary 
and the accompanying accelerometer signal. The additional ambulatory stress conditions 
were defined only for participants who reported the testing day to be a working day and 
who actually reported in the diary to have been at the work location during the testing 
day. For these participants all periods in which the participant was engaged in sitting 
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activities or light physical activity at work during a working day between 9 am and 6 pm 
were defined as work. Because there were multiple periods that fit this condition, mean 
IBI, pvRSA and PEP levels were determined across the entire working period (‘work’) and 
across a selection of periods at work when the participants were sitting (‘work_sitting’). 
Finally, an ambulatory stress condition was created from a time frame of at least half an 
hour with the highest HR while the participant was sitting at work between 9 am and 
6 pm. Because this timeframe only consisted of few coded periods and we wanted to 
prevent that relatively high weight would be given to extreme values, the median instead 
of the mean IBI, pvRSA, and PEP values of the periods with the highest HR was selected 
to represent ‘work_peak’. 
Table 4.2. Ambulatory conditions for ambulatory reactivity assessment. The reactivity measures that 
were calculated are listed separately. 
Ambulatory condition Description
Baseline
sleep Mean level during sleep 
leisure The mean of periods while the participant is sitting and engaged in 
recreational activities like internet, reading, watching television, but not 
eating or drinking. Periods sum to at least half an hour. Only periods in 
the evening, from 6 pm till bedtime, are considered eligible.
Stress
wake The mean waking level – including sitting and light physical activity only
work The mean of all periods in which the participant was engaged in sitting 
or light physical activity between 9 am and 6 pm during a working day 
at the work location
work_sitting Similar to ‘work’, except that the mean of all periods in which the 
participant was engaged in sitting activities only between 9 am and 6 
pm during a working day at the work location was calculated 
work_peak A time frame of periods with the highest heart rate while the participant 
is sitting between 9 am and 6 pm during a working day at the work 
location. Periods sum to at least half an hour. The median of the 
selected periods is taken to represent work_peak
Reactivity
Δ wake - sleep Absolute difference score between wake and sleep level
Δ work - sleep Absolute difference score between work and sleep level
Δ work_sitting - sleep Absolute difference score between work_sitting and sleep level
Δ work_sitting - leisure Absolute difference score between work_sitting and leisure level
Δ work_peak - sleep Absolute difference score between work_peak and sleep level
Δ work_peak - leisure Absolute difference score between work_peak and leisure level
Six different ambulatory reactivity measures were calculated by computing absolute diffe-
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rence scores between wake minus sleep (Δ wake – sleep), work minus sleep (Δ work – sleep), 
work_sitting minus sleep (Δ work_sitting – sleep), work_sitting minus leisure (Δ work_sitting 
– leisure), work_peak minus sleep (Δ work_peak – sleep), and work_peak minus leisure (Δ 
work_peak – leisure). The standard stress reactivity was computed as the mean of the two 
mental stress tasks minus the baseline rest condition. For an overview of the ambulatory 
conditions and ambulatory reactivity measures, see Table 4.2.
Statistical analyses
Sample selection, data preparation, and all non-genetic statistical analyses were 
performed using IBM SPSS 20.0. The distributions of ambulatory IBI and PEP levels and 
all ambulatory reactivity measures were normal. For ambulatory pvRSA levels, a natural 
logtransformation was applied to obtain a normal distribution. Significant differences 
between ambulatory conditions were tested by a MIXED model ANOVA with age and sex 
(and with respiration rate for pvRSA only) as covariates and family as a random factor and 
ambulatory condition as a repeated fixed factor (sleep, leisure, wake, work, work_sitting, 
and work_peak). A similar ANOVA was used to test the difference between mental stress 
and baseline conditions during the standard part of the recording. Temporal stability of 
the ambulatory measures across the two waves of Study 1 was calculated as an intraclass 
correlation. Associations between ambulatory reactivity scores amongst themselves and 
with the standard stress reactivity were assessed by Pearson correlations. For all statistical 
testing, effects were considered significant when p < .01.
Genetic analysis
In a twin-study, variance is typically decomposed into latent genetic and environmental 
components. Genetic variance can be further decomposed into shared additive (A) 
and non-additive (D) components. Environmental variance can be decomposed in a 
component that is common in family members (C) or that is unique (E) to the individual. In 
a study design that only includes twins and siblings, estimates of C and D are confounded, 
and cannot be estimated simultaneously. In that case, the pattern of the twin correlations 
is used to guide the experimenters’ choice to model either an ACE or an ADE model. An 
ACE model is chosen when the MZ correlations are less than twice as high as the DZ and 
sibling correlations. Dominance or non-additive genetic factors may be present when the 
MZ correlations are more than twice as high as the DZ and sibling correlations, and in that 
case an ADE model will be chosen (de Geus, 2010). MZ correlations can also be useful to 
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explore the reliability of the trait. Estimation of the ratio of Var(E) to the total variance (e²) 
provides a first impression of the unreliability of the trait. The E factor contains true unique 
environmental effects on the trait plus measurement error. As MZ twins are correlated 
perfectly for genetic and for common environmental factors, 1 – e2 is equal to the MZ twin 
correlation (rMZ). Therefore, rMZ is a lower bound for the test-retest reliability coefficient, 
because at the level of an individual unique environment (E) may also lead to stability.
Genetic analyses were performed using structural equation modeling (SEM) in the 
software package Mx (Neale et al., 2006). In SEM, models are fitted to the data and a 
goodness of fit statistic is calculated for each model. Subsequently, the fit of the more 
parsimonious nested models is compared to the fit of the full model by means of the 
likelihood ratio test in which the difference in minus twice the logarithm of the likelihood 
(-2LL) is calculated, this difference has a χ² distribution. When the χ² test is significant (p < 
.01), the more parsimonious model is considered to fit significantly worse to the data than 
the fuller model it is tested against. Before the variance was decomposed into genetic 
and environmental components, saturated models were fitted to the data. In these fully 
parameterized models, we tested for heterogeneity in male and female variances and 
family correlations. More specifically, we tested if sex differences were present and if 
there was evidence for a twin-specific resemblance. The allowed limitations were carried 
forward in the specification of the genetic models. Overall, we did not find evidence for 
twin specific resemblance nor for systematic quantitative or qualitative sex differences. 
We therefore continued estimating all parameters by combining data from males and 
females. Sex and age (and respiration rate for pvRSA) effects on the mean were regressed 
out simultaneously with variance decomposition.
Bivariate genetic models were specified to examine the genetic architecture and 
the change in the genetic influences from baseline ambulatory conditions to ambulatory 
stress conditions (Supplemental Figure 4.1). More specifically, the heritability of the 
baseline condition, or the effect of A1, is estimated by the relative contribution of genetic 
variance to the total variance in the baseline condition and is assessed by the ratio of a11² 
/ (a11² + c11² + e11²). Because the genetic variance during stress conditions can consist of 
the genetic variance that is shared with baseline activity and with new genetic variance 
that emerges during stress, heritability of the ambulatory stress condition is calculated as 
follows: a21² + a22² / (a21² + a22² + c21² + c22² + e21² + 22²). The effects of the genetic factors 
that are expressed during baseline can be amplified (a21 > a11) or deamplified (a21 < a11) 
during stress. The significance of stress-specific genetic effects can be assessed by testing 
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if the path coefficient a22 is significantly different from zero. The part of the heritability that 
is due to these new genetic factors (A2) can be calculated as: a22² / (a21² + a22² + c21² + c22² 
+ e21² + 22²). The heritability of ambulatory reactivity was also calculated by procedures 
described in more detail elsewhere (de Geus et al., 2007). Briefly, it was calculated as a 
change score within the bivariate model by adding a latent factor with fixed loadings 
of +1 and -1 on baseline and stress, respectively. The total variance of the ambulatory 
reactivity score is equal to the sum of the variance during baseline and stress, minus the 
covariance between baseline and stress conditions. So the genetic part of the variance 
of ambulatory reactivity is a11² + a21² + a22² - 2 a11 x a21 which is equal to (a21 - a11)² + a22². 
Heritability of the ambulatory reactivity score is calculated by ((a21 - a11)² + a22²) / ((a21 - a11)² 
+ a22² + (c21 - c11)² + c22² + (e21 - e11)² + e22²). 
Results
Table 4.3 gives the mean levels and standard deviations of the three variables of interest 
for the six conditions and the means and standard deviations of the different reactivities 
that were calculated based on these conditions. The table shows that all participants have 
data during waking time. However, only 56.7% of the participants who reported that the 
testing day was a working day actually reported to be at the work location during the 
testing day. 13.9% of participants reported that the testing day was a working day, but 
they did not spend time in an external working environment (housewives, people working 
at home).
A significant main effect of ambulatory condition was found for all ANS variables; 
IBI, (F (5, 4422) =3127.954, p < .001), pvRSA (F (5, 4458) = 335.281, p < .001), and 
PEP (F(5, 4337) = 235.841, p < .001). Post hoc testing of the reactivity values showed 
this to mainly reflect the four daytime versus sleep contrasts for all three ANS variables 
(see Table 4.3). For IBI and pvRSA, the two contrasts including leisure time as baseline 
measure were also significant (p’s < .001).
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Table 4.3. Means and standard deviations (SD) of IBI, pvRSA and PEP in the six ambulatory conditi-
ons. Reactivity is listed separately.
IBI (ms) pvRSA (ms) PEP (ms)
N Mean (SD) N Mean (SD) N Mean (SD)
Levels
sleep 1242 983.62 (132.37) 1242 55.80 (24.63) 1225 106.28 (15.72)
leisure 1075 837.67 (115.93) 1075 48.30 (22.31) 1044 99.20 (16.32)
wake 1288 759.58 (95.46) 1288 40.86 (15.10) 1285 96.74 (15.67)
work 730 749.92 (113.52) 730 41.27 (16.65) 725 97.12 (16.79)
work_sitting 686 784.63 (112.70) 686 44.89 (18.25) 677 99.49 (17.78)
work_peak 633 739.26 (105.45) 633 39.83 (16.49) 624 97.93 (21.01)
Reactivities
Wake-sleep 1242 -223.51 (85.46) 1242 -15.07 (19.00) 1225 -9.42 (12.89)
Work-sleep 701 -240.58 (106.43) 701 -14.89 (22.16) 685 -8.77 (14.81)
Worksit-sleep 657 -205.89 (100.75) 657 -11.48 (21.30) 639 -6.23 (15.17)
Workpeak-sleep 609 -254.71 (104.33) 609 -16.99 (22.83) 591 -8.06 (15.83)
Worksit-leisure 564 -58.70 (84.00) 564 -3.66 (14.77) 544 1.70 (10.03)
Workpeak-leisure 523 -106.08 (87.13) 523 -8.91 (16.75) 506 0.02 (11.11)
There were significant intercorrelations between all six reactivity measures for IBI, pvRSA 
and PEP (see Supplemental Table 4.1), but the choice of baseline was critical; the four 
reactivity measures using sleep as a baseline were highly correlated amongst each other 
(r’s > 0.87) and so were the two reactivity measures using leisure time sitting as a baseline 
(r’s > 0.89). Correlation was less strong between to the reactivity measures based on 
sleep versus those based on leisure time sitting (0.30 < r < 0.61 for IBI, 0.28 < r < 0.58 for 
pvRSA, and 0.29 < r < 0.60 for PEP). 
Table 4.4 presents the levels attained during the standard stress testing protocol 
that took place at home preceding the ambulatory monitoring in Study 2. In this setting, 
task levels also significantly declined compared to rest for IBI (F (1, 520) = 602.974, p < 
.001), pvRSA (F (1, 519) = 33.785, p < .001), and PEP (F (1, 482) = 98.296, p < .001). The 
standard reactivity measure was very poorly correlated with each of the six ambulatory 
reactivity measures (see Supplemental Table 4.2), particularly for PEP. 
Table 4.5 depicts the temporal stability for the ambulatory levels and reactivity 
measures. Higher temporal stability is more consistently found for the ambulatory 
levels (0.71 < r < 0.90) compared to the reactivity scores which nonetheless show very 
good stability over time for all three ANS parameters (0.36 < r < 0.91). The fact that 
the ambulatory levels capture stable individual traits is further reinforced by the MZ 
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twin correlations that can be used as a proxy of the minimal test-retest reliability for the 
ambulatory levels (Supplemental Figure 4.2).
Table 4.4. Means and standard deviations (SD) of IBI, pvRSA, and PEP levels and reactivity during 
the standard stress protocol. 
IBI (ms) pvRSA (ms) PEP (ms)
N Mean (SD) N Mean (SD) N Mean (SD)
Rest 522 834.62 (120.27) 522 48.36 (22.22) 493 107.12 (20.75)
Tasks 521 774.32 (111.43) 521 44.75 (17.73) 493 103.06 (21.01)
Δ task – rest 521 -59.82 (55.65) 521 -3.51 (13.87) 483 -4.22 (9.30)
Table 4.5. Temporal stability of the ambulatory levels and reactivity measures over an average time 
period of 3.3 years. 
IBI pvRSA PEP 
N ICC N ICC N ICC
sleep 53 .80 53 .86 51 .84
leisure 48 .68 48 .82 47 .87
wake 62 .79 62 .82 62 .89
work 19 .77 19 .90 19 .87
work_sitting 19 .71 19 .89 18 .86
work_peak 16 .74 16 .85 15 .85
Δ wake - sleep 53 .71 53 .83 51 .49
Δ work - sleep 17 .91 17 .84 16 .48
Δ work_sitting - sleep 17 .89 17 .79 15 .52
Δ work_sitting - leisure 15 .36 15 .58 13 .76
Δ work_peak - sleep 17 .40 17 .68 15 .73
Δ work_peak - leisure 13 .44 13 .85 12 .65
MZ twin correlations were higher than DZ twin correlations suggesting a role for genetic 
factors in explaining individual differences in IBI, pvRSA, and PEP levels during rest and 
stress periods in real-life. This was confirmed by genetic structural equation modeling. 
For all conditions, IBI and pvRSA in both the ambulatory and the standard setting and 
for PEP in the standard setting only, ACE models were fitted to the data. For PEP in the 
ambulatory conditions, ADE models were fitted to the data as the MZ twin correlations in 
these instances were more than twice as high as the DZ twin correlations. Formal testing 
showed that C and D factors could be dropped from all models and AE models provided 
90 Chapter 4
the most parsimonious fit for all three ANS measures in all conditions in both settings. 
Heritability estimates for the IBI, pvRSA, and PEP levels in all baseline and stress conditions 
and the ambulatory and standard reactivity measures are listed in Table 4.6. In general, 
heritability for the baseline levels was lower than heritability of the stress levels but, as 
can also be judged from the confidence intervals, this difference was only significant for 
work_sitting compared to leisure and sleep where it went from 51 to 69% and from 53 to 
69%, respectively, for IBI. For PEP, heritability of work_sitting (44%) was also significantly 
higher than leisure (25%) and there was a clear trend for work_peak for which heritability 
was estimated at 42%.
For all ambulatory reactivity contrasts, there was a common genetic factor that 
influenced both baseline and stress levels but, in addition, new genetic factors were 
found to emerge during stress compared to the baseline conditions, yielding significant 
heritability of the corresponding ambulatory reactivity measures. For IBI, significant 
heritability of reactivity was found for five reactivity measures, except for leisure compared 
to work_peak. For the pvRSA, heritability of four reactivity measures were significant, the 
exceptions being work_sitting compared to leisure and work_peak compared to leisure. 
For PEP, heritability of ambulatory reactivity was significant for the wake compared to 
sleep and both the work_sitting and work_peak compared to leisure contrasts. During 
stress, genes acting at the resting level were deamplified for all ambulatory IBI and pvRSA 
reactivity measures, with the exception of Δ work_sitting – leisure for IBI and pvRSA, and 
Δ work_peak – leisure for pvRSA only. Deamplification of genetic variance means that 
the effect of the genes active during rest accounted for a smaller part of the variance 
during stress. For the ambulatory PEP reactivity measures, no significant deamplification 
of genetic factors was found when going from rest to stress and the genetic factors 
influencing leisure time were even significantly amplified by the work_sitting and the 
work_peak conditions. 
For standard stress reactivity, too, a common genetic factor was found to influence 
both rest and task levels and new genetic factors emerged during task stress for all ANS 
measures. Although these effects were significant, they were less pronounced in the 
standard stress environment compared to real-life. 
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Discussion
This study describes a large twin study on changes in ambulatory levels of IBI, PEP, and 
pvRSA when going from sleep and resting in leisure time to more socially and mentally 
engaging activities during the working day. We found that ambulatory autonomic 
reactivity is a stable, heritable individual trait, showing moderate to high temporal stability 
over a three-year follow-up period. Depending on the definition of ambulatory reactivity 
employed, heritability ranged from 29 to 40% for IBI, 34 to 47% for pvRSA, and 10 to 19% 
for PEP, although not all reactivity measures showed heritability. Heritability of ambulatory 
autonomic reactivity was largely due to new genetic variance specifically emerging during 
stress, while the genetic factors influencing resting baseline levels became less prominent 
under stress. 
These results replicate and extend previous findings in laboratory stress testing. In 
an earlier laboratory study of our group stress-specific heritability for HR was seen in an 
adolescent and in a middle-aged sample (de Geus et al., 2007). No stress-specific genetic 
effects for RSA were found in both age groups, but another study in adolescents did 
report stress-specific genetic effects on heart rate variability (HRV) (Wang et al., 2009). For 
PEP, stress-specific genetic effects were found in adolescent but not in middle-aged twins 
(de Geus et al., 2007). Although we did find stress-specific genetic effects on HR, RSA 
and PEP in the current study during standard task stress, the influence of stress-specific 
genetic effects in real-life was generally larger. The partly divergent findings may be due 
to the nature of the stress tasks that were used. De Geus et al. (de Geus et al., 2007) used 
short mental stress tasks to induce stress while Wang et al. (2009) used tasks that more 
closely approached stress in real-life by including virtual reality car driving, a video game 
challenge, and a social competence interview. Combining this with the evidence from the 
current ambulatory study, we hypothesize that the use of more ecologically valid stressors 
tends to increase the contribution of novel genetic factors to individual differences in 
stress-reactivity.
Previous prospective studies on the health effects of reactivity have been limited to 
short-term reactivity to standard laboratory stress tasks (Chida & Steptoe, 2010; Treiber et 
al., 2003). Correlations between short-term stress reactivity calculated from our standard 
rest and stress tasks with ambulatory reactivity were weak which confirms previous 
research finding poor generalizability of artificial to more realistic reactivity measures 
(Johnston et al., 2008; Kamarck et al., 2000; Kamarck et al., 2003; Schwerdtfeger et al., 
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2014). This again suggests that the stress induced in the typical laboratory setting may 
not fully capture the individual differences measured during stress in real-life.
An important question is whether our results allow us to select a clear favorite 
ambulatory autonomic reactivity measure from unstructured 24-h recordings for use in 
stress research, using the temporal stability, heritability, and the ability to detect stress-
specific genetic variance as prioritization criteria. For IBI, these criteria do not point to 
an optimal reactivity measure nor do they disqualify any of the six reactivity measures. 
Temporal stability was good, and of similar magnitude or even better as in previous 
ambulatory studies (Goedhart et al., 2006; Goedhart et al., 2007; Vrijkotte, Riese, & 
de Geus, 2001). It was particularly good when compared to the temporal stability of 
laboratory reactivity for HR (Allen, Sherwood, Obrist, Crowell, & Grange, 1987; Burleson 
et al., 2003; Cohen et al., 2000; Hamer, Gibson, Vuononvirta, Williams, & Steptoe, 2006; 
Hassellund, Flaa, Sandvik, Kjeldsen, & Rostrup, 2010; Llabre et al., 1993; Manuck & 
Garland, 1980; Sherwood et al., 1997; Veit, Brody, & Rau, 1997), PEP (Allen et al., 1987; 
Burleson et al., 2003; Llabre et al., 1993; Sherwood et al., 1997), or HRV (Burleson et al., 
2003; Bertsch, Hagemann, Naumann, Schachinger, & Schulz, 2012; Dragomir, Gentile, 
Nolan, & D’Antono, 2014). Five IBI reactivity measures were heritable and, due to genetic 
emergence, more than half of the variation in stress levels of heart rate was due to 
genetic factors. For PEP and RSA, temporal stability was moderate to good and with 
few exceptions all reactivity measures were also significantly heritable. For PEP during 
work_sitting and work_peak no new genetic variance emerged compared to leisure time, 
instead existing variance got amplified. Using MZ correlations as an indicator of reliability, 
IBI, RSA and PEP levels also performed well for all six conditions, with no clear ‘best’ 
baseline or stress condition. We therefore conclude that all six measures as defined here 
have comparable properties from a psychometric viewpoint. 
To select an optimal ambulatory autonomic reactivity measure additional criteria, 
more related to content, need to be considered. Three of these are the mean absolute 
size of reactivity, the extent of the individual differences (variance), and the avoidance 
of contrasts incorporating changes in posture and physical activity. Statistical power to 
detect correlation of reactivity with health outcomes scales with its variance and effect 
size. Standard deviations for the reactivity values were of near comparable magnitude 
as those for the IBI, pvRSA, and PEP levels, implying there is considerable variation in 
individual responses to daily life situations. This held true for all reactivity measures 
incorporating either sleep or leisure time as a baseline, although most variation was seen 
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in the reactivity measures that included sleep as a baseline. When higher absolute values 
of reactivity (reflecting larger autonomic engagement) are considered, reactivity measures 
based on sleep also seem most favorable as they yield the strongest reactivity. However, 
sleep versus wake contrasts also contain changes in posture and physical activity which 
are known to influence RSA and PEP through effects other than true changes in cardiac 
autonomic control (Houtveen et al., 2005; Grossman et al., 2004). Validity of PEP as a 
readout for cardiac sympathetic control is sensitive to distortion by postural shifts as it is 
affected by both preload and afterload (Houtveen et al., 2005). The contrasts that avoid 
large influences of posture change and that are characterized by low physical activity may 
therefore be optimal, i.e. Δ work_sitting – leisure and Δ work_peak – leisure. However, 
these were also the contrasts with lowest absolute reactivity, making them less attractive. 
The magnitude of reactivity computed for these two work conditions with sleep as a 
baseline (Δ work_sitting – sleep and Δ work_peak – sleep) was much higher. Work_sitting 
and work_peak were likely characterized by active mental and/or social engagement with 
the environment, but in the presence of minimal physical activity. As the postural shift 
from supine to sitting is less severe than the shift from supine to standing (which could 
occur frequently during wake and non-sitting work periods) Δ work_sitting – sleep and 
Δ work_peak – sleep may be the preferred measures for studies seeking to link (genetic 
variants for) individual differences in ambulatory reactivity to health outcomes. 
A limitation of this study is the use of objective landmarks in unstructured 24-h 
recordings to delineate periods as stressful without subjective confirmation of stress by 
the participant. We reasonably assumed that time spent at work would be more enriched 
than leisure or sleep by mentally and socially engaging activities and that the presence 
of a high heart rate within a period of accelerometer-confirmed minimal physical activity 
was likewise attributable to the effects of such activities. However, the selection of periods 
of high HR at work is meaningful only when all participants encounter comparable work 
stressors at the recording day and at least one stressor with sufficient salience to trigger 
substantial HR reactivity. Therefore, our physiology-driven definition of peak stress may 
have led us to inadvertently label people who did not encounter a strong stressor at work as 
low HR reactors. To resolve this circularity, we should have assessed individual differences 
in the amount of subjective stress exposure at work, which we did not. On the other 
hand, subjective experience is known to be only very poorly correlated to physiological 
reactivity (a topic recently covered in a special issue of Biological Psychology, see for 
example Friedman, Stephens, & Thayer, 2014). The critical question is whether autonomic 
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reactivity as defined here is a good predictor of health outcomes. This of course remains 
to be tested – here we have shown that there is stable, heritable variation in ambulatory 
reactivity that can be meaningfully used in future predictive studies.
A further limitation is that the ambulatory baseline conditions that were defined for 
this study, leisure time and sleep, occurred post-stress in the real-life assessment. This 
means that recovery processes instead of a ‘true baseline’ level may have been measured. 
If recovery processes were indeed involved during leisure time or sleep, this may have 
contributed to the poor correlation between our standard and ambulatory reactivity 
measures, as a pre-test baseline was used to compute the standard stress reactivity. 
In conclusion, ambulatory autonomic reactivity extracted from an unstructured real-
life setting shows reliable, stable and heritable individual differences. Real-life situations 
uncover new and different genetic variation compared to that seen in resting baseline 
conditions, including sleep. The contrasts between sitting work levels, including the 
peak stress period, and sleep baseline seem the most promising ambulatory reactivity 
measures for research in the field of psychosomatic medicine. 
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Supplement to Chapter 4
Heritability and temporal stability of ambulatory autonomic stress reactivity  
in unstructured 24-h recordings 
Supplemental Table 4.1. Intercorrelations (N) among the ambulatory reactivity measures.
∆ wake - 
sleep
∆ work - 
sleep
∆ work 
sitting - 
sleep
∆ work 
sitting - 
leisure
∆ work_
peak - 
sleep
IBI
Δ wake - sleep
Δ work - sleep .91 (701) **
Δ work_sitting - sleep .90 (657) ** .95 (657) **
Δ work_sitting - leisure .31 (552) ** .54 (552) ** .58 (552) **
Δ work_peak - sleep .87 (609) ** .88 (609) ** .94 (609) ** .51 (513) **
Δ work_peak - leisure .30 (513) ** .47 (513) ** .52 (513) ** .92 (523) ** .61 (513) **
RSA
Δ wake - sleep
Δ work - sleep .96 (701) **
Δ work_sitting - sleep .94 (657) ** .96 (657) **
Δ work_sitting - leisure .28 (552) ** .44 (552) ** .47 (552) **
Δ work_peak - sleep .92 (609) ** .92 (609) ** .94 (609) ** .47 (513) **
Δ work_peak - leisure .33 (513) ** .43 (513) ** .44 (513) ** .89 (523) ** .58 (513) **
PEP
Δ wake - sleep
Δ work - sleep .96 (685) **
Δ work_sitting - sleep .93 (639) ** .96 (639) **
Δ work_sitting - leisure .31 (529) ** .47 (529) ** .55 (529) **
Δ work_peak - sleep .90 (591) ** .92 (591) ** .96 (591) ** .52 (494) **
Δ work_peak - leisure .29 (494) ** .41 (494) ** .48 (494) ** .90 (506) ** .60 (494) **
Note. ** = significant correlation (p < .01).
Supplemental Table 4.2. ‘Lab-real life’ correlation (N) between the reactivity to structured stressors 
and ambulatory reactivity measures.
∆ wake - 
sleep
∆ work - 
sleep
∆ work_
sitting - 
sleep
∆ work_
sitting - 
leisure
∆ work_
peak - 
sleep
∆ work_
peak - 
leisure
Δ task – rest IBI .16 (511) ** .02 (297) .06 (273) -.04 (216) .16 (248) * .08 (196)
Δ task – rest pvRSA .14 (511) ** .09 (297) .05 (273) .12 (216) .12 (248) .20 (196)**
Δ task – rest PEP -.06 (471) -.10 (270) -.12 (245) -.13 (185) -.07 (222) -.06 (168)
Note. ** = significant correlation (p < .01), * = significant correlation (p < .05).
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Supplemental Figure 4.1. Example of a bivariate genetic ACE model that was fitted to  
the ambulatory baseline and stress conditions.
E1 
baseline 
c11 
C1 A1 
a11 e11 
E2 
stress 
c22 
C2 A2 
a22 e22 
a21 c21 e21 
ambulatory 
reactivity 
+1 -1 
Note. A1 and A2, C1 and C2, and E1 and E2 are the latent genetic, shared environmental, and 
unique environmental factors, that influence the observed baseline and stress measures. The a11, 
c11, and e11 paths are unique to the baseline measure, whereas paths a22, c22, and e22 are unique 
to the stress measure. With the a21, c21, and e21 paths the genetic, shared environmental, and 
unique environmental factors of the covariance between baseline and stress levels, is described. The 
model also specifies a ‘delta score’ ambulatory reactivity which represents the difference between 
baseline and stress scores.
Supplemental Figure 4.2. MZ and DZ correlations of the IBI, pvRSA, and PEP levels as obtained 
from the saturated Mx models.
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A novel approach to Holter data analysis 
improves phenotyping and increases 
the precision of genetic analysis of ECG 
biomarkers
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Abstract
The resting ECG is routinely used to assess cardiac electrical activity, which is a 
highly dynamic process. We wanted to determine whether analysis of frequency 
specific data from Holter ECGs allows for a more complete genetic dissection 
of cardiac electrophysiology. Holter ECGs were recorded from 221 twin pairs 
and analyzed using a novel multi-parameter beat classifier to extract heart rate 
specific data. Heart rate dependent estimates of heritability for QRS duration, QT 
interval, Tpeak–Tend and T-wave amplitude (TWA) were calculated using structural 
equation modelling. Our data showed that QRS duration is largely determined by 
environmental factors whereas repolarization is primarily genetically determined. 
Heritability estimates of both QT interval and TWA were significantly higher when 
measured from Holter compared to resting ECGs and the heritability estimate 
of each was heart rate dependent. Analysis of the genetic correlation between 
repolarization parameters demonstrated that while most of the genes that 
contribute to covariance of individual ECG parameters at different heart rates 
overlap, at each specific heart rate there was relatively little overlap between the 
genes that determine the different repolarization parameters. Here we present the 
first study of heritability of repolarization parameters measured from Holter ECGs. 
Our data demonstrate that higher heritability can be estimated from the Holter 
than the resting ECG and reveals rate dependence in the genetic – environmental 
determinants of the ECG that has not previously been tractable. Future uses of 
this analysis include deeper dissection of the ECG of participants with inherited 
cardiac electrical disease.
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Introduction
The electrocardiogram (ECG) represents the summed electrical activity of all the action 
potentials of individual myocytes in the heart (Einthoven, 1912; Nerbonne & Kass, 2005). 
The generation of these action potentials reflects the finely tuned and coordinated 
opening and closing of ion channels that conduct either depolarizing inward currents 
(sodium and calcium) or repolarizing outward currents (potassium) (Nerbonne & Kass, 
2005). Regional variation in ion channel density results in distinct action potential 
waveforms in different parts of the heart (Gaborit et al., 2007). When combined, they form 
the P-QRS-T complexes of the electrocardiogram. Specifically, the P wave corresponds to 
atrial depolarization, the QRS complex reflects ventricular depolarization and the T wave 
corresponds to ventricular repolarization. As such, the ECG has been an extraordinarily 
useful non-invasive diagnostic tool for assessing abnormalities of cardiac electrical activity 
for over a century (Fye, 1994).
Typically, a resting ECG is recorded over ~10 seconds and gives a ‘snapshot’ of the 
electrical activity of the heart. The cardiac electrical cycle however, particularly in relation 
to repolarization, is an incredibly dynamic process modulated by multiple inputs including 
sympathetic and parasympathetic nervous systems (Coumel, Fayn, Maison-Blanche, & 
Rubel, 1994), sleep-wake cycles (Jeyaraj et al., 2012), heart rate, and gender (James, 
Choisy, & Hancox, 2007; Stramba-Badiale, Locati, Martinelli, Courville, & Schwartz, 1997). 
A wealth of information relating to an individual’s cardiac electrical phenotype is therefore 
missed when recording just a snapshot of the ECG. As an alternative, recording cardiac 
electrical activity over a 24-hour period using continuous ambulatory ECG (Holter) is a 
much richer source of information that has the potential to provide a more complete and 
accurate phenotypic picture (Coumel et al., 1994). Holter ECGs are already a routinely used 
diagnostic tool in monitoring heart rate variability (Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology, 1996) and 
detecting the presence of arrhythmia episodes. They have also been used in a research 
setting to assess repolarization parameters. However, these previous studies used low 
temporal resolution recordings (Extramiana et al., 2010; Merri et al., 1992; Neyroud et 
al., 1998; Sobue et al., 2011; Sugao et al., 2006; Vaglio et al., 2008) and furthermore, the 
usefulness of ambulatory recording in diseases of repolarization has been questioned 
(Mauriello, Johnson, & Ackerman, 2011). Two of the reasons for this are the difficulties 
associated with manipulating and analyzing the large data sets produced over 24 hours 
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and secondly the problem of accounting for the range of physiological scenarios sampled. 
One approach to overcome these issues is to use a classification algorithm to “bin” beats 
that are representative of specific physiological states. Averaged representative beats can 
then be analyzed quickly and easily. Analyzing ECG parameters in this manner offers two 
main advantages over the resting ECG. First, one can obtain data that are representative 
of multiple physiological conditions such as specific heart rates. Second, by averaging 
multiple beats obtained from specific physiological states, one can obtain a better signal 
to noise ratio, thus improving the accuracy when measuring the intervals and amplitudes 
of ECG waveforms.
In this study we have used a novel dual-parameter beat classification algorithm 
to investigate whether analysis of ambulatory Holter ECG recordings can provide more 
accurate and detailed information about the genetic basis of cardiac electrical phenotypes 
relative to that obtained from analysis of the resting ECG. Specifically, we tested: (1) 
whether heritability of ambulatory recordings, after frequency binning, is larger than 
heritability of resting ECG, (2) the extent to which genetic influences on the ambulatory 
depolarization and repolarization parameters are heart rate-dependent, and (3) whether 
different genes are involved in the manifestation of repolarization in the three different 
parameters used. Taken together, we test the hypothesis that analysis of frequency binned 
beats from ambulatory ECG recordings allow for a more complete genetic dissection of 
individual differences in cardiac electrophysiology than a short resting ECG recording.
Methods
Participants
Holter recordings were carried out on 442 participants – 123 monozygotic (MZ) complete 
pairs and 98 dizygotic (DZ) complete twin pairs. Participating twins were registered 
with the Netherlands Twins Registry and all took part in the third wave of a large 24-h 
ambulatory cardiac monitoring study (Neijts et al., 2014). Zygosity was confirmed by DNA 
analysis for 97.3% of same-sex twin pairs. For the remaining same-sex pairs, zygosity was 
based on survey questions regarding physical similarity and the frequency of confusion 
of the twins by parents, other family members, and strangers (Willemsen et al., 2013). 
A priori reasons for exclusion from this cohort were heart transplantation, presence of a 
pacemaker, known ischemic heart disease, congestive heart failure, diabetic neuropathy, 
and pregnancy. In addition, 79 of the participants were taking medication with the 
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potential to the ECG (Supplemental Table 5.1) and were excluded from the main analysis. 
For comparison, twin correlations including participants on cardioactive medications are 
shown in Supplemental Table 5.2. The study protocol was approved by the medical Ethics 
Committee of the VU University Medical Center Amsterdam and the Human Research 
Ethics Committee of the New South Wales Ministry of Health (Australia). All participants 
gave written consent before entering the study. 
Holter ECG recording procedure
On the recording day, participants were visited either at home or at work and information 
on health status and current medication use was obtained. Participants were fitted with 
the 5fs version of the Vrije Universiteit Ambulatory Monitoring System (VU-AMS device, 
VU University Amsterdam, www.vu ams.nl) to acquire both electrocardiogram (ECG) 
and impedance cardiogram (ICG) data continuously over a 24-h period (de Geus et al., 
1995; van Dijk et al., 2013; Willemsen et al., 1996). Participants were asked to refrain 
from vigorous exercise during the measurement day. For acquisition of ECG data three 
electrodes were placed in modified CS5 lead positions - right subclavicular region 4 cm to 
the right of the sternum (negative electrode), under the left breast, 4 cm under the nipple 
(positive electrode) and the lower right thorax (ground electrode) – to obtain a derived 
Lead II. A typical averaged ECG obtained using the modified CS5 lead positions is shown 
in Figure 5.1. The raw ECG signal was imported into the VU-DAMS software (version 3.2, 
VU University Amsterdam, www.vu-ams.nl) and exported to an ASCII file sampled at 1 kHz 
for further processing.
Five landmarks were identified on each averaged ECG waveform: (i) Q: first 
deflection from the isoelectric line after the P-wave, (ii) R: peak of the QRS complex, (iii) S: 
intersection of S wave upstroke and T-P isoelectric line, (iv) Tpeak: peak of the T-wave, (v) 
Toffset: the point 95 % of the distance from T-peak to the minimum of the T wave. Since 
the modified CS5 lead positioning can result in biphasic T-waves (where the end of the 
T wave overshoots the isoelectric line; Figure 5.1), this estimate of the minimum point is 
typically taken as the end of the T wave (van Lien et al., 2015).
From these landmarks we measured the QRS duration (time from Q to S), a measure 
of ventricular depolarization, and QT interval (time from Q to Toffset), Tp-Te (time from 
Tpeak to Toffset) and TWA (amplitude from Tpeak to Toffset), all measures of ventricular 
repolarization (Figure 5.1).
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Figure 5.1. ECG acquisition. Three electrodes (positive, negative and ground) were placed in mo-
dified CS5 lead positions to obtain a derived Lead II. The example averaged waveform shows ECG 
landmarks and the measured intervals (QRS, QT, Tp-Te) and amplitudes (TWA).
TWA 
 
Extraction of averaged ECGs from Holter recording
Recordings were initially processed using a modified version of R-wave detection and 
waveform boundary recognition software available from the open source PhysioNet 
resource (Moody, Mark, & Goldberger, 2000; Goldberger et al., 2000). Every beat of the 
24 hour recording was classified first by the R-R interval into 0.1 Hz frequency ‘bins’ and 
then by R wave amplitude, before each bin was averaged (Figure 5.2). For subsequent 
analysis of heritability, three frequencies were considered - 1 Hz (Low heart rate, 60 bpm), 
1.3 Hz (Medium heart rate, 78 bpm) and 1.6 Hz (High heart rate, 96 bpm).
To permit comparison with previous estimates of heritability for ECG parameters 
derived from a standard resting ECG, an averaged QRS-T complex was generated for 
each participant from 10 successive beats with the lowest frequency and lowest standard 
deviation of R-R interval chosen from the period between 09.50 am and 10.10 am (the 
period that on average, for the entire participant dataset, had the lowest SD of RR interval) 
(Supplemental Figure 5.1). This approach ensured that we had the ‘best’ resting ECG in 
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terms of both stability and resting heart rate (average heart rate was 67 ± 0.6 bpm or 
1.12 ± 0.01 Hz (SEM; n=385)). In addition to the 4 standard ECG measurements, we also 
calculated corrected QT intervals for the resting ECGs, using Bazett’s formula (Bazett, 
1920).
Rate corrected QT has consistently been shown to have lower heritability 
than uncorrected QT (Haarmark, Kyvik, Vedel-Larsen, Budtz-Jorgensen, & Kanters, 
2011; Carter et al., 2000), a trend that was confirmed in our first pass twin correlation 
calculations (see Supplemental Table 5.3). Therefore all further analysis was carried out 
using uncorrected QT for the resting ECG, as the most stringent comparison to our Holter 
derived heritability estimates. Both the binned Holter data and the resting ECG data 
went through a two-step process of quality control. First, data was deemed unusable if 
there was an insufficient number of beats at the specified frequency or if it was too noisy. 
This left 323, 365 and 346 participants for low, medium and high heart rate respectively. 
Usable data was extracted to derive ‘resting ECGs’ for 427 participants. In stage two, 
two blinded independent investigators checked the computer-detected points for the 
Q-wave, the J-point, T-peak and T-offset for every tracing. If the computer-generated data 
were deemed inaccurate, all measurements for that participant at that particular heart 
rate were discarded. After quality control, we had data for 322 participants at low heart 
rate, 357 participants at medium heart rate and 313 participants at high heart rate (this 
corresponds to 90-99% of traces deemed usable). For the resting ECGs, data from 385 
participants were suitable for heritability analysis.
Genetic analysis based on twin data
Genetic models, addressing the etiology of individual differences, were fitted to the data 
using structural equation modelling (SEM) in the software package Mx (Neale et al., 2006). 
When data from twins are available, variance in an observed trait, called phenotypic 
variance, is typically decomposed into variance due to latent additive genetic factors (A), 
non-additive genetic factors (D), common environment (C) shared by family members, 
and non-shared or unique environment (E). In the classical twin design, which includes 
monozygotic (MZ) and dizygotic (DZ) twins, estimates of C and D are confounded as 
the total phenotypic variance, the MZ covariance, and the DZ covariance only provide 
sufficient information to estimate three out of four parameters (Boomsma, Busjahn, & 
Peltonen, 2002). Based on the pattern of twin correlations, we chose to model either an 
ACE or an ADE model. For all twins (MZ and DZ), common environmental factors are set 
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to correlate 1.0. Additive genetic factors are set to correlate 0.5 in DZ twins, and 1.0 in MZ 
twins, and non-additive genetic factors are set to correlate 0.25 in DZ twins, and 1.0 in MZ 
twins. Nonshared, or unique environmental factors are by definition uncorrelated in family 
members. These theoretical values among latent factors form the basis of the model to 
estimate the influence of A, C or D and E on the phenotype.
After establishing the most parsimonious variance components model (ACE or 
ADE, AE, CE, or E) for each ECG phenotype at each frequency two separate analyses 
were conducted. First, to test if heritability of the resting ECG differs from the Holter 
ECG and to examine whether the heritability of the different variables extracted from 
the Holter ECG was rate dependent, quadrivariate genetic models were fitted to the 
data for the three rate specific Holter groups (1.0Hz, 1.3Hz and 1.6Hz) and the resting 
ECG data (Supplemental Figure 5.2). Fit statistics of constrained models that equated 
the heritability for various combinations of the parameters where compared to those of 
the full model that estimated a separate heritability for each of the four ECG parameters. 
Second, to examine whether the three repolarization parameters were influenced by 
common or different genetic factors, trivariate genetic models were fitted to the rate 
specific Holter data. (Supplemental Figure 5.3) From these models we computed the 
genetic correlations between the three parameters and the contribution of the common 
genetic factor to the phenotypic correlation. The comparison of the fit of restricted 
models to the full model was performed by means of likelihood-ratio (χ²) tests in which 
the difference in -2LL between the two models is calculated. When the likelihood-ratio 
test is significant, the restricted model is considered to fit significantly worse to the data 
than the fuller model it is tested against.
All models regressed the effects of age and sex on the phenotype. A priori, we 
assumed no quantitative or qualitative sex differences in the variance decomposition to 
be present so only one MZ and one DZ correlation was estimated for each variable.
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Results
Dual parameter beat classification of Holter ECGs
To obtain ECG signals representative of specific physiological states, we used a beat 
binning approach (Figure 5.2A). For every beat in the Holter record, three parameters 
were measured: 1) The interval from the previous R wave to that of the selected beat 
(RRn), 2) The interval from the R wave of the selected beat to the subsequent R wave 
(RRn+1), and 3) The amplitude of the R wave of the selected beat (Ramp).
Based on these criteria, every beat was classified according to RRn and Ramp and 
a ‘heatmap’ created showing the frequency distribution of beats as a function of these 
parameters (Figure 5.2B). From this heatmap, subsets of beats representative of particular 
heart rates can be extracted. For example, the shaded region in Figure 5.2B corresponds 
to a heart rate of 1 Hz or 60 bpm. To reduce the number of abnormal and/or ectopic 
beats included in the analysis, only those beats that had an Ramp within 1 standard 
deviation (SD) of the mean Ramp at that frequency were included in the average for 
that frequency bin (Figure 5.2C). Furthermore, beats with an abnormally short or long 
coupling interval to the subsequent beat (RRn+1), were also excluded from the analysis 
for similar reasons (Figure 5.2D). A family of beats extracted at 1 Hz according to the 
criteria described above are shown in Figure 5.2E. This family of beats, all of similar 
morphology and timing, are then ensemble averaged, based on alignment of the peak 
of the R wave, to give a beat representative of a particular physiological state that has 
high signal to noise ratio, and is amenable to further analysis (Figure 5.2F). In order to 
test the efficacy of our binning approach in extracting beats from the Holter recording 
that are representative of different heart rates, we examined the rate dependent trends in 
ECG parameters measured from low, medium and high heart rate beats (Figure 5.3 and 
Supplemental Table 5.4). All measures of repolarization showed rate dependence. Both 
QT interval and Tp-Te shortened with faster heart rates, while TWA reduced. In contrast, 
the QRS duration, a measure of depolarization of the myocardium, was relatively rate 
independent.
108 Chapter 5
Figure 5.2. Dual parameter beat binning from Holter ECG. A) 10 beats from a typical raw Holter 
trace. For the beat highlighted in red, three measured parameters are shown: the interval from the 
peak of the R wave to the previous R peak (RRn), the interval from the R peak to the next R peak 
(RRn+1) and the R- amplitude (Ramp). B) A typical ‘Heatmap’ of the distributions of ECG beat  
characteristics over the 24hr period classified according to RRn and Ramp. The region incorporating 
beats with a frequency of 1 +/- 0.025 Hz is highlighted in grey. C) Frequency distribution of R peak 
amplitude (Ramp) within the region defined by 1+/- 0.025Hz in (B). The region incorporating 1 SD of 
Ramp variation is highlighted in grey. D) Frequency distribution of RRn+1 within the region defined 
by 1SD variation in (C). The region incorporating 2SD in RRn+1 is highlighted in grey. E) Represen-
tative family of 100 beats at 1Hz after the filtering procedure described in B, C and D. F) Averaged 
beat derived from the data in (E).
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Figure 5.3. Heart rate dependence of ECG parameters. Box plots of the raw frequency- binned 
ECG measurements showing the rate dependence of QRS duration (A), QT interval (B), Tp–Te (C) 
and TWA (D). For each box plot, the centre line marks the mean value, the outer box edges the 25th 
and 75th percentile and the ‘whiskers’ denote the 5th and 95th percentile.
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Heritability of ECG parameters
Scatterplots of the MZ versus DZ pairwise correlations for QT intervals obtained from the 
low heart rate ECGs and from the resting ECGs are shown in Figure 5.4A & B respectively. 
From these plots it is clear that there is a greater correlation in the monozygotic (MZ) twins 
compared to the dizygotic (DZ) twins, consistent with there being a significant genetic 
contribution to QT interval. The twin correlations for each of the 4 ECG parameters at low, 
medium and high heart rates as well as from the resting ECG, for participants not taking 
cardioactive medications are summarized in Table 5.1. MZ pair correlations were higher 
than the DZ correlation for every parameter at all heart rate categories and in the resting 
ECG indicating that there is a genetic component for all parameters. As a general trend, 
the MZ twin correlations were highest for low and medium rate Holter data and lower for 
high rate Holter and for the resting ECG. Very similar results were also obtained when 
participants taking cardioactive medication were included (see Supplemental Table 5.2). 
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To eliminate the potential confounding influence of these medications all subsequent 
analyses were undertaken solely using participants not taking cardioactive medications.
Table 5.1. Monozygotic and dizygotic twin correlations from the saturated model. 99% CIs are 
shown in parentheses.
ECG parameter Rate MZ correlation DZ correlation
TpTe Low 0.62 (0.36-0.77) 0.12 (-0.27-0.46)
Medium 0.69 (0.49-0.81) 0.07 (-0.40-0.49)
High 0.55 (0.23-0.73) -0.39 (-0.71-0.34)
Resting 0.55 (0.29-0.71) 0.00 (-0.35-0.36)
TWA Low 0.65 (0.34-0.80) 0.34 (-0.05-0.61)
Medium 0.66 (0.43-0.79) 0.46 (0.10-0.69)
High 0.53 (0.22-0.72) 0.42 (0.02-0.67)
Resting 0.54 (0.26-0.71) 0.06 (-0.25-0.36)
QT Low 0.71 (0.49-0.82) 0.07 (-0.33-0.45)
Medium 0.62 (0.38-0.76) 0.15 (-0.20-0.50)
High 0.50 (0.18-0.69) 0.25 (-0.17-0.57)
Resting 0.51 (0.23-0.69) 0.14 (-0.16-0.41)
QRS Low 0.52 (0.19-0.72) -0.10 (-0.46-0.30)
Medium 0.52 (0.23-0.71) -0.10 (-0.43-0.27)
High 0.42 (0.12-0.62) 0.07 (-0.47-0.55)
Resting 0.34 (0.06-0.56) -0.14 (-0.44-0.21)
Having established that there is a genetic component to each of the ECG parameters, we 
performed formal twin modelling to estimate heritability. Our initial modelling included 
additive genetic factors (A), non-additive genetic factors (D), and non-shared or unique 
environment (E). Univariate genetic analyses showed that non-additive genetic effects 
could be dropped from the ADE models without significant loss of fit. For all parameters, 
therefore, a model including only additive genetic and unique environmental factors, or 
an AE model, was retained for further analyses.
A quadrivariate AE model for the ECG parameters for low, medium and high rate 
Holters and the resting ECG was fitted to the data (see Supplemental Figure 5.2). The 
heritability estimates obtained from this model are summarized in Table 5.2. On the whole, 
repolarization parameters (QT, Tp-Te and TWA) showed a larger heritability estimate 
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(ranging from 56% to 72% at low heart rates) than QRS, the depolarization parameter 
(41% at low heart rate). Significantly higher heritability estimates could be obtained when 
measured from the Holter compared to the resting ECG for QT interval (p <.01) and TWA 
(p < .05). Likewise, significant rate dependence of the heritability estimate from Holter 
recordings was observed for QT interval (p < .01) and TWA (p < .05). A formal statistical 
analysis of these relationships is presented in Supplemental table 5.5.
Figure 5.4. QT interval correlations in twin pairs. Scatter plots and linear regression of QT interval 
for monozygotic (MZ) and dizygotic (DZ) twin pairs measured from low rate Holter ECG (A) of resting 
ECG (B). For each twin pair, Y- axes depict QT interval of the first born twin and X- axes the QT  
interval of the second born twin.
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Table 5.2. Heritability of ECG parameters for Low, Medium and High heart rate Holter and resting 
ECG. Asteriks denote statistical difference compared to low Holter where ** = p < .01 and * = p < 
.05. Full statistical analysis is presented in Supplemental Table 5.5.
Parameter Best Model ECG type Heritability (99% CI)
TpTe AE Low 56% (32-73%)
Medium 63% (36-79%)
High 52% (21-73%)
Resting 56% (30-72%)
TWA AE Low 72% (53-83%)
Medium 68% (49-80%)
High 58% (36-73%)*
Resting 55% (31-71%)*
QT AE Low 69% (48-82%)
Medium 58% (33-75%)
High 34% (14-53%)**
Resting 40% (18-58%)**
QRS AE Low 41% (10-64%)
Medium 41% (13-63%)
High 42% (14-62%)
Resting 32% (7-55%)
 
 
Rate dependence of genetic factors influencing Holter ECG parameters
To further investigate the rate dependence observed above, we tested the extent of the 
correlation among ECG parameters measured at different heart rates and to what extent 
genetic or environmental factors explained this phenotypic correlation (see Table 5.3). 
Phenotypic correlations across heart rates ranged from 0.47-0.94 and were highest for 
TWA and QRS. The genetic contributions to these phenotypic correlations were higher 
for the repolarization parameters than for QRS. The 3rd column of Table 5.3 lists the 
genetic correlation for the two ECG parameters being considered in each case. With 
the exception of the comparisons between Tp-Te at low and high heart rates and QT at 
low and high heart rates, all the other genetic correlations are very high, up to 1.0 for 
QRS between medium and high heart rates. This indicates that largely the same genetic 
factors influence the different ECG parameters irrespective of the heart rate at which they 
are being measured.
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Table 5.3. Phenotypic and genetic correlation between different heart rates for individual ECG  
parameters. 99% CIs are shown in parentheses.
Parameter / Frequency 
comparison
Phenotypic 
Correlation
Genetic Correlation 
between rates
Contribution of genetic 
factors to phenotypic 
co-variance
Tp-Te
Low-Medium 0.76 (0.67-0.83) 0.88 (0.73-0.97) 68% (39-86%)
Low-high 0.56 (0.41-0.67) 0.56 (0.20-0.80) 54% (14-82%)
Medium - High 0.76 (0.68-0.83) 0.89 (0.72-0.97) 66% (32-87%)
TWA
Low-Medium 0.93 (0.90-0.95) 0.98 (0.94-1.00) 74% (55-85%)
Low-high 0.82 (0.75-0.87) 0.91 (0.79-1.00) 72% (51-85%)
Medium - High 0.93 (0.90-0.95) 0.97 (0.93-1.00) 66% (45-79%)
QT
Low-Medium 0.70 (0.61-0.78) 0.77 (0.57-0.92) 69% (42-86%)
Low-high 0.47 (0.32-0.59) 0.52 (0.15-0.78) 54% (14-81%)
Medium - High 0.72 (0.64-0.79) 0.84 (0.62-0.95) 52% (24-72%)
QRS
Low-Medium 0.94 (0.92-0.96) 0.97 (0.84-1.00) 42% (12-65%)
Low-high 0.86 (0.81-0.90) 0.95 (0.79-1.00) 46% (13-69%)
Medium - High 0.90 (0.87-0.93) 1.00 (0.95-1.00) 46% (15-68%)
 
Genetic correlations between the repolarization parameters
We next investigated whether the three repolarization parameters (QT, TWA and Tp-
Te) were influenced by similar or different genetic factors. This is an important question 
as it pertains to whether measuring multiple parameters provides significantly more 
information about the genetic signature of repolarization or whether a single parameter 
is sufficient. The phenotypic correlations between parameters at any given rate (Table 5.4, 
second column) are clearly much lower than the correlations for individual parameters 
at different heart rates (Table 5.3, second column). At low and medium heart rates, 
phenotypic and genetic correlations between the repolarization parameters were 
significant but of modest size. However, what phenotypic covariance was observed was 
almost entirely caused by genetic factors (Table 5.4, last column). For high heart rates, no 
significant phenotypic and genetic correlations between the repolarization parameters 
was found. These data therefore show that while there is low phenotypic correlation 
between the three repolarization parameters, this correlation is almost entirely due to a 
common genetic factor shared by all three repolarization parameters.
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Table 5.4. Phenotypic and genetic correlation between repolarization ECG parameters at each 
heart rate. 99% CIs are shown in parentheses.
Frequency/parameter 
comparison
Phenotypic 
correlation
Genetic correlation 
between parameters
Contribution of genetic 
factors to phenotypic 
covariance
Low
QT-TpTe 0.38 (0.22 - 0.51) 0.38 (0.05 - 0.63) 65% (9 – 97%)
QT-TWA -0.28 (-0.43 - -0.12) -0.42 (-0.70 - -0.12) 100% (39 – 100%)
TpTe-TWA -0.39 (-0.52 - -0.24) -0.58 (-0.93 - -0.26) 92% (47 – 100%)
Medium
QT-TpTe 0.32 (0.16 - 0.45) ns ns
QT-TWA -0.25 (-0.40 - -0.09) -0.46 (-0.82 - -0.15) 100% (58 – 100%)
TpTe-TWA -0.18 (-0.33 - -0.02) -0.36 (-0.75 - -0.06) 100% (58 – 100%)
High
QT-TpTe 0.31 (0.15 - 0.46) ns ns
QT-TWA ns ns -
TpTe-TWA ns ns -
Discussion
In this study we present the first measurement of the heritability of repolarization 
parameters from Holter ECGs. To achieve this we have developed a novel beat binning 
algorithm allowing extraction of averaged beats that are representative of specific heart 
rates and physiological states. Twin modelling based on this approach resulted in similar 
heritabilities for Tp-Te and QRS, compared to the resting ECG, but higher estimates 
for TWA and QT interval. Furthermore, our novel analysis allowed us to interrogate 
the overlap between the genetic factors influencing individual ECG parameters at 
different heart rates as well as between the genetic factors that determine the different 
repolarization parameters at each heart rate separately. Our data therefore demonstrates 
the potential for analysis of Holter ECGs to give a more complete insight into the genetic 
underpinnings of the cardiac electrical system than the standard resting ECG.
Beat Binning approach
We set out to test the hypothesis that analysis of Holter ECGs can provide more in 
depth information regarding the cardiac electrical genotype that the standard resting 
ECG. This hypothesis is based on the assumption that the Holter ECG samples a broad 
range of physiological states over the 24-hour acquisition period compared to the limited 
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physiological range of the typical resting ECG based on 10 beats or recordings up to 
a maximum of 300s, and is therefore potentially a much richer source of information if 
analyzed effectively. However, extraction of meaningful measurements from the Holter 
is complicated both by the volume of information that needs to be processed, and the 
often noisy data, both in terms of physiological variability and signal noise, that result 
from the varied activity and physiological states of the participant throughout the time-
course of the acquisition.
With this in mind we have developed a dual parameter beat binning approach 
to extract averaged beats that are representative of different physiological states. This 
approach eliminates the two main problems outlined above. First, by binning beats 
with similar properties from throughout the Holter recording based on RR interval and 
R amplitude, we can extract families of beats that are representative of specific heart 
rates. Furthermore, by eliminating outliers from the analysis we can ensure that we are 
only considering ‘normal’ beats, with ectopic and/or abnormal beats excluded from the 
analysis. Second, by averaging these families of normal beats with common characteristics, 
we eliminate the large computational overhead of measuring ECG parameters from every 
individual beats, and obtain low noise, clean waveforms that are amenable to analysis. 
Not only does this approach allow for more like-for-like analysis between participants, i.e. 
we can directly compare a 1Hz/60 bpm waveform from each participant, it also allows us 
to analyze rate dependent trends in phenotype and the genetic contributions to these 
trends. This is not possible considering the resting ECG alone.
By way of validation, analysis of rate dependent trends in the characteristics of 
the idealized waveforms were consistent with previously published data. Specifically, 
QT inter val and Tp-Te shortened, and TWA decreased with faster rates (Couderc et al., 
2007; Lehmann & Yang, 2001). Conversely, the QRS interval was rate-independent in 
our data, also consistent with previous observations (Simoons & Hugenholtz, 1975). This 
consistency of rate dependent trends in ECG parameters in comparison to the previously 
published lite rature supports our dual-parameter beat binning approach, and presents us 
with the oppor tunity to analyze the heritability and genetic underpinnings of these rate 
dependent trends.
Heritability of ECG parameters
To assess heritability of ECG characteristics, and to dissect the genetic-environmental 
interplay in defining features of the ECG, we used a classical twin study. Under the best 
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fitting models, the parameters were explained by a combination of additive genetic 
factors and unique environmental influences (which include measurement error). Broad 
sense heritability (h2) of parameters related to depolarization (QRS duration) was 
lower than for repolarization-related parameters (QT interval, Tp-Te and TWA), with a 
maximum heritability of 42 % for QRS duration, compared to between 63 % and 72% 
for repolarization parameters. Previous studies have not been able to demonstrate a 
significant contribution of additive genetic factors to QRS duration, possibly related to 
sample size (Havlik, Garrison, Fabsitz, & Feinleib, 1980; Mathers, Osborne, & Degeorge, 
1961; Mutikainen et al., 2009; Russell, Law, Sholinsky, & Fabsitz, 1998). Our study 
is therefore the first to present a formal measure of the role of additive genetics in 
determination of this parameter.
The corollary of modest heritability of QRS is a greater contribution of environmental 
factors. It is well established that ventricular depolarization depends on an intact 
conduction system and can be affected by many extrinsic factors. In this study, we 
corrected for gender, age and medications, and excluded participants with overt cardiac 
pathology (see Methods). However, many other acquired factors known to affect QRS 
duration (Surawicz et al., 2009) such as body habitus, valvular dysfunction, overall LV 
function, cardiac afterload and other organ pathology such as pulmonary disease, all have 
the potential to increase the environmental contribution to the phenotype.
For parameters related to repolarization, heritability measured from our rate specific 
Holter data was at least comparable, or higher, than our measures based on resting ECGs. 
In particular, significantly higher heritability of QT (69 % for low rate Holter compared 
to 40% for the resting ECG, p < .01) and TWA (72 % from low rate Holter compared to 
55 % for the resting ECG, p < .05) were measured from the rate specific Holter analysis 
compared to the resting ECG. It should be noted that in spite of our good sample size 
power to detect heritability differences was modest. For example, computation showed 
that differences of 19% or higher were required for our analysis to show significance of p 
< .01. However, confidence in the added value of Holter data is increased because the 
same trend (of increased heritability when measured from the Holter ECG) was evident 
when our estimates were compared to previously published data based on resting ECGs. 
For example, the most comprehensive twin study of repolarization parameters in resting 
ECGs to date reported heritability of 67 % for QT interval, 46% for Tp-Te and between 
34 % and 47% for TWA, after correction for confounding factors such as age and sex 
(Haarmark et al., 2011), in comparison to our measures of 69%, 63 % and 72 % respectively. 
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More broadly, other studies have reported the contribution of additive genetic influences 
to QT interval of zero (Mutikainen et al., 2009), 25 % (Carter et al., 2000), 36 % (Russell et 
al., 1998) and 60 % (Dalageorgou et al., 2008).
Likewise for TWA, previous publications report values for the contribution of 
additive genetic factors between zero and 72% (Haarmark et al., 2011), though these 
values are heavily dependent on the lead selected from the resting ECG. Of most direct 
comparison to our data, Mutikainen reported a h2 of 61% when measured from lead II in 
a cohort of older women (Mutikainen et al., 2009). These data show that by considering 
data extracted from Holter ECGs, higher heritability can be measured for most ECG 
parameters and that rate specific ECG waveforms extracted from Holter recordings give 
a more precise measure of the effect of the underlying genotype, that is confounded by 
rate effects in measurements from the resting ECG.
Rate dependence of genetic factors influencing the ECG
A major advantage in analyzing the genetic determinates of ECG parameters from 
Holter records is that by deriving beats that are representative of specific physiological 
states, we are able to measure the rate dependence of genetic factors influencing ECG 
parameters – something that is not tractable using the resting ECG. As a result of this, no 
previous studies have looked at the rate dependence of the genetic influences on the T 
wave. This is an important consideration in understanding the rate dependent changes 
that occur in T wave morphology in both physiological (Bazett, 1920; Fisch, 1997) and 
pathophysiological states (Corrado et al., 2010; Hanna & Glancy, 2011; Moss et al., 1995; 
Sadrieh et al., 2013; Sadrieh et al., 2014). Our data showed that for QT interval and 
TWA, heritability was dependent on the heart rate (heritability measured at low versus 
high heart rates were significantly different for these parameters). Possible explanations 
for these observations included non-genetically determined adrenergic responses, such 
as to exposure to chronic stressors or the conditioning effect of exercise, which varies 
between individuals (Corrado et al., 2010). In contrast, no significant effect of heart rate 
could be determined for QRS and Tp–Te.
Additional analysis showed that whilst the genetic contribution to phenotypic 
covariance between rates varied for different parameters (but was higher for all 
repolarization parameters compared to QRS duration), the overall genetic factors 
that influenced each of the ECG parameters between heart rates largely overlapped. 
In most cases around 90% of the genes that contribute to phenotypic covariance of 
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ECG parameters were shared between rates. This supports the concept that the same 
components of the rhythmonome define individual parameters regardless of the heart 
rate. These data therefore demonstrate that in general, the genetic factors contributing 
to defining the ECG are similar at all heart rates, but that they explain the largest part of 
the total variance at low heart rates, while at higher heart rates, environmental factors play 
an increasing role in defining ECG characteristics.
Genetic overlap between repolarization parameters
In addition to examining the contribution of genetic factors to covariance of specific 
ECG parameters at different heart rates, we also examined the genetic overlap between 
different repolarization parameters at a given heart rate. Cross-parameter comparison 
clearly show a much lower genetic correlation (between 0.38 for QT and Tp-Te and 0.58 
for Tp-Te and TWA) compared to what we observed for within-parameter comparison at 
different heart rates. Genetic correlation further decreased at medium and high heart rates. 
This data therefore suggests that while the phenotypic covariance between parameters 
is mostly genetically determined, there is relatively little overlap between the genes that 
influence these parameters. This is consistent with our previous studies examining the 
molecular basis of T wave morphology that showed that individual ECG parameters had 
very different sensitivities to variability in cardiac ion channel genes (Sadrieh et al., 2013; 
Sadrieh et al., 2014). This is an important observation as it establishes that in order to fully 
reflect an individual’s genotype, multiple parameters describing the ECG waveform must 
be measured. Measuring one individual parameter, the QT interval for example, only 
represents a fraction of the participants whole cardiac ion channel gene complement.
Limitations
The biphasic T wave produced by the electrode configuration in this study limited 
the analysis of T wave parameters. Specifically, the QT interval measured using the 
intersection of a tangent to the downslope of the T wave with the isoelectric line, the 
most widely used method in clinical practice, could not be accurately determined. As 
previously published (Goldberger et al., 2000) and described here (see Methods), Toffset 
was used as the end of the T wave in this study. A further limitation is that we did not 
model the heritability of the rate corrected QT interval for the resting ECG data. However, 
this was a deliberate choice, since rate corrected QT has consistently been shown to have 
lower heritability than uncorrected QT (Haarmark et al., 2011) as was confirmed by our 
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first pass twin correlation calculations for QT and QTc. Heart rate itself is known to be a 
heritable phenotype so a ratio separating the overlapping genes between QT and heart 
rate heritability is problematic (Dalageorgou et al., 2008). Finally, specific limitations apply 
to all twin research (Boomsma et al., 2002). For the purposes of heritability calculations, 
monozygotic twins are assumed to be genetically identical and neither epigenetic effects 
nor somatic mutations are accounted for.
Conclusion
In conclusion, our novel beat binning approach to analysis of the Holter ECG has allowed 
the first rate specific estimate of the heritability of ECG parameters from the Holter 
ECG. Our data demonstrates that higher measures of heritability can be estimated from 
the Holter than the resting ECG, suggesting that this approach allows a more precise 
measure of the effect of the underlying genotype that is confounded by rate effects in 
the resting ECG. Furthermore, we show rate dependence in the genetic-environmental 
determinants of the ECG that has not previously been tractable. Future potential uses of 
this type of analysis include deeper dissection of the ECG of participants with inherited 
cardiac electrical disease.
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Supplement to Chapter 5
A novel approach to Holter data analysis improves phenotyping and increases  
the precision of genetic analysis of ECG biomarkers
Supplemental Table 5.1. Participants taking medications with potential to alter ECG intervals.  
Anatomical Therapeutic Classification (ATC) Codes are shown.
Medication 
(Anatomical therapeutic chemical classification code) Number of participants
Anti Hypertensives (ATC C02) 1
Diuretics (ATC C03) 8
Beta Blockers (ATC C07) 7
Ca Channel Blockers (ATC C08) 3
Renin-Angiotensin system agents (Renin-Angiotensin C09) 10
Lipid modifiers (Renin-Angiotensin C10) 7
Anti Psoriatics (ATC D05) 2
Hormone replacement therapy (ATC G03) 3
Urologicals (ATC G04) 2
Thyroid therapy (ATC H03) 6
Endocrine therapy (ATC L02) 1
Immunosuppressants (ATC L04) 3
Immunostimulants (ATC L03) 1
Anti Epileptics (ATC N03) 5
Anti Parkinson drugs (ATC N04) 1
Psycholeptics (ATC N05) 15
Psychoanaleptics (ATC N06) 18
Obstructive airway disease agents (ATC R03) 17
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Supplemental Table 5.2. Monozygotic and duzygotic twin correlations from the saturated model 
including participants taking cardioactive medication. 99% CIs are shown in parentheses.
ECG parameter Rate MZ correlation DZ correlation
TpTe Low 0.58 (0.35-0.72) 0.01 (-0.32-0.33)
Medium 0.67 (0.51-0.78) 0.11 (-0.27-0.44)
High 0.63 (0.44-0.75) -0.18 (-0.57-0.36)
Resting 0.56 (0.36-0.70) 0.08 (-0.25-0.37)
TWA Low 0.58 (0.34-0.74) 0.38 (0.08-0.59)
Medium 0.56 (0.33-0.71) 0.43 (0.15-0.62)
High 0.54 (0.29-0.71) 0.39 (0.11-0.61)
Resting 0.45 (0.19-0.63) 0.19 (-0.06-0.41)
QT Low 0.69 (0.52-0.80) 0.07 (-0.30-0.41)
Medium 0.57 (0.37-0.71) 0.24 (-0.07-0.50)
High 0.47 (0.20-0.65) 0.25 (-0.09-0.52)
Resting 0.52 (0.29-0.68) 0.09 (-0.17-0.34)
QRS Low 0.46 (0.20-0.64) 0.10 (-0.24-0.41)
Medium 0.49 (0.25-0.66) 0.08 (-0.25-0.39)
High 0.39 (0.14-0.59) 0.25 (-0.24-0.58)
Resting 0.30 (0.07-0.50) 0.00 (-0.29-0.29)
Supplemental Table 5.3. Monozygotic and dizygotic twin correlations for Bazett corrected QT  
and uncorrected QT. Numbers of twin pairs are shown in parentheses.
MZ DZ
QT 0.52 (95) 0.11 (76)
QTc 0.34 (95) 0.10 (76)
Supplemental Table 5.4. Rate dependent analysis of ECG parameters. Mean data +/-SD are shown.
Heart rate TpTe (ms) TWA (mV) QT (ms) QRS (ms)
Low (60 bpm) 88.9 +/- 8.1 1.6 +/- 0.6 392.9 +/- 20.4 80.4 +/- 10.6
Medium (78 bpm) 85.2 +/- 8.2 1.4 +/- 0.5 357.9 +/- 17.3 79.2 +/- 10.0
High (96 bpm) 84.2 +/- 8.6 1.1 +/- 0.5 335.9 +/- 18.4 79.3 +/- 10.3
Resting 79.0 +/- 10.5 1.5 +/- 0.7 354.1 +/- 25.2 78.8 +/- 9.3
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Supplemental Figure 5.1. Extraction of resting ECG. A) R peak frequency in the period between 
8 am and 12 pm for a typical participant. Beats with a frequency above 2 Hz (120 bpm, red dashed 
line) were considered non-physiological and excluded from further analysis. Within the entire patent 
dataset, the region between 9.50 am and 10.10 am showed the lowest SD of RR interval on average. 
This region was therefore selected for extraction of a typical resting ECG from each participant. B-C) 
The 10 s with the lowest frequency and SD (Red aterisk) between 9.50 am and 10.10 am was selected  
as the typical resting ECG for each participant. D) 10 s of Holter ECG activity selected according to 
the criteria identified in B-C. E) An average beat from the 10 s of data presented in D (optimized 
resting ECG, Blue), compared to an averaged beat taken random from 10 s of data at 11 am.
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Supplemental Figure 5.2. Quadrivariate model.
Supplemental Figure 5.3. Trivariate model.
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Abstract
In this study we examined the genetic architecture of variation in the pro-inflam-
matory state, using an extended twin-family design. Within the Netherlands Twin 
Register (NTR) Biobank, fasting Tumor Necrosis Factor-α (TNF-α), Interleukin-6 
(IL-6), C-Reactive Protein (CRP) and fibrinogen levels were available for 3,534 
twins, 1,568 of their non-twin siblings and 2,227 parents from 3,095 families. 
Heritability analyses took into account the effects of current and recent illness, 
anti-inflammatory medication, female sex hormone status, age, sex, BMI, smoking 
status, month of data collection, and batch processing. Moderate broad-sense 
heritability was found for all inflammatory parameters (39%, 21%, 45% and 46% for 
TNF-α, IL-6, CRP and fibrinogen, respectively). For all parameters, the remaining 
variance was explained by unique environmental influences and not by environment 
shared by family members. There was no resemblance between spouses for any of 
inflammatory parameters, except for fibrinogen. Also, there was no evidence for 
twin-specific effects. A considerable part of the genetic variation was explained by 
non-additive genetic effects for TNF-α, CRP and fibrinogen. For IL-6, all genetic 
variance was additive. This study may have implications for future genome-wide 
association (GWA) studies by setting a clear numerical target for genome-wide 
screens that aim to find the genetic variants regulating the levels of these pro-
inflammatory markers.
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Introduction
Chronic low-grade inflammation plays an important role in numerous diseases including 
major depression and heart disease, and it has been implicated as one of the major 
causes for the comorbidity of these diseases (Capuron et al., 2008; Vaccarino et al., 2008; 
Vaccarino et al., 2007). The inflammatory response is activated by pro-inflammatory 
cytokines, of which TNF-α and IL-1 are the first to appear (Tracey, 2002). The inflammatory 
cascade is further promoted by the production of IL-6 that in turn stimulates the acute-
phase response which is reflected in the synthesis of fibrinogen and CRP (Gabay, 2006; 
Gabay & Kushner, 1999; Packard & Libby, 2008). Elevations in TNF-α, IL-6, CRP and 
fibrinogen have been associated with an increased risk for both cardiac disease (Cesari 
et al., 2003; Danesh et al., 2008; Danesh et al., 2004; Humphries, Cooper, Talmud, & 
Miller, 2007; Libby & Theroux, 2005; Packard & Libby, 2008; Woods, Brull, Humphries, & 
Montgomery, 2000) as well as major depression (O’Brien, Scott, & Dinan, 2004; Penninx 
et al., 2003). 
In spite of the obvious importance of these pro-inflammatory markers in depression 
and cardiovascular disease, which are both in the top 4 of burden of disease prediction 
for 2020 (Mathers & Loncar, 2006), very little is known about the etiology of the individual 
differences in TNF-α, IL-6, CRP and fibrinogen levels. A first important question is to what 
extent the variance in these biological parameters is innate, caused by environmental 
factors that are shared by family members, or caused by environmental factors unique to 
each individual member of a family. This question can be addressed by the classical twin 
design comparing the resemblance between monozygotic (MZ) and dizygotic (DZ) twins 
(Boomsma et al., 2002; van Dongen, Slagboom, Draisma, Martin, & Boomsma, 2012). A 
few twin studies in healthy samples have estimated the heritability of cytokines and acute 
phase reactants with estimates varying between 21% and 60% for fibrinogen (de Lange, 
Snieder, Ariens, Spector, & Grant, 2001; de Lange et al., 2006; de Maat et al., 2004; 
Jermendy et al., 2011; Reed, Tracy, & Fabsitz, 1994; Su et al., 2008), between 20% and 
76% for CRP (de Maat et al., 2004; Jermendy et al., 2011; MacGregor, Gallimore, Spector, 
& Pepys, 2004; Rahman et al., 2009; Su et al., 2008; Su et al., 2009a; Su et al., 2009b; 
Wessel et al., 2007; Wang et al., 2011; Worns, Victor, Galle, & Hohler, 2006), between 
17% and 26% for TNF-α (de Maat et al., 2004; Sas et al., 2012), and between 15% and 
61% for IL-6 (de Maat et al., 2004; Grunnet, Poulsen, Klarlund, Mandrup-Poulsen, & Vaag, 
2006; Sas et al., 2012; Su et al., 2008; Su et al., 2009a; Su et al., 2009b; Worns et al., 
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2006). With a few exceptions heritability estimates of the aforementioned studies have 
been based on relatively small twin samples. Such studies are fairly accurate in estimating 
broad-sense heritability but they lack precision and power to estimate the contribution 
of non-additive genetic effects or shared family environment like the dietary habits or 
neighborhood factors shared by parents and offspring. As the average sample size of 
previous studies was around 400 individuals, these studies were not sufficiently powered 
to detect an effect of shared environmental factors explaining less than 40% of the 
variance or to discriminate between additive and non-additive genetic factors (Posthuma 
& Boomsma, 2000). Also, the relatively small sample sizes may explain the large range of 
heritability estimates based on previous studies. 
Here we extend the classical twin design, including only MZ and DZ twin pairs, by 
including non-twin siblings, and their parents in the largest set of twin- and family data 
on TNF-α, IL-6, CRP, and fibrinogen described to date. Inclusion of non-twin siblings 
increases statistical power and offers the possibility to assess twin-specific effects. 
The inclusion of parents allows taking into account assortative (non-random) mating 
effects, which can influence heritability estimates. Data from parents also allow for the 
examination of shared household effects in spouses who share a household, but are not 
biologically related (e.g. Distel et al., 2010; Rebollo & Boomsma, 2006). The availability 
of a large sample size allowed for the exclusion of subjects with current and recent illness 
and for the examination of a number of health-related variables and methodological 
factors that could affect the reliability of the assessment of plasma levels of inflammatory 
variables, while retaining adequate power to detect shared environmental factors and to 
discriminate between additive and non-additive genetic factors. 
Methods
Subjects
The data were obtained from the NTR Biobank study that was conducted among twins and 
their family members registered with the Netherlands Twin Register in the period of 2004-
2008 (Willemsen et al., 2010). Subjects were visited between 7 am and 10 am at home 
or, when preferred, at work, to collect blood and urine samples. Subjects were instructed 
to fast from the evening before, to abstain from physical exertion and, if possible, not to 
take medication at the day of the home visit, and to refrain from smoking one hour before 
the home visit. Fertile women were visited on the 2nd-4th day of their menstrual cycle or, if 
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they took oral contraceptives, in their pill-free week. During the visit, a brief interview was 
conducted on health status, including an inventory of medication use, illness (last time 
occurrence, duration and type of illness), and adherence to the protocol.
The study consisted of 9,405 subjects with data on at least one of the four pro-
inflammatory parameters of interest. Values exceeding 15 pg/ml for IL-6 and TNF-α, 15 
mg/L for CRP and/or 6 g/L for fibrinogen were set to missing, leading to the exclusion of 
11 subjects. Subjects who were on anti-inflammatory medication, medication impacting 
on the Hypothalamic Pituitary Adrenal (HPA)-axis, or both, were excluded from further 
analyses (N = 408). We also excluded subjects suffering from a cold, the flu, inflammation, 
or allergy at the time of blood sampling (N = 1,013). The remaining subjects (N = 7,973) 
served as the reference group to quantify the effects of the various covariates and to 
compute residual scores for every immune parameter.
 For the twin-family analyses we additionally excluded non-biological parents and 
siblings (N=35), spouses of twins (N = 409), subjects under 18 years of age (N = 87), the 
third member of triplets, and additional twins from families with more than one twin pair 
(N = 4). When zygosity was missing for a twin pair and both twins participated in the study, 
we randomly selected one of the two to be excluded (N = 10). To simplify the genetic 
model fitting procedure, we included a maximum of two singleton brothers and two 
singleton sisters per family and randomly selected two siblings from families with more 
than two same-sex siblings (N = 99 excluded). The final sample was comprised of 3,095 
families with 7,329 family members of which 3,534 subjects were twins, more specifically 
590 MZ male (MZM), 320 DZ male (DZM), 1,281 MZ female (MZF), 624 DZ female (DZF) 
and 719 dizygotic opposite-sex (DOS) twins. The following numbers of complete twin 
pairs were included: 201 MZM, 96 DZM, 466 MZF, 211 DZF and 217 DOS. Furthermore, 
464 non-twin male siblings, 1,104 non-twin female siblings, 1,003 fathers of twins and 
1,224 mothers of twins were included. Zygosity of twins was determined by DNA typing 
for 85.1% of the same-sex twin pairs. For the other same-sex pairs, zygosity was based 
on survey questions on physical similarity and the frequency of confusion of the twins by 
parents, other family members, and strangers. Agreement between zygosity based on 
these items and zygosity based on DNA was 96.1% (Willemsen et al., 2013).
Assessment of TNF-α, IL-6, CRP and fibrinogen
During the home visit, eight blood tubes were collected in the following order; 2 × 9 ml 
EDTA, 2 × 9 ml heparin, 1 × 4.5 ml CTAD, 1 × 2 ml EDTA, 1 x 4.5 ml serum. To prevent 
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clotting, all tubes were inverted gently 8–10 times immediately after collection (for detail, 
see Willemsen et al., 2010).
Tumor Necrosis Factor-α (TNF-α) and Interleukin-6 (IL-6) were measured in EDTA 
plasma, obtained from one of the 9 ml tubes. During transport this tube was stored in 
melting ice and upon arrival at the laboratory, it was centrifuged for 20 minutes at 2000x 
g at 4°C. EDTA plasma, buffy coat, and red blood cells were harvested and aliquoted (0.5 
ml), snap-frozen in dry ice, and stored at –30°C. Plasma levels of TNF-α and IL-6 were 
determined using an UltraSensitive ELISA (R&D systems, Minneapolis, USA, Quantikine 
HS HSTA00C). The inter-assay coefficient of variation (CV) for TNF-α was < 12.8%, for IL-6 
the inter-assay CV was < 11.6%. 
C-reactive protein (CRP) was obtained from one of the 9 ml heparin tubes. The tube 
was stored in melting ice during transport. At the laboratory the tube was centrifuged for 
15 minutes at 1000x g at 4°C, after which heparin plasma was obtained and divided into 
8 subsamples of 0.5 ml, snap-frozen and stored at –30°C. The processing took place in a 
sterile flow cabinet. CRP level in heparin plasma was determined using the Immulite 1000 
CRP assay (Diagnostic Product Corporation, USA). The inter-assay CV was < 5.1%.
Fibrinogen. Fibrinogen level was obtained from the 4.5 ml CTAD tube, which was 
stored in melting ice during transport. Upon arrival at the laboratory, it was centrifuged 
for 20 minutes at 2000x g at 4°C, after which citrated plasma was harvested from the 
buffy coat and red blood cells, aliquoted (0.5 ml), snap-frozen in dry ice, and stored at 
–30° C. Fibrinogen levels in CTAD plasma were determined on a STA Compact Analyzer 
(Diagnostica Stago, France), using STA Fibrinogen (Diagnostica Stago, France). The inter-
assay CV was < 6.1%.
 Fibrinogen values were normally distributed whereas data on the other variables 
were skewed. Therefore, we took the natural logarithm of these values.
Assessment of covariates
For the heritability analyses, we took into account the effects of age, sex, health-related 
covariates known to be associated with inflammatory parameters (body mass index (BMI), 
smoking status), and several methodological covariates that could lead to inflation of 
family correlations (month of blood sampling and batch effect). During the home visit, 
height and weight were assessed and BMI was calculated. Subjects were also asked 
about their past and current smoking behavior and were categorized into one of five 
groups (never smoked, ex-occasional smoker, ex-regular smoker, current occasional 
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smoker, current regular smoker). The month of blood sampling was used to correct for 
the effects of time of year on the four pro-inflammatory markers. For the cytokines, we 
also took into account differences in values due to the plate on which the samples were 
processed, by using the plate mean value for the cytokines as a covariate. The levels 
of the acute phase reactants were determined on a per sample basis, so plate effects 
for these variables are not applicable. Previous research suggested that when using the 
ELISA assay of R&D systems, individuals with blood group O may show higher TNF-α 
and IL-6 levels than other ABO blood groups, which may in part be due to assay-specific 
cross-reactivity with ABO antigens (Melzer et al., 2008; Naitza et al., 2012). To investigate 
this potential confounding effect we used a SNP (rs644234) that showed the strongest 
association with TNF-α and IL-6 in our data, of all SNPs in the ABO gene region plus/
minus a 10 Kb border. The rs644234 SNP explained 7% and 4 % of TNF-α and IL-6 values, 
respectively. Data on this SNP were available for 5,950 healthy subjects with TNF-α data 
and for 5,947 subjects with IL-6 data. Because the twin-family models yielded similar 
results with and without taking the effect of the ABO SNP into account, we only report 
the analyses on the full sample.
Statistical analyses
Data preparation, sample selection and tests for the effects of covariates were conducted 
using IBM Statistical Package of Social Sciences 20.0. The covariates were included 
in a multiple regression analysis (forced entry) and the residual scores were saved for 
the heritability analyses. As there was a significant age-by-sex interaction for CRP, 
fibrinogen and IL-6, regression coefficients for age were estimated separately for men 
and women for these variables. Genetic models were fitted to the data using structural 
equation modeling (SEM) in the software package Mx (Neale et al., 2006). First, a fully 
parameterized, or saturated, model was fitted and a goodness-of-fit statistic based on 
minus twice the logarithm of the likelihood (-2LL) was calculated. Next, the fully saturated 
model was simplified to a more restricted model to test whether constraints were allowed 
to be put on the data. The comparison of fit of a restricted model to the full model is 
performed by means of likelihood-ratio (χ²) tests in which the difference in -2LL between 
the two models is calculated. When the likelihood-ratio test is significant (p < .01), the 
nested model is considered to fit significantly worse to the data than the fuller model it 
is tested against. 
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Figure 6.1. Path diagram of an extended twin family showing four subjects belonging to one family: 
father (Pfa), mother (Pmo), twin 1 (Pt1) and twin 2 (Pt2), where P is phenotype. In the genetic model 
(without constraints) a maximum of 10 parameters is estimated. Path loadings a, d, c and e represent 
the influence of additive and non-additive genetic effects and shared and unique environmental 
factors on the phenotype. Spousal resemblance is modeled as a function of phenotypic assortment, 
denoted by the delta path (Δ). When the delta path coefficient is larger than zero, this indicates non-
random mating. The residual variance of additive genetic effects in parents (Ra) will then become 
larger than 1 to account for increased transmission of additive genetic effects from parents to children 
under conditions of non-random mating. Finally, two means and two age regression coefficients (for 
males and females separately) are estimated. Fixed parameters include the .5 genetic relatedness of 
the parents and their children (path running from the A of both parents to the A of their children with 
a path loading of .5). The residual variance of A in the offspring is constrained at .5. Finally, MZ twins 
correlate 1 regarding A and D factor scores (because they are assumed to share all of their genetic 
material), whereas DZ or sibling pairs correlate .5 and .25, respectively.
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First, we tested if constraints on the means and variances for men and women were 
allowed and if different types of family correlations were equal. In the full model, 19 
parameters were estimated: separate means, standard deviations, and regression co-
efficients for age on the phenotype for men and women, and 13 family correlations 
(for MZM, MZF, DZM, DZF, DOS twin pairs, male siblings, female siblings, opposite-sex 
siblings and for mother-daughter, mother-son, father-daughter, father-son and one spouse 
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correlation). Quantitative sex differences, indicating that the heritability of a trait is 
different in men and women, were assessed by testing whether correlations in male-male 
and female-female pairs of first-degree relatives (DZ twins and non-twin siblings) were 
equal. Next, we tested if the same genes regulate cytokine and acute phase reactant 
levels in men and women (Vink et al., 2012). When correlations for a trait are the same in 
same-sex and opposite-sex pairs of family members, there is no evidence for qualitative 
sex differences in the genetic architecture. When the correlations in DZ twin pairs are of 
similar magnitude as the correlations in sib-sib pairs, there is no evidence for twin-specific 
resemblance. Generation effects were tested by equating parent-offspring correlations to 
the correlations between all other first-degree relatives (DZ twins and non-twin siblings). 
If this constraint is allowed, there is no evidence that gene expression changes with age. 
Spousal resemblance was assessed by testing if the correlation between the parents of 
the twins was significantly different from zero. The most parsimonious model with the 
maximal number of allowable restrictions was carried forward to the genetic structural 
equation analyses. In these analyses, the family covariance structure is used to estimate 
the relative contribution of latent additive (A) and non-additive or dominant (D) genetic 
factors and common (C) and unique (E) environmental factors to the phenotypic variance. 
Based on the variance estimates from the full genetic model, sequentially constrained 
submodels were compared to the fit of the full model to arrive at the most parsimonious 
genetic model describing the total phenotypic variance best (see Figure 6.1 for a sche-
matic representation of the extended twin-family model).
Results
Descriptive statistics for the four immune parameters of interest in the twins, siblings and 
parents are given in table 6.1. Table 6.2 presents the amount of variance explained by the 
various technical and biological covariates that were taken into account. 
The effect of age on all parameters was significant and positive (p’s < .01). Sex 
differences were present only for CRP and fibrinogen with women having significantly 
larger mean values than men (p’s < .01). For TNF-α and CRP values, standard deviations 
were significantly larger in females than in males. Table 6.3 shows the family correlations 
for each of the immune parameters estimated for the values only adjusted for age and sex 
and for the values additionally adjusted for the other covariates.
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Table 6.1. Mean values (and standard deviations) and mean age (range) for Tumor Necrosis 
Factor-α (TNF-α), Interleukin-6 (IL-6), C-Reactive Protein (CRP) and fibrinogen.
Marker N total Mean (sd) Mean age (range)
TNF-α (pg/ml)
 Fathers 987 1.21 (1.25) 61 (33-89)
 Mothers 1,215 1.20 (1.10) 60 (26-89)
 Male twins/siblings 1,594 1.02 (0.85) 37 (18-82)
 Female twins/siblings 3 218 1.07 (1.14) 38 (18-90)
Total 7,014 1.10 (1.10) 45 (18-90)
IL-6 (pg/ml)
 Fathers 984 2.10 (1.77) 61 (33-88)
 Mothers 1,213 1.91 (1.50) 60 (26-89)
 Male twins/siblings 1,590 1.37 (1.38) 37 (18-82)
 Female twins/siblings 3,220 1.41 (1.27) 38 (18-90)
Total 7,007 1.59 (1.44) 45 (18-90)
CRP (mg/L)
 Fathers 975 2.47 (2.58) 61 (33-89)
 Mothers 1,171 2.73 (2.75) 60 (26-89)
 Male twins/siblings 1,672 1.77 (2.23) 35 (18-82)
 Female twins/siblings 3,244 2.59 (2.91) 38 (18-90)
Total 7,062 2.40 (2.71) 44 (18-90)
Fibrinogen (g/L)
 Fathers 983 2.94 (0.70) 61 (33-89)
 Mothers 1,188 3.02 (0.68) 60 (26-89)
 Male twins/siblings 1,550 2.51 (0.59) 37 (18-82)
 Female twins/siblings 3,136 2.69 (0.65) 38 (18-90)
Total 6,857 2.74 (0.68) 45 (18-90)
Table 6.2. Proportion of variance that is explained by the covariate with the number of subjects 
within brackets .
Covariates TNF-α IL-6 CRP Fibrinogen 
Age .021** (7,566) .118** (7,559) .024** (7,684) .097** (7,397) 
Sex .000 (7,566) .000 (7,559) .014** (7,684) .008** (7,397) 
BMI .013** (7,521) .098** (7,515) .139** (7,645) .100** (7,357)
Smoking .001* (7,553) .030** (7,546) .007** (7,678) .009** (7,392)
Plate effect .106** (7,558) .079** (7,551) - -
Month of blood 
sampling
.006** (7,566) .007** (7,559) .002** (7,684) .009** (7,397) 
* = p < .05, ** = p < .01
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For all parameters male and female MZ correlations did not differ significantly and same-
sex and opposite- sex DZ twin and non-twin sibling correlations were also similar in all 
cases (p’s > .01), so no quantitative and qualitative sex differences were present, nor 
did we find evidence for twin-specific environmental effects. Parent-offspring correlations 
were not significantly different from DZ twin and non-twin sibling correlations (p > .01), 
except for the fibrinogen values adjusted for age and sex only (p = .003). This effect was 
not present in the fully adjusted fibrinogen values. These results suggest that genetic 
regulation of cytokine and acute phase reactant levels does not change significantly 
across age. Overall, adjustment for BMI, smoking, month and plate effects in addition to 
age and sex tended to reduce all familial correlations, including the spouse correlations. 
Only the spouse correlation for the fully adjusted fibrinogen values was significantly 
different from zero (r = .16, p < .01), which indicates that the effects of assortative mating 
or sharing a household without being biologically related are negligible, except for the 
small resemblance found for fibrinogen.
For the heritability analyses on the fully adjusted values, contributions of A, D, C 
and E factors to the total phenotypic variance were constrained over sex while taking 
into account sex differences in phenotypic variance in TNF-α, CRP and IL-6. Assortative 
mating was only modeled for fibrinogen. Table 6.4 shows the genetic models that were 
fitted to the data, supplemented with the proportions of the phenotypic variance that can 
be explained by the different genetic and environmental factors for both the full ADCE 
model and the model that provided the most parsimonious fit. 
The broad-sense heritability was 39%, 21%, 45% and 46% for TNF-α, Il-6, CRP and 
fibrinogen, respectively. The models that provided the best fit to the data on TNF-α, 
CRP and fibrinogen included additive and non-additive genetic factors, and unique 
environmental factors. Non-additive genetic effects explained 22% of the variance of 
TNF-α, 18% of the variance of CRP, and 16% of the variance of fibrinogen. For CRP and 
fibrinogen, a small amount of variation was attributed to sibling-shared environmental 
factors in the full ADCE model, but an ADE model without shared environmental factors 
did not fit significantly worse. For IL-6, a model with additive genetic factors and unique 
environmental factors explained the data best, with no role for non-additive genetic 
factors, nor for shared environmental factors. 
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Discussion
This is the most comprehensive twin-family study of the genetic architecture of the pro-
inflammatory state that has been performed thus far. Results replicate the importance of 
genetic factors in pro-inflammation observed before (de Lange et al., 2001; de Lange et 
al., 2006; de Maat et al., 2004; Grunnet et al., 2006; Jermendy et al., 2011; MacGregor 
et al., 2004; Rahman et al., 2009; Reed et al., 1994; Sas et al., 2012; Su et al., 2008; Su 
et al., 2009a; Su et al., 2009b; Wessel et al., 2007; Worns et al., 2006; Wang et al., 2011) 
and extend the findings of previous studies by showing that genetic non-additivity is an 
important factor in explaining individual differences in TNF-α, CRP and fibrinogen levels 
and by ruling out a large role for environmental factors shared by family members. 
There have only been three previous heritability studies employing a sample size 
of over 1,000 twins for CRP (Wang et al., 2011; Rahman et al., 2009), IL-6 and TNF-α 
(Sas et al., 2012). For fibrinogen, the study with the largest sample size included 962 
subjects (de Lange et al., 2001). None of these studies systematically corrected for recent 
illness, medication use, menstrual cycle, oral contraceptives use, batch effects, month of 
sampling, BMI, and smoking status as done in the present study. In spite of the more strict 
correction for confounders, our heritability estimate for CRP was of comparable magnitude 
to these previous studies. For CRP, we confirmed the importance of non-additive genetic 
factors that was found in the largest of the two previous twin studies (Rahman et al., 2009), 
whereas the smaller of the two (Wang et al., 2011) only detected additive effects, likely 
reflecting insufficient power. For fibrinogen, our broad-sense heritability estimate was 
comparable to the estimate reported by de Lange and colleagues (de Lange et al., 2001), 
but our study additionally indicated that a significant proportion of the heritability was 
due to non-additive genetic effects. 
For TNF-α and IL-6 our results do not completely support the results of the only large 
(N > 1,000) previous twin study (Sas et al., 2012). For both cytokines, Sas and colleagues 
(Sas et al., 2012) found substantial family resemblance, but they could not discriminate 
between genetics and shared environment as the source of that resemblance. The twin 
correlations reported in a smaller study on IL-6 (Worns et al., 2006) were suggestive of 
genetic factors and a potential role of shared environment with the MZ correlation being 
less than twice as high as the DZ correlation. Our study clearly shows that shared genetic 
make-up rather than shared family environment is the major source of familial resemblance 
in these parameters. Furthermore, we show a significant effect of non-additive factors 
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on TNF-α. Four smaller twin studies of TNF-α and IL-6 values in healthy unchallenged 
subjects are consistent with our findings, as the MZ correlations found in those studies 
were about twice as high as the DZ correlations, in elderly subjects (de Maat et al., 2004), 
young adults (Grunnet et al., 2006), and middle-aged twins (Su et al., 2008; Su et al., 
2009b). In their sample of young adult subjects, Grunnet and colleagues (Grunnet et al., 
2006) even found the MZ correlations for TNF-α to be more than twice as high than the 
DZ correlations. 
Taken together, our results and those from previous studies suggest that about a 
third of the variation in these core pro-inflammatory cytokines and acute phase reactants 
in healthy subjects with values in the non-extreme range is explained by genetic variation. 
This means that some individuals are more susceptible than others to have higher levels 
of pro-inflammatory markers and this increased susceptibility is, at least partly, due to 
genetic differences between individuals. Large scale collaborative attempts to find the 
actual genes that underlie this genetic variation are under way. In 2011, a meta-analysis 
of GWA studies of CRP in over 80,000 subjects identified several genes implicated in 
immune system functioning and inflammation (CRP, IL6R, NLRP3, IL1F10, IRF1, PPP1R3B, 
SALL1, PABPC4, ASCL1, RORA and BCL7B) and the metabolic syndrome (APOC1, 
HNF1A, LEPR, GCKR, HNF4A and PTPN2) to be associated with circulating CRP levels 
(Dehghan et al., 2011). In a meta-analysis of six GWA studies on fibrinogen in over 22,000 
subjects, significant genome-wide hits were found in the FGB, IRF1, PCCB and NLRP3 
genes (Dehghan et al., 2009). For IL-6 and TNF-α no meta-analysis has been published 
to our knowledge. A single large GWA study on IL-6 (N = 6,145) found significant hits in 
the IL6R and ABO genes (Naitza et al., 2012). With our study we have accomplished a 
clear numerical target for these ongoing genome-wide screens that aim to find the actual 
genetic variants regulating the levels of these pro-inflammatory markers. Heritability 
studies conducted in large representative samples continue to be valuable, because the 
heritability of traits can vary between populations and can change across generations. 
We should also keep in mind that 54 to 79% of the variation found was due to unique 
environmental factors that are not shared between family members. This estimate may 
derive from unique environmental factors or measurement error, but it may also result from 
gene-by-environment interactions that may inflate estimates of unique environmental 
effects. Unravelling the genetics of these pro-inflammatory parameters may greatly 
contribute to our understanding of the aetiology of cardiac disease and major depression 
since chronic low-grade inflammation has repeatedly been shown to be associated with 
142 Chapter 6
both (Cesari et al., 2003; Danesh et al., 2004; Danesh et al., 2008; Humphries et al., 2007; 
Libby & Theroux, 2005; O’Brien et al., 2004; Packard & Libby, 2008; Penninx et al., 2003; 
Woods et al., 2000).
Because of the large sample size and the extended twin-family design this study 
had sufficient power to decompose the variance in the levels of an important set of 
pro-inflammatory markers into additive and non-additive genetic factors, and shared 
and unique environmental factors. The inclusion of parents and siblings allowed us to 
detect and correct for assortative mating, quantitative and qualitative sex differences, 
and effects of age that could potentially affect the heritability estimates. The sample size 
also allowed us to employ strict exclusion criteria concerning the recent health status and 
medication use of the subjects without losing power so that we were ensured analyses 
were run on healthy individuals only. Furthermore, our study design controlled for female 
sex hormone status.
This study also had limitations. First, we selected only a subset of the many immune 
parameters that co-determine the pro-inflammatory state, including IL-1 and interferon-γ, 
and we did not take into account the action of the soluble receptors for the cytokines, 
levels of which may be substantial heritable. Secondly, we used the ELISA assay by R&D 
systems that may yield higher TNF-α and IL-6 values in individuals of blood group O levels 
than other ABO blood groups which may in part by due to assay specific cross-reactivity 
with ABO antigens (Melzer et al., 2008; Naitza et al., 2012). We indeed found a significant 
association of SNPs in the ABO region to TNF-α and IL-6. Although it explained only a 
small amount of variance in TNF-α (7%) and IL-6 (4%) compared to the larger effects of 
plate and BMI, they may cause overestimation of non-additivity or underestimation of 
shared environment since the shared blood group O will make MZ twins appear more 
alike than DZ twins or non-twin siblings. Thirdly, we tested whether different genes 
are expressed at different ages by testing whether parent-offspring correlations and 
correlations in first-degree relatives (DZ twins and non-twin siblings) were of comparable 
magnitude. Because there was a partial overlap in age between the parent and the 
offspring generation, we cannot completely rule out the possibility that the expression of 
pro-inflammatory genes changes across age. 
In conclusion, the familial resemblance in these core pro-inflammatory cytokines 
and acute phase reactants is explained by genetic variation and not by the shared family 
environment. For three out of four markers, both additive and non-additive genetic 
factors contribute to the heritability.
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Chapter 7
Reciprocal association between 
ambulatory autonomic nervous system 
functioning and pro-inflammatory 
and metabolic risk profiles
This chapter is submitted: 
Neijts, M., Willemsen, G., Boomsma, D., & de Geus, E. J. C. 
Reciprocal association between ambulatory autonomic nervous system 
functioning and pro-inflammatory and metabolic risk profiles. 
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Abstract
Previous cross-sectional research in laboratory settings has shown significant 
associations between cardiac autonomic functioning and metabolic and 
inflammatory risk. The nature of this association remains unclear. Prospective 
associations of cardiac sympathovagal control and inflammatory and metabolic 
risk were tested in both directions in two independent studies. Study 1 linked 
autonomic functioning to inflammatory and metabolic risk measured 4.9 years 
later, Study 2 tested the reverse link with 5.4 years in between. Participants were 
measured in their natural environment. Study 1 and 2 included 433 and 540 
healthy adults registered with the Netherlands Twin Register, respectively. 24-
hour autonomic activity was measured and included heart rate (HR), respiratory 
sinus arrhythmia (RSA, parasympathetic activity), and pre-ejection period (PEP, 
sympathetic activity). Stress reactivity was computed by contrasting the levels 
during work with levels during  leisure time. Inflammatory and metabolic risk were 
calculated by summing the Z-scores of several key markers of the pro-inflammatory 
and the metabolic state. Higher leisure time HR (βzIBI = -0.94, p = .02) and larger 
PEP reactivity (βzΔPEP = -0.43, p = .04) were associated with increased inflammatory 
risk at follow-up. Larger PEP reactivity was also associated with higher metabolic 
risk at follow-up (βzΔPEP = -0.80, p = .01). No significant associations in the reverse 
direction were found. High resting HR together with exaggerated sympathetic 
reactivity has adverse effects on inflammatory risk. Exaggerated sympathetic 
reactivity also negatively impacts metabolic risk. No evidence for a reverse 
association was found.
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Introduction
A cluster of metabolic dysregulations, commonly referred to as the metabolic syndrome, is 
implicated in the development of cardiovascular disease and diabetes (Wilson, D’Agostino, 
Parise, Sullivan, & Meigs, 2005). Chronic low-grade inflammation has emerged as an 
additional risk factor (Danesh et al., 2008; Libby & Theroux, 2005; Packard & Libby, 2008) 
that often accompanies metabolic dysregulation (Grundy et al., 2005; Marques-Vidal et 
al., 2002). The metabolic and inflammatory risk factors may have a common biological 
ground: a shift in autonomic nervous system (ANS) activity from parasympathetic towards 
sympathetic dominance. Previous cross-sectional research showed that such a shift was 
indeed associated with high waist circumference, and higher levels of several metabolic 
markers including low density lipoprotein cholesterol (LDL-cholesterol), total cholesterol, 
triglyceride values, increased systolic blood pressure (SBP), and increased fasting glucose 
levels (Intzilakis et al., 2013; Licht et al., 2010; Thayer & Fischer, 2013). Licht, de Geus, & 
Penninx (Licht, de Geus, & Penninx, 2013) tested this association in a longitudinal study in 
which ANS functioning was used to predict a change in the metabolic components over 2 
years. They found that increased cardiac sympathetic control at rest (indexed as the pre-
ejection period, or PEP) predicted an increase in the number of metabolic components. 
In addition, low vagal control at rest (indexed as respiratory sinus arrhythmia, or RSA) 
predicted a future decrease in HDL cholesterol. 
There is solid biological ground to additionally expect that an inflammatory risk 
profile, in particular the TNF-α/IL-1/IL-6 pathway, is also sensitive to the activity of both 
branches of the ANS. When the body is inflamed, the acute parasympathetic (PNS) and 
sympathetic (SNS) nervous system responses act to prevent a further inflammatory cascade 
by inhibiting the release of pro-inflammatory cytokines and the ensuing production of 
acute phase reactants, and by stimulating the production of anti-inflammatory cytokines 
(Elenkov, Wilder, Chrousos, & Vizi, 2000). However, when ANS activity shifts more 
chronically to SNS dominance, either through decreased PNS activity or through increased 
sympathetic activity or a combination, chronic low-grade inflammation may be the result 
(Sternberg, 2006). Cross-sectional HRV studies have indeed shown that reduced cardiac 
vagal control as assessed during short-term (Haarala et al., 2011; Kon et al., 2006; Sloan 
et al., 2007; Singh, Hawkley, McDade, Cacioppo, & Masi, 2009; von Kanel, Nelesen, Mills, 
Ziegler, & Dimsdale, 2008) or prolonged laboratory (Lampert et al., 2008) conditions was 
associated with higher C-reactive protein (CRP) and interleukin(IL)-6. In addition, 24-h 
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ambulatory HRV recordings also point to inverse associations of vagal control with CRP, 
IL-6, and fibrinogen (Araujo et al., 2006; Sajadieh et al., 2004; Stein et al., 2008; Thayer 
& Fischer, 2009; von Kanel, Thayer, & Fischer, 2009). These associations appear to hold 
in prospective studies. Lower nighttime HRV at baseline, for instance, predicted higher 
CRP measured at 3 to 4-year follow-up (Jarczok, Koenig, Mauss, Fischer, & Thayer, 2014; 
Singh et al., 2009). Two studies found the vagal effect to be independent of urinary 
epinephrine (Lampert et al., 2008; Thayer & Fischer, 2009). The link between cardiac 
sympathetic control and chronic low-grade inflammation is not yet clearly established. In 
humans, cardiac contractility was not associated with CRP (Singh et al., 2009), whereas 
animal studies pointed to significant positive associations between cardiac contractility 
and TNF-α levels (Bozkurt et al., 1998; Murray & Freeman, 1996). 
A first concern about the studies linking autonomic functioning to metabolic or 
inflammatory risk factors is that they explicitly assume an unidirectional causal effect of the 
ANS on metabolic and inflammatory risk. The observed association may, however, also 
derive from reverse effects of metabolic and inflammatory risk on autonomic functioning. 
Soares-Miranda and colleagues (Soares-Miranda et al., 2012), for instance, found that 
high levels of SBP, triglyceride, glucose levels and CRP at baseline predicted lower HRV 
at 2-year follow-up, although these associations disappeared at the 3-year follow-up. The 
finding of prospective associations in both directions hints at the possibility of reciprocal 
(bidirectional) causality. Alternatively, parallel patterns of unfavourable ANS functioning and 
metabolic or inflammatory risk may reflect the effects of underlying factors independently 
acting on ANS functioning and metabolic/inflammatory risk across time, like socioeconomic 
position, lifestyle (e.g. physical activity, smoking) or genetic pleiotropy. 
A second concern about the extant literature is that many studies were conducted 
in a laboratory or clinic setting with measures of SNS and PNS activity recorded during 
periods of quiet rest (Haarala et al., 2011; Kon et al., 2006; Licht et al., 2010; Licht et al., 
2013; Sloan et al., 2007; von Kanel et al., 2008). Various studies have indicated that the 
ecological validity and clinical predictive value of risk factor recording may be increased 
when they are done in the participant’s natural environment by ambulatory monitoring 
(Bussmann, Ebner-Priemer, & Fahrenberg, 2009; Ebner-Priemer & Trull, 2009a; Fahrenberg 
et al., 2007). A huge advantage of ambulatory monitoring over laboratory assessments 
is that it captures physiological processes that have a prolonged time scale, including 
circadian rhythms, and better capture the effects of changes in mental and emotional 
challenge as seen during work-non-work, and wake-sleep transitions. 
 Reciprocal association between ANS and pro-inflammatory and metabolic risk profiles 149
7
Here we examined the prospective association between autonomic functioning in daily 
life and metabolic and inflammatory risk in both directions. We used measures of cardiac 
vagal and sympathetic control assessed by ambulatory monitoring, which allowed the 
computation of prolonged resting levels (e.g. sleep, leisure time) as well as stress reactivity 
to real-life psychological challenge as typically encountered in a work setting. Two 
independent prospective studies were conducted linking (1) ambulatory parasympathetic 
and sympathetic cardiac control to inflammatory and metabolic risk measured 4.9 
years later, and (2) inflammatory and metabolic risk to ambulatory parasympathetic 
and sympathetic cardiac control measured 5.4 years later. We expected to find that 
sympathetic overdrive coupled to vagal withdrawal at rest, and its enhancement during 
exposure to psychological stress, would be associated with an unfavorable inflammatory 
and metabolic profiles 4.9 years later. In addition, we expected that the effects would 
be reciprocal and that subjects with unfavorable inflammatory and metabolic profiles 
would show sympathetic overdrive coupled to vagal withdrawal at 5.4 year follow-up, 
and exaggerated autonomic reactivity to psychological stress.
Methods 
ANS Study sample 1
A total of 816 participants participated in the first part (Study 1, 1998-2003) of a 
large cardiac ambulatory monitoring study conducted in families registered with the 
Netherlands Twin Register (NTR). A subgroup of 68 participants participated twice in this 
period, so in total 884 ambulatory cardiac recordings were available. A priori reasons 
for exclusion were heart transplantation, presence of a pacemaker and known ischemic 
heart disease, congestive heart failure, diabetic neuropathy, or pregnancy. We selected 
ANS recordings of participants with valid data on both heart rate variability (HRV) and 
PEP measures (N=21 recordings excluded). Cardiac recordings of participants who were 
on antidepressant medication (ATC code N06A), beta blocking agents (ATC code C07), 
or cardiac therapy (ATC code C01) were excluded from further analyses (N=43). Of the 
remaining recordings, 62 still belonged to participants that participated twice. When 
the difference in the duration between the two recordings was greater or equal to 200 
minutes, the shorter recording was excluded (N=10). When both twins participated, the 
recording of the twins in which both participated were kept (N=26 excluded). For the 
remaining duplicate recordings, the recording of the study in which most family members 
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participated were kept (N=26 recordings excluded). The remaining sample comprised 
758 participants. A total of 433 of these participants also participated in a large NTR 
biobank study (Willemsen et al., 2010) that was conducted between 2004 and 2008, on 
average 4.9 (SD = 1.7) years later.
ANS Study sample 2
A total of 592 participants who took part in the NTR biobank study also participated 
in the second part (Study 2, 2010-2012) of the cardiac ambulatory monitoring study. 
We employed the same a priori reasons for exclusion as for Study 1 and selected ANS 
recordings of participants with valid data on both heart rate variability (HRV) and PEP 
measures (N=16 recordings excluded). Cardiac recordings of participants who were on 
antidepressant medication (ATC code N06A), beta blocking agents (ATC code C07), 
or cardiac therapy (ATC code C01) were excluded from further analyses (N=32). The 
remaining sample was comprised of 540 participants having valid IBI, pvRSA, or PEP 
data during sleep, leisure time, and/or during sitting activities at work. The average time 
interval between these studies was 5.4 (SD = 1.1) years.
24-hour ambulatory monitoring studies: set up and measures
For both studies, participants were visited at home, before starting their normal daily 
activities. During a short interview, information on health status and current medication 
use was obtained. The VU-AMS was attached and its operation explained. Participants 
were instructed to wear the device the entire day and night up until awakening the 
next morning. Instructions were supplied that explained how to respond to potential 
alarm beeps (e.g., on loose electrode contacts), and telephone assistance was available 
during waking hours. Participants were requested to keep a diary and to write down a 
chronological account of activity, posture, location, and social situation over the past 
time period. For Study 1 this was done every 30 minutes, for Study 2 every 60 minutes. 
Participants were instructed to refrain from vigorous exercise during the ambulatory 
recording day.
For Study 1, the VU University Ambulatory Monitoring System (VU-AMS) version 4.6 
was used (VU University, Amsterdam, The Netherlands, www.vu-ams.nl). This version of 
the VU-AMS continuously recorded the electrocardiogram (ECG) and changes in thoracic 
impedance (dZ) from a six-electrode configuration (de Geus et al., 1995; de Geus & van 
Doornen, 1996; Willemsen et al., 1996). The device automatically detects each R wave in 
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the ECG signal, at which it reads out and resets a millisecond counter to obtain the heart 
period time series. The thoracic impedance (Z), assessed against a constant current of 50 
KHz, 350 microamperes, was amplified and led to a precision rectifier. The rectified signal 
was filtered at 72 Hz (low pass) to give basal impedance Z. Filtering Z at 0.1 Hz (high pass) 
supplied the dZ signal, which was band pass filtered with 0.1 and 0.4 Hz cutoffs, after 
tapering with (sin(x))2, to yield the respiration signal. 
The IBI time series was obtained from the ECG by an online automated R-wave 
peak detector, where IBI is the interval in milliseconds between two adjacent R waves of 
the ECG. Artifact processing was performed on the IBI data offline. When the IBI deviated 
more than 3 SD from the moving mean of a particular period it was automatically coded as 
an artifact and the IBI was either rejected during visual inspection, new IBIs were created 
by summing too short IBIs or too long IBIs were split in two IBIs of equal length.
For Study 2, the 5fs version of the VU-AMS was used, which improved on the 4.6 
version in that it stores the entire ECG for offline analysis rather than online R-wave peak-
detection (van Dijk et al., 2013). The ECG signal was imported into the VU-DAMS software 
(version 3.2, VU University Amsterdam, www.vu-ams.nl). After automated detection of bad 
ECG signal fragments (artefacts), R-wave peak detection was done using a modified version 
of the algorithm by Christov (Christov, 2004). From the R-wave peaks, the IBI time series was 
again constructed and visually displayed for interactive correction of missed or incorrect 
R-wave peaks. In addition to the ECG, the 5fs version also stores the entire dZ at 1000 Hz 
to obtain the respiration signal. The dZ signal is filtered using a second order band pass 
filter that passes all frequencies in the range of 0.1 to 0.4 Hz. An Exponential Smoothing 
Average technique is then applied on the filtered DZ signal, which acts as an additional 
low pass filter. The output of this filter is a weighted combination of previous smoothed 
value and the newest measured data, or in formula: 
St = α* St −1 + (1 − α) * xt
where St is the smoothed average, α is the tunable smoothing factor (which is in the range 
of 0 to 1), xt is the observation at time t, and St−1 is the previous smoothed value. 
Computation of the RSA measures was done in the same way for both studies. 
Combining the IBI time interval series with the respiration signal extracted from the thorax 
impedance signal (dZ), the ‘peak–valley’ RSA method was used to asses pvRSA (de Geus et 
al., 1995; Grossman & Wientjes, 1986; Grossman et al., 1990). In this method, RSA is scored 
from the combined respiration and IBI time series by detecting the shortest IBI during 
inspiration and the longest IBI during expiration on a breath-to-breath basis according to the 
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procedures detailed elsewhere (de Geus et al., 1995; Houtveen et al., 2005; van Lien et al., 
2011). Breathing cycles that showed irregularities like gasps, breath holding and coughing, 
were considered invalid and were removed from further processing. If no shortest or longest 
IBI could be detected in inspiration and expiration respectively, the breath was either set to 
missing or to zero when computing the average per condition for pvRSA. Similar results were 
found for pvRSA computed either way and we employed only one (breaths set to missing) 
in further statistical analyses. As previous research suggests that results may be biased 
if participants with RSA ceiling effects at low heart rates are included, all analyses were 
performed twice; once including the participants with RSA ceiling effects at low heart 
rates and once excluding these participants (Neijts et al., 2014; van Lien et al., 2011). 
For the assessment of the PEP, a measure of cardiac contractility, both the ECG and the 
ICG were used. The ICG signal was large-scale ensemble averaged across the diary-coded 
activity periods (described below), time-locking the signal to the R-wave peaks (Riese et al., 
2003). The PEP is defined as the time interval between the Q-wave onset of the ECG and 
the B-point of the dZ/dt signal. The Q-wave reflects the onset of left ventricular activity and 
the B-point reflects the opening of the aortic valves. In both VU-AMS versions, the R and B 
points were scored automatically by the software. In the newer 5fs version of the VU-AMS, 
the entire ECG signal was stored, so the Q-onset time was available as well. All automated 
scoring was visually checked by the experimenter. For the calculation of PEP in Study 1, a 
fixed Q-R interval of 48 msec was added to the duration of the R-B interval (Willemsen et 
al., 1996). For Study 2, the true Q-onset point was used when present; otherwise the grand 
average of the Q-R interval was summed to the R-B interval of the individual participant. If 
R-onset was additionally missing, we subtracted the grand average Q-onset time from the 
individual participants’ B-point (van Lien et al., 2013).
Ambulatory data reduction and specification of ambulatory conditions
Using the activity diary entries in combination with a visual inspection of the output of 
the inbuilt accelerometer, the entire 24-h recording was divided into fixed periods. These 
periods were coded for posture (supine, sitting, standing, walking, bicycling), activity (e.g. 
desk work, dinner, meetings, watching TV), physical load (no load, light, intermediate, 
heavy), and location (e.g. at home, at work, public space). Minimum duration of periods 
was 5 min and maximum duration was 1 hour. If periods with similar activity and posture 
lasted more than 1 hour (e.g. during sleep), they were divided into multiple periods of 
maximally 1 hour. 
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From the ambulatory ANS recording, two resting conditions and one ambulatory stress 
condition were specified. For the first resting condition, the mean IBI, pvRSA, and PEP 
value across all sleeping periods was calculated (‘sleep’). For the second resting condition 
the period with the lowest heart rate in the evening from 6 pm till bedtime in which the 
participant was sitting was selected (‘leisure’). As ambulatory stress conditions, we used 
‘work’ (the mean of all periods in which the participant was engaged in sitting activities 
at the work location between 9 am and 6 pm during a reported working day). Reactivity 
was calculated as the difference score between work and leisure (Δ work - leisure). These 
ambulatory reactivity measures from unstructured 24-h recordings have been described 
in more detail in (Neijts et al., submitted). 
Biobank study: set up and measures
For the biobank study, the participants were visited in the morning at home, or when 
preferred at work, to collect blood and urine samples after an overnight fast. They were 
instructed to abstain from physical exertion and, if possible, not to take medication at the 
day of the home visit, and to refrain from smoking one hour before the home visit. Fertile 
women were, when possible, visited on the 2nd- 4th day of their menstrual cycle or, if they 
took oral contraceptives, in their pill-free week. During the home visit, a brief interview 
was conducted on health status, including an inventory of medication use, illness (last 
time occurrence, duration and type of illness), and adherence to the protocol. Also, 
height, weight and waist circumference were assessed. A total of eight blood tubes were 
collected. To prevent clotting, all tubes were inverted gently 8–10 times immediately after 
collection. The blood tubes of the biomarkers that were used for the current study (2 × 
9 ml EDTA, 1 × 9 ml heparin, 1 × 4.5 ml CTAD ) were transported in melting ice during 
transport to the laboratory. Both EDTA tubes and the CTAD tube were centrifuged for 
20 minutes at 2000x g at 4˚C upon arrival at the laboratory. EDTA plasma was harvested 
and aliquoted (0.5 ml), snapfrozen in dry ice, and stored at -30˚C. Citrated plasma from 
the CTAD tube was harvested from the buffy coat and red blood cells, aliquoted (0.5 
ml), snapfrozen in dry ice, and stored at -30˚C. The heparin tube was centrifuged for 15 
minutes at 1000x g at 4˚C, heparin plasma was obtained and divided into 8 subsamples 
of 0.5 ml, snapfrozen and stored at -30˚C (Willemsen et al., 2010). TNF-α and IL-6 were 
measured in EDTA plasma, using an UltraSensitive ELISA (R&D systems, Minneapolis, 
USA, Quantikine HS HSTA00C) (Neijts et al., 2013). CRP was measured in heparin plasma, 
using Immulite 1000 CRP assay (Diagnosic Product Corporation, USA). Fibrinogen levels 
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were measured in citrate plasma, on a STA Compact Analyzer (Diagnostica Stago, France), 
using STA Fibrinogen (Diagnostica Stago, France). Glucose was measured using the 
Vitros 250 Glucose assay (Johnson & Johnson, Rochester, USA). Total cholesterol, HDL-
cholesterol, and triglycerides were measured in heparin plasma, using Vitros 250 direct 
HDL cholesterol and Vitros 250 Triglycerides assays (Johnson & Johnson, Rochester, 
USA). LDL-cholesterol was calculated using the Friedewald Equation (Friedewald, Levy, & 
Fredrickson, 1972).
For the current analyses, values of the pro-inflammatory markers were excluded 
in case of current illness of the participant (allergy, cold, flu, infection), medication use 
(medication impacting the hypothalamic pituitary adrenal [HPA] axis [ATC codes H01, 
H02] and anti-inflammatoy medication [ATC codes L01 to L04, M01]). A value > 15 pg/
mL for TNF-α, IL-6, and CRP, or > 6 g/L for fibrinogen was considered an outlier and was 
hence set to be missing. Metabolic variables were only included when participants had 
been fasting from 00:00h the previous night until the blood sampling took place. Lipid 
variables were excluded from further analyses when participants were on lipid modifying 
medication (ATC code C10). Glucose values were set to be missing when antidiabetic 
drugs were used at the time of the study (ATC code A10). Values deviating more than four 
standard deviations from the mean were considered outliers and were set to be missing 
for all metabolic variables (glucose, LDL-cholesterol, HDL-cholesterol, triglycerides, waist 
circumference, and BMI). 
Assessment of covariates
The effects of age and sex were taken into account for all variables. For the inflammatory 
markers, the month of blood sampling and plate-effects for the cytokines were also taken 
into account because of their known effects on these variables (Neijts et al., 2013). Age, 
sex, plate mean and/or month mean for the inflammatory markers were included in 
multiple regression analyses (forced entry) and the residual scores were saved and used 
for subsequent risk score computation.
Metabolic and inflammatory risk scores
All residual metabolic and inflammatory variables were transformed to Z-scores. An 
inflammatory risk score was calculated as: ZTNF-α + ZIL-6 + ZCRP + ZFibrinogen, with 
higher values representing higher inflammatory risk. A metabolic risk score was calculated 
as: ZWaist + ZBMI + ZGlucose + ZTriglycerides + ZLDL – ZHDL, with higher waist, BMI, 
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fasting glucose levels, triglycerides, and LDL-cholesterol and lower HDL-cholesterol 
representing higher metabolic risk.
Statistical analyses
Data preparation and statistical analyses were conducted using IBM SPSS 21.0. A mixed 
model ANOVA with age and sex as fixed factors, family as a random factor, and time of 
day as a repeated measures factor was used to study the effects of time of day and the 
effects of the covariates. Pearson correlations were calculated to test the associations 
of the ANS variables with the z-transformed residuals of the variables constituting the 
metabolic and inflammatory risk scores, and the risk scores themselves. 
Since the pattern of bivariate correlations may reflect consistency that may be 
partly derived from the intercorrelation between the ANS measures and conditions 
and because there may be chance findings due to multiple testing, we used multiple 
regression analyses to simultaneously test for an effect of all three measures of ANS 
functioning during sleep and leisure time and their work-leisure reactivity on metabolic 
and inflammatory risk scores. These analyses were run after a careful check for potential 
problems due to multicollinearity, which remained within acceptable boundaries. For 
Study 1, general linear models were used to predict inflammatory and metabolic risk 
from the ambulatory IBI, pvRSA, and PEP levels at sleep and leisure and the work-leisure 
reactivities. Two models were run with either the inflammatory or the metabolic risk score 
as dependent variable. In these models, the ANS predictors were entered as fixed factors, 
and family was included as a random factor. ANS predictors included sleep, leisure and 
the Δ work - leisure reactivity measure. For Study 2, general linear models were used to 
predict IBI, pvRSA, and PEP levels at sleep and leisure and the work-leisure reactivity from 
the inflammatory and metabolic risk scores. Nine models were run with the inflammatory 
or the metabolic risk scores as predictors and IBI, pvRSA, and PEP levels in sleep and 
leisure and Δ work – leisure reactivity as the nine dependent variables. In these models, 
the predictors were entered as fixed factors, and family was included as a random factor. 
All general linear models were rerun without the participants with ceiling effects for RSA 
during sleep. 
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Results
Table 7.1 shows the means and standard deviations of the variables for Study 1 and 2. 
As expected, PEP, RSA and IBI were lower during sleep than during the two daytime 
recordings for both Study 1 (F (2, 1118) = 1374.596, p < .001, for IBI, F (2,1134) = 77.052, 
p < .001, for RSA, and F (2,1093) = 179.600, p < .001 for PEP) and Study 2 (F (2, 809) = 
789.532, p < .001 for IBI, F (2,817) = 64.271, p < .001 for RSA, and F (2,799) = 42.935, p < 
.001 for PEP). RSA was lower with increasing age at both time points (F (1,373) = 120.296, 
p < .001 for Study 1 and F (1,268) = 44.307, p < .001 for Study 2) but the influence of 
age on heart rate and PEP was not significant. Sex differences were found for all ANS 
variables, with females showing higher heart rate (F (1,752) = 71.399, p < 001 for Study 
1 and F (1,537) = 14.980, p < 001 for Study 2), higher RSA (F (1,757) = 20.234, p < .001 
for Study 1 and F (1,510) = 34.079, p < .001 for Study 2), and generally longer PEP (F 
(1,720) = 1.986, p = .159 for Study 1 and F (1,513) = 8.808, p = .003 for Study 2) values 
than males. 
Tables 7.2 and 7.3 depict for Study 1 and Study 2, respectively, the correlations 
between ANS measures and the z-transformed residuals for the variables constituting the 
metabolic and inflammatory risk scores, and the risk scores themselves. From the pattern 
of correlations for Study 1 depicted in table 7.2, it becomes clear that higher heart rate 
during sleep and leisure time, and during sitting activities at work was associated with 
higher inflammatory risk at follow-up. This effect was most pronounced for IL-6 where 
heart rate during sleep, leisure time, and work were significantly associated with future 
IL-6 (-0.18 < r < -0.20, p < .001). Higher heart rate during sleep and leisure time was also 
associated with higher future CRP levels (-0.16 < r < -0.19, p < .001), and higher heart 
rate during work and sleep was associated with higher future fibrinogen (-0.22 r < -0.24, 
p < .01). TNF-α levels were not significantly associated with ANS functioning 4.9 years 
earlier. Predictors of higher metabolic risk at follow-up were higher heart rate during 
leisure time (r = -0.17, p = .001) and lower RSA during leisure time (r = -0.18, p = .001), 
and PEP at work (r = -0.19, p = .008). The main determinants of these associations were 
lower HDL-cholesterol levels (0.18 < r < 0.25, p < .001), larger waist circumference (-0.10 
< r < -0.17, p < .05) and, to a lesser extent, higher BMI (r = -0.14, p = .037 for PEPwork), 
and higher LDL-cholesterol (r = -0.16, p = .001 for RSAleisure) and triglyceride levels (r = 
-0.14, p = .006 for IBIleisure). 
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Table 7.1. Means and standard deviations of the ANS and biobank variables included in Study 1 
and Study 2. 
Study 1 N Study 2 N
Age at baseline (mean +/- sd) 32.0 (11.1) 433 31.8 (5.5) 540
Sex (% female) 60.3 433 61.3 540
ANS measures
IBI (msec)
Sleep 971.34 (131.61) 421 986.83 (131.42) 533
Leisure 861.97 (116.63) 416 896.77 (129.05) 501
Work 766.07 (115.09) 223 804.30 (106.12) 292
Δ work – leisure -98.14 (86.56) 214 -97.31 (97.76) 272
pvRSA (msec)
Sleep 54.95 (25.88) 421 54.29 (23.21) 533
Leisure 52.06 (25.60) 416 49.81 (23.61) 501
Work 44.45 (19.88) 223 43.92 (17.04) 292
Δwork – leisure -8.78 (17.48) 214 -6.21 (16.82) 272
PEP (msec)
Sleep 105.08 (15.18) 414 107.84 (16.12) 526
Leisure 97.83 (15.88) 413 102.15 (17.64) 475
Work 98.11 (16.50) 222 101.74 (18.94) 284
Δwork – leisure 0.42 (7.04) 213 1.31 (13.83) 251
Pro-inflammatory markers 
Tumor Necrosis Factor (TNF)-α 
(pg/ml)
1.14 (1.37) 352 1.06 (1.06) 469
Interleukin(IL)-6 (pg/ml) 1.37 (1.21) 353 1.26 (1.19) 469
C-Reactive Protein (CRP) 
(mg/L)
2.39 (2.90) 345 2.17 (2.65) 458
Fibrinogen (g/L) 2.58 (0.65) 350 2.46 (0.56) 454
Metabolic markers 
Body Mass Index (BMI) 24.48 (3.92) 427 23.72 (3.57) 537
Waist circumference (cm) 83.82 (11.67) 427 80.77 (10.60) 535
Glucose (mmol/L) 5.30 (0.58) 395 5.20 (0.51) 498
Low density lipoprotein 
cholesterol (LDL-C) (mmol/L)
3.00 (0.83) 398 2.79 (0.86) 496
High density lipoprotein 
cholesterol (HDL-C) (mmol/L)
1.39 (0.34) 398 1.42 (0.36) 499
Triglycerides (mmol/L) 1.19 (0.53) 396 1.19 (0.63) 495
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To take the significant intercorrelation between the predictor variables as well as the 
outcome variables into account, multiple regression with all predictors was used as the 
main test of the effect of the ANS on metabolic and inflammatory risk scores. These 
analyses showed that a higher heart rate during leisure time (βzIBI = -0.95, p = .02) and 
larger PEP reactivity (βzΔPEP = -0.43, p = .04) were independently associated with higher 
inflammatory risk after 4.9 (SD = 1.7) years. Larger PEP reactivity also tended to be 
associated with higher metabolic risk at follow-up (βzΔPEP = -0.80, p = .01). Figures 7.1 and 
7.2 illustrate that the findings did not depend on a set of outliers. 
Figure 7.1. Heart rate during leisure time (left panel) and PEP reactivity to work (right panel) predict 
a higher inflammatory risk score.
Figure 7.2. PEP reactivity to work predicts a higher metabolic risk.
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Correlations for Study 2 are depicted in Table 7.3. In contrast to Table 7.2, few correlations 
achieved significance. The metabolic risk score predicted future RSA levels at work (r = 
-0.16, p = .009). The main determinants of this association were higher BMI (r = -0.17, p 
= .003) and lower HDL-cholesterol levels (r = 0.18, p = .003). Furthermore, higher BMI 
predicted shorter PEP at work (r = -0.18, p = .002) and higher LDL-cholesterol levels 
predicted shorter PEP during sleep (r = -0.12, p = .008), and higher triglycerides predicted 
higher heart rate during sleep and leisure time (-0.17 < r < -0.24, p < .001). 
The inflammatory risk score did not predict future ANS functioning, although higher 
IL-6 levels were associated with higher heart rate during sleep (r = -0.15, p = .001). 
The metabolic risk score did not predict future ANS functioning. Multiple regression 
simultaneously using inflammatory and metabolic risk scores as predictors also revealed 
no significant associations between metabolic or inflammatory risk measured at baseline 
and ambulatory ANS (re)activity measured 5.4 years later. 
Overall, a similar pattern of outcomes was found for Study 1 and 2 when the analyses 
were repeated excluding the data of participants with a ceiling effect on RSA during sleep 
(results not shown). 
Discussion
This was the first study to jointly investigate whether heart rate, cardiac sympathetic, and 
cardiac parasympathetic control in a natural environment can predict inflammatory and 
metabolic risk five years later, as well as the reverse prediction of whether inflammatory 
and metabolic risk at baseline can predict ambulatory autonomic cardiac control at 
five year follow-up. We found that higher heart rates during leisure time in the evening 
together with exaggerated cardiac sympathetic reactivity to work were associated 
with higher inflammatory risk over time. In addition, exaggerated cardiac sympathetic 
reactivity to work was associated with higher metabolic risk over time. The reactivity effect 
was corrected for possible confounding by physical activity by selecting only periods of 
sitting activities during leisure and work. An unfavorable metabolic or inflammatory risk 
profile, however, was not associated with later ANS functioning. This pattern of results is 
thus not compatible with bidirectional causal effects or with an underlying factor model. 
These would have led to significant associations between inflammatory risk and future 
heart rate and PEP reactivity, and between metabolic risk and future PEP reactivity. Such 
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associations were not observed. Instead our results are most compatible with a model that 
has unidirectional causal effects of resting heart rate and cardiac sympathetic reactivity 
on inflammatory risk and additional effects of cardiac sympathetic reactivity on metabolic 
risk. Below we compare these results to previous studies on the association between ANS 
functioning and inflammatory or metabolic risk.
Inflammatory risk
High mean HR across 24-h (Intzilakis et al., 2013; Sajadieh et al., 2004; Stein et al., 
2008), daytime (Kon et al., 2006; Sloan et al., 2007; Whelton et al., 2014) and nighttime 
recordings (Hartaigh et al., 2014; Intzilakis et al., 2013; Sajadieh et al., 2004) have all 
been associated with increased inflammation previously. Whereas the group of Sajadieh 
and colleagues found a significant association of both 24-h and nighttime HR with CRP 
and TNF-α (Intzilakis et al., 2013; Sajadieh et al., 2004), Hartaigh et al. (Hartaigh et al., 
2014) only found nighttime HR, and not 24-h or daytime HR, to be significantly associated 
with CRP. Our correlational analysis suggests that HR throughout all phases of the day is 
associated with higher IL-6, CRP and/or fibrinogen, but not TNF-α. When HR, RSA and 
PEP levels and reactivity were simultaneously used as predictors in multivariate models, 
only higher heart rate during leisure time in the evening remained a significant predictor 
of higher future inflammatory risk. HR reactivity to work did not independently contribute 
to the prediction of future inflammatory risk.
Reduced cardiac vagal control, measured as HRV across different times of day 
and/or varying physical activities, has repeatedly been associated with an unfavourable 
inflammatory profile in cross-sectional studies (Araujo et al., 2006; Haarala et al., 2011; 
Intzilakis et al., 2013; Jarczok et al., 2014; Lampert et al., 2008; Kon et al., 2006; Sajadieh 
et al., 2004; Sloan et al., 2007; Stein et al., 2008; Thayer & Fischer, 2009; von Kanel et 
al., 2009; von Kanel et al., 2008; Whelton et al., 2014). To our knowledge, only one 
longitudinal ambulatory study was performed. This study found that higher nighttime 
cardiac vagal control was associated with lower CRP assessed 4 years later (Jarczok et 
al., 2014). A reverse association has also been shown where higher CRP values predicted 
higher, instead of lower, vagal control in each of the following three years (Singh et al., 
2009). Neither of these findings was supported by our study as RSA was not significantly 
associated with inflammatory risk at follow-up, and inflammatory risk did not predict RSA. 
Methodological differences between studies may account for the divergent findings. We 
measured vagal control by the peak-valley method linking ECG and respiratory signals 
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on a breath-to-breath basis, whereas others used frequency-domain based measures of 
HRV not always restricted to the respiratory range. Also, some studies recorded vagal 
control under laboratory conditions as opposed to the more ecologically valid real-life 
setting used here. The studies that did use ambulatory recording, did not always control 
as stringently as we did for differences in posture or activities throughout the day (Araujo 
et al., 2006; Intzilakis et al., 2013; Lampert et al., 2008; Sajadieh et al., 2004; Stein et al., 
2008; Thayer & Fischer, 2009; von Kanel et al., 2009). 
Research testing the association between cardiac sympathetic control and 
inflammation is scarce. Previous cross-sectional studies have mainly used the LF/HF ratio 
as indicator of sympathetic effects despite the controversy surrounding this measure (de 
Geus et al., 2015). None of these studies found this ratio to be significantly associated 
with the inflammatory profile (Araujo et al., 2006; Haarala et al., 2011; Stein et al., 2008; 
von Kanel et al., 2008). The study of Singh et al. (Singh et al., 2009) included the PEP as a 
measure of cardiac sympathetic control but no significant cross-sectional or longitudinal 
associations with CRP in either direction was found. In our study we also did not observe 
a longitudinal association between ambulatory PEP levels and inflammatory risk in either 
direction, but stronger PEP decreases at work compared to leisure time were associated 
with higher future inflammatory risk. No such association in the reverse direction was 
found. 
Metabolic risk
In our study, correlational analyses showed that lower daytime HR with lower RSA and 
shorter PEP were associated with less favourable levels of the metabolic risk factors five 
years later. These effects were largely driven by reduced HDL-cholesterol levels. This is 
in line with the finding in a large study performed by Jiang et al. (Jiang et al., 2015) that 
reported both a cross-sectional (N = 89,860) and a prospective (N = 43,725) positive 
association between laboratory resting HR and the development of the metabolic 
syndrome 4 years later. It is also partly in line with the cross-sectional study by Licht and 
colleagues that found that lower levels of RSA and PEP were independently associated 
with the presence of the metabolic syndrome (Licht et al., 2010). Surprisingly they found 
an association for all individual components measured, except HDL-cholesterol. When 
they retested the same participants 2 years later, they again found that increased heart 
rate and cardiac sympathetic control were predictive of an increase in the number of 
metabolic components, but now high heart rate and low RSA also predicted a 2-year 
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decrease in HDL-cholesterol, which is again in keeping with our findings (Licht et al., 
2013). In a systematic review of the literature on the association between cardiac vagal 
activity and the metabolic syndrome, Stuckey and colleagues (Stuckey, Tulppo, Kiviniemi, 
& Petrella, 2014), reported consistent reduced vagal activity in women with the metabolic 
syndrome while studies on men were inconsistent. We have however not investigated sex 
differences as this would greatly reduce the sample size and the power of both studies. 
Instead, sex was entered as a covariate in both studies.
In spite of the congruence with previous studies caution is in order in the 
interpretation of our study. Using the full metabolic risk score, only a significant prediction 
of the metabolic risk by ambulatory PEP reactivity was found over a 5 year period. 
Levels of HR, RSA or PEP did not predict the full metabolic risk score. We also found 
no evidence for a reverse association between metabolic risk measured at baseline and 
ANS functioning measured at 5 year follow-up. It is important to note, however, that our 
metabolic risk factor cannot be equated with the metabolic syndrome as used in some of 
the above studies, as we did not measure blood pressure. 
Gentile and colleagues (Gentile, Dragomir, Solomon, Nigam, & D’Antono, 2014) 
were the first to include autonomic responses to psychological laboratory stress in their 
prediction of metabolic burden few years later. They found no effect of HR reactivity to 
laboratory stressors in the prediction of metabolic burden, but they did find a positive 
association between vagal reactivity and metabolic burden at 3 year follow-up, though 
this was evident mostly in men. In women on the other hand, blunted vagal reactivity 
predicted increased metabolic burden 3 years later. 
A limitation of the ambulatory approach of this study was that it left us with relatively 
small sample sizes for the measures that build on the presence of prolonged recordings 
at work and in leisure time. Only about half of the participants spent considerable time 
sitting at their work location on the testing day. This strongly reduced the number of 
participants available for analyses, particularly in the multiple regression models. Total 
numbers of complete MZ and DZ twin pairs in either Study 1 (NMZpairs = 43, NDZ pairs = 46) or 
Study 2 (NMZpairs = 112, NDZ pairs = 89) also did not allow us to calculate genetic correlations 
between the ANS variables and the various components constituting the metabolic 
and inflammatory risk scores to more formally test for possible pleiotropy. Full pairwise 
correlations in Tables 7.2 and 7.3 mitigated against the loss of participants with work 
time recordings, but these correlations were not corrected for clustering in families and 
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otherwise suffer from a multiple testing burden, such that formally only p-values < .0003 
(=0.05/144) would survive Bonferroni correction. These limitations are balanced by some 
strong points, including the ambulatory design, the fact that two independent studies 
were done to test the association between ANS functioning and metabolic/inflammatory 
risk in both directions, and the extensive control for batch and other (technical) covariates 
on the metabolic and inflammatory parameters.
Taken together, the results from ‘raw’ correlations and the multivariate linear 
regression models largely tell the same coherent story. In real life settings, high resting 
heart rates together with a shift in cardiac control from parasympathetic to sympathetic 
dominance has adverse effects on the inflammatory and metabolic risk profiles. In 
contrast, an unfavorable metabolic or inflammatory risk profile does not seem to exert 
reciprocal detrimental effect on ANS functioning. Our finding that the causal effects flow 
mainly from the ANS to inflammatory and metabolic risk, rather than in reverse is in good 
keeping with our current biological understanding. There is solid evidence for SNS and 
PNS innervation of metabolically active tissues (Romijn & Fliers, 2005; Yi, La Fleur, Fliers, 
& Kalsbeek, 2010) and various parts of the immune system (Steinman, 2004). Together 
with the well-known effects of stress on the SNS and PNS, these connections can explain 
how, in a single swoop, behavioral states can affect three of the major players (cardiac 
autonomic control, metabolic and inflammatory risk) in the development of cardiovascular 
disease and diabetes. 

Chapter 8 
Summary and general discussion
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Summary
The aim of this thesis was twofold: 1) to investigate the causes of individual differences 
in cardiac autonomic nervous system (re)activity in a healthy adult population using 
ambulatory recording, and 2) to investigate the consequences of these individual 
differences in (re)activity for the inflammatory and metabolic risk profile. 
In chapter 3, the heritability of the three HRV measures that are currently used most 
in the fields of cardiology and physiology were researched in the largest 24-h ambulatory 
ANS dataset in twins to date. Moderate heritability estimates of about 50% were found 
for all three HRV measures across three different physical activity categories inventoried 
(sleep, sitting activities, and non-sitting light physical activity during the day). In addition, 
about 50% of the phenotypic covariance between any two HRV measures in this research 
could be explained by genetic factors. Interestingly, the genetic overlap between the three 
HRV measures turned out to be very high, especially between pvRSA and RMSSD and 
between RMSSD and SDNN, where genetic correlations were estimated at .94 and .89 in 
ambulatory sitting conditions. These findings provide us with the important message that 
HRV studies that assessed pvRSA, RMSSD or SDNN, can be safely pooled in future meta-
analyses of genome-wide association studies because the genetic architecture is expected 
to be highly similar. A secondary goal of this study was to test whether heritability estimates 
were robust against confounding by RSA ceiling effects that may occur at low heart rates. 
Although 10.7% of the participants showed a quadratic IBI-RSA relationship, controlling 
for this ceiling effect did not lead to significant differences in the heritability estimates. 
This implicates that there is no pressing need to exclude recording periods (e.g. nighttime 
recording) or participants with low heart rates from genetic studies of HRV.
In chapter 4, we focused on the quantification of several rest and stress conditions 
in unstructured ambulatory recordings for future use in cardiovascular stress research. 
We used prolonged (24-h) ambulatory recordings of ANS activity during a representative 
weekday to research real-life stress reactivity. On the basis of the activity diaries filled 
out by the participants and the inbuilt accelerometer in the VU-AMS, two ambulatory 
rest (sleep, leisure) and four ambulatory stress (wake, work, work_sitting, work_peak) 
conditions were extracted for each participant. From these conditions several ambulatory 
reactivity measures were defined. The usability of these real-life reactivity measures 
was tested by investigating their reliability, temporal stability and heritability. We found 
that the ambulatory reactivity measures that were employed in this study were reliable 
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and showed moderate to high temporal stability over a period of three years (0.36 < 
r < 0.91 for IBI, 0.58 < r < 0.85 for pvRSA, and 0.48 < r < 0.76 for PEP). Almost every 
ambulatory autonomic reactivity measure showed significant heritability, ranging from 
10 to 47%. Heritability of reactivity in daily life was largely due to new genetic variance 
emerging during real-life situations compared to that seen in the more relaxing ‘baseline’ 
conditions. It was concluded that real-life reactivity in ambulatory cardiac ANS data can 
be reliably assessed when recordings encompass a workday supplemented by periods of 
leisure time, preferably including sleep. 
In chapter 5, we took a completely different approach to organize the 24-h 
ambulatory ANS data. Whereas in chapter 4 we sought to divide the day into homogeneous 
periods based on physical activity and psychosocial circumstances, as extracted from the 
combination of dairy self-report and the inbuilt accelerometer signals, chapter 5 used a 
physiological criterion to create homogeneity in the ambulatory signals analyzed. In this 
chapter the continuous ECG registrations were divided into several distinct heart rate 
bins, under the assumption that these bins represent different physiological states: low 
HR at 1 Hz (60 bpm), medium HR at 1.3 Hz (78 bpm), and high HR at 1.6 Hz (96 bpm) bins 
were defined using a beat binning algorithm. The heritability of four clinically relevant 
ECG repolarization (TpTe, QT, and TWA) and depolarization (QRS) parameters were 
estimated in the bins and compared to the heritability estimates of the same parameters 
obtained from a typical 10 sec resting ECG at 1.12 Hz (67 bpm) as commonly used in 
clinical practice. Results showed moderate to high heritability for all parameters (TpTe: 
52 to 63%, QT: 34 to 69%, TWA: 55 to 72%, and QRS: 32 to 42%). Heritability estimates 
of the clinical resting ECG were generally lower compared to those of the binned 
ambulatory ECG. The difference reached significance for the resting QT interval and the 
TWA when compared to that obtained from the binned ambulatory ECG at the lowest 
frequency. A secondary goal of this study was to examine possible rate dependency 
of the genetic factors influencing the ECG parameters. For all parameters the genetic 
correlations among the different frequencies were very close to unity suggesting that 
the same genetic factor influences the parameters at all three heart rates. Furthermore, 
no significantly different heritability estimates were found for TpTe and QRS at the three 
heart rates. For QT, heritability significantly decreased with increasing HRs and, albeit less 
pronounced, a similar trend was observed for the TWA. Overall, we showed that the beat 
binning approach may provide better endophenotypes for genetic studies of the ECG 
than the classical clinical resting ECG. 
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Finally, we investigated the genetic overlap among the three repolarization parameters. 
Repolarization is strongly influenced by the SNS, and ECG parameters strongly related 
to repolarization might be useful as indices of cardiac SNS control (van Lien et al., 2015). 
We found that although the phenotypic covariance between the three repolarization 
parameters was mostly genetically determined, the overlap between the genetic factors 
influencing the three repolarization parameters was only modest, which indicates that 
these parameters provide unique genetic information on the repolarization phase. 
In chapter 6 and chapter 7 we focused on the potential consequences of the 
individual differences in autonomic regulation as measured in chapter 4. First, in chapter 
6 the heritability of a set of parameters forming another cardiovascular risk cluster, 
inflammation, was researched. The large biobank dataset that was available allowed for 
extensive genetic analyses including not only twins and siblings, but also the parents of 
the twins and siblings. Adding parents of twins to the design enabled us to test for the 
presence of assortative mating and by including data of other family members than twins, 
the contribution of both additive and non-additive genetic effects could be estimated 
without the need to remove estimation of common environmental effects. The sample 
size in combination with the extended twin family design furthermore ensured substantial 
statistical power for the estimations. We found that TNF-α, IL-6, CRP and fibrinogen 
showed moderate heritability (39%, 21%, 45%, and 46%, respectively). A considerable part 
of the genetic variation in TNF-α, CRP and fibrinogen was non-additive while heritability 
of IL-6 was due to additive genetic effects only. Surprisingly, the environment shared by 
family members was not relevant for any of the inflammatory parameters. Furthermore, 
with the exception of a small effect for fibrinogen, no evidence was found for spousal 
resemblance for any of the other pro-inflammatory markers. From this study, we conclude 
that a clear numerical target has been set for future genome wide screens attempting to 
find the actual genetic variants regulating the levels of these pro-inflammatory markers.
In the past, both a shift in autonomic balance towards sympathetic dominance and 
exaggerated cardiac autonomic reactivity to stress have been associated with increased 
cardiovascular disease risk. Previous research, mostly cross-sectional studies conducted 
in the laboratory, points to parallel autonomic effects on the metabolic and inflammatory 
profiles that are hypothesized to account in part for this risk. In chapter 7, the long-term 
bidirectional association between cardiac ANS activity and reactivity and inflammatory 
and metabolic risk was tested in two independent prospective studies. Metabolic and 
inflammatory risk scores were calculated by adding the Z-scores of several key markers 
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of the pro-inflammatory (TNF-α, IL-6, CRP and fibrinogen) and the metabolic (waist 
circumference, body mass index, glucose, triglyceride, low-density cholesterol, and high-
density cholesterol levels) state. Ambulatory 24-h ANS data collection took place five years 
before, and five years after the biobank study. On the basis of the results from the study 
described in chapter 4, IBI, RSA, and PEP sleep and leisure resting levels and the reactivity 
measure (work_sitting versus leisure time activity) that suffered least from confounding 
by posture and/or physical activity was included. It was found that a higher resting HR 
during leisure time paired with increased cardiac sympathetic reactivity were associated 
with higher inflammatory risk five years later. In addition, higher sympathetic reactivity 
was associated with higher metabolic risk after five years. An unfavorable metabolic or 
inflammatory risk profile, in turn, had no detrimental effect on ANS functioning measured 
at follow-up. From this we conclude that our results are most compatible with a model that 
has unidirectional causal effects of resting heart rate and cardiac sympathetic reactivity 
on inflammatory risk and additional unidirectional effects of cardiac sympathetic reactivity 
on metabolic risk. 
General discussion
This thesis builds on a database created during two previous data collections in twin 
families (ANS Study 1, wave 1 and wave 2) that used the VU-AMS system developed at the 
VU University two decades ago. It added to this database by conducting a second study 
(ANS Study 2, wave 3) with a specific focus on the association between ambulatory cardiac 
ANS (re)activity and cardiovascular risk factors. Due to technical improvements of the 
ambulatory monitoring device over time, cardiac ANS assessments for Study 2 embodied 
continuous recordings of the entire ECG signal (compared to R-peak registrations only for 
Study 1). This allowed for genetic analyses of other clinically relevant ECG components 
as well, such as the QT interval, the T-peak-T-end interval, QRS duration, and the T-wave 
amplitude. In this section, the findings will be evaluated in the light of current knowledge 
and directions for future research will be provided.
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Individual differences in cardiac autonomic nervous system (re)activity
This thesis shows that individual differences in cardiac autonomic nervous system (re)
activity in a real life setting are to a large extent caused by genetic variation, at least in a 
healthy adult population. These findings corroborate previous findings from ambulatory 
studies on twins (Busjahn et al., 1998; Kupper et al., 2004; Kupper et al., 2005; Kupper et 
al., 2006; Su et al., 2010) and extend them in a number of ways. First, cardiac sympathetic 
control has previously been operationalized by measurement of the systolic time intervals, 
with the PEP being the measure of first choice (de Geus et al., 2015). Recent research 
by our group has shown that the TWA during cardiac repolarization can be used as an 
additional indicator of cardiac sympathetic control (van Lien et al., 2015). Here we confirm 
that this measure, like the PEP, shows substantial heritability in ambulatory recordings, 
strengthening our confidence in the role of genetic factors in cardiac sympathetic control. 
Secondly, we parsed the ambulatory recordings into different conditions using two 
new approaches: 1) behaviorally informed conditions that can be expected to reflect 
states of low versus high emotional and mental engagement with the environment, and 
2) physiologically informed conditions where the ECG was ensemble-averaged across 
fragments with similar heart rates across the day and night. In our previous studies, 
including chapter 3 in this thesis, conditions were created mainly by focusing on the 
control for posture and physical activity level.
The added value of the TWA
Although PEP is the current gold standard in clinical physiological research, PEP scoring 
is highly laborious especially when research moves to an epidemiological scale with 
ambulatory data measured across extended time periods in thousands of participants. 
For this reason, the TWA has recently been put forward as a valuable addition to PEP to 
index sympathetic nervous system activity (van Lien et al., 2015). Earlier twin studies of 
the TWA estimated heritability between 34 to 72% (Haarmark et al., 2011; Mutikainen 
et al., 2009). The broad range in these estimates was ascribed to the lead that was used 
to derive the TWA. The TWA in these earlier studies was mostly assessed during quiet 
sitting in the laboratory. In the study described in chapter 5, heritability of the TWA was 
estimated between 58% and 72%, depending on the heart rate at which the TWA was 
measured. A remaining task is to determine the genetic underpinnings of the TWA in the 
same content-based way as was done for the PEP in chapter 4 and test for differences 
in heritability as a function of sleep, leisure and work time. Furthermore, an interesting 
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question is to what extent the genetic factors influencing the PEP and the TWA overlap. 
The phenotypic correlation is significant but moderate and many different biological 
processes may be involved in the manifestation of cardiac contractility and ventricular 
repolarization. However, the PEP-TWA correlation may be due entirely to shared genetic 
factors which would suggest that a bivariate approach with both traits simultaneously 
could help detect genetic effects on cardiac SNS activity in gene finding studies. 
Different ways to parse unstructured ambulatory ANS recordings  
into meaningful conditions
The major advantage of ANS recordings in real-life over laboratory assessments is the 
gain in ecological validity. Where laboratory recordings claim to capture ANS activity 
or responsivity to stress in general, the stress induced in the laboratory setting is 
actually quite artificial. Psychological challenges and mental effort experienced in real-
life will correspond more closely to the chronic and repeated stress that may ultimately 
predispose us to adverse health conditions like cardiovascular disease. The major 
drawback of using real-life recordings is that they are unstructured by nature, stressful 
events are less demarcated and, importantly, stress during a recording on an arbitrary 
day is not guaranteed unless a stressful event is planned. On top of this, ambulatory 
measurements are more prone to confounding influences of posture, physical activity, 
and time of day compared to typical laboratory assessments in which measurements are 
typically short and recordings take place with the participants being under controlled 
(physical) conditions. 
In this thesis, two different strategies to organize unstructured ambulatory ANS 
data have been explored. For one strategy, the focus was on clustering data based on 
the reported activities by the participants and accelerometer data obtained from the 
recordings (content-based, chapter 4). The other approach concerned organizing the 
data based on physiology and grouped ECG complexes of comparable heart rates 
(physiology-based, chapter 5). The latter physiology-based approach has the advantage 
of completely controlling for heart rate, and strongly, albeit not perfectly, reduces 
the confounding effects of postural change and physical activity. The disadvantage is 
that it cannot deal with effects of the emotional state of the subject at the time of the 
physiological recording. For this approach thousands of frequency-defined heart beats 
scattered across the entire measurement are used to constitute the different bins. As 
such, it is no longer possible to integrate the physiological signal with the emotion and/
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or activity that the participant was exposed to at a particular time during the recording. 
The content-based approach fares better here. However, posture and physical activity are 
far less stringently controlled for as compared to the physiology-based approach. Also, 
effects of heart rate on ECG parameters of interest cannot be as well controlled as with 
the physiology-based approach. Strong heart rate effects were for instance found for the 
TWA (van Lien et al., 2015).
From chapter 4, we concluded that all content-based rest (sleep, evening leisure time 
activity) and stress conditions (wake, work, work_sitting, work_peak) performed equally 
well from a psychometric point of view. Control for physical activity becomes particularly 
manifest when studying cardiovascular reactivity since this may put constraints on the 
pairs of conditions that can be used to define ambulatory reactivity (i.e. only make rest-
and-stress-pairs of conditions that are equal in posture and physical activity). One way to 
overcome the issue of confounding by postural change or physical activity in the content-
based approach would be to more rigorously control for these effects. A few decades ago, 
Blix, Stromme, & Ursin (Blix, Stromme, & Ursin, 1974) introduced the concept ‘additional 
heart rate’ which refers to heart rate increments that can be ascribed to (non-metabolic) task 
demands. This requires that metabolic demands are continuously monitored in addition 
to heart rate. Co-registration of heart rate and oxygen consumption (VO2) during different 
levels of physical activity can establish the linear slope between heart rate and VO2. This 
can be used to predict the heart rate at a given VO2 . Deviations of the actual heart rate 
form this predicted heart rate is known as the ‘additional heart rate’. This additional heart 
rate method could be partly extended to PEP and RSA, as cardiac SNS and PNS activity 
may also scale linearly with VO2, at least at low intensity physical activity.
For heart rate, this method has already proven to be successful in the laboratory 
(Carroll, Turner, & Rogers, 1987; Carroll, Turner, & Hellawell, 1986; Carroll, Turner, & 
Prasad, 1986; Sherwood, Allen, Obrist, & Langer, 1986; Stoney, Langer, & Gelling, 1986; 
Turner & Carroll, 1985). Since implementation of this method in prolonged ambulatory 
recordings is technically not possible due to the demanding requirements for VO2 
measurements, Myrtek & Brugner (Myrtek & Brugner, 1996) introduced a new method in 
which continuous co-registrations of the ECG and physical activity was realized by means 
of accelerometery. In this method, heart rate and accelerometer values at a given time 
point (during an event) were compared to the moving average of the previous minutes. 
When the difference in heart rate between these periods was at least 3 beats and the 
concurrent change in physical activity was minimal, an event was considered ‘emotional’. 
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Higher levels of physical activity were dealt with by an algorithm that is explained in 
detail in Myrtek (Myrtek, 2004). Although additional heart rate was succesfully captured 
by this method in several studies, associations with the emotional appraisal of the events 
have not been consistently found in the ambulatory situation (Ebner-Priemer et al., 
2007; Myrtek, Aschenbrenner, & Brugner, 2005; Myrtek & Brugner, 1996). This may in 
part be due to the fact that postural changes, with a large impact on heart rate through 
venous pooling effects on stroke volume, are not taken into account in their approach. 
The increased precision of accelerometer data and the improved algorithms for both 
posture and metabolic demands detection from such signals may well make it worthwhile 
to revive this method.
Gene by environment interaction
The most striking pattern observed in the ambulatory setting was the increase in genetic 
variance during psychologically engaging events. This increase, which reflects gene-
environment interaction, had already been noted in previous laboratory stress research 
(de Geus et al., 2007; Wang et al., 2009). Stress-specific genetic effects were generally 
more evident in the ambulatory setting (up to 40%) compared to those found in the 
standardized part of our study (4% to 11%) and previous laboratory studies (7% to 23%) 
(de Geus et al., 2007; Wang et al., 2009). This can probably be ascribed to the difference 
in the appraisal of the stressors encountered in the different studies. Whereas de Geus et 
al. (2007) included typical short mental stress tasks in their study, Wang et al. (2009) used 
tasks that more closely approached stress in real-life, and the ambulatory part of our study 
described in chapter 4 solely comprised of real-life work-related demands. The latter are 
more likely to be motivationally relevant for the individual and invoke more subjective 
stress. Unfortunately, we did not confirm this by adequate measurements of subjective 
stress, as an added set of items to the paper diary was considered to increase the already 
high burden of ambulatory monitoring for the subject. Current day smartphone-based 
ecological momentary assessment was not yet in reach when Study 1 was started. In 
retrospect, our data show that it is not necessary to include pre-planned stressors in 
the measurement protocol to induce sufficient reactivity. The choice of measurement 
days will depend on the research question. The inclusion of a work day with social 
engagement paired to mental effort seems important, but other stressors like child care 
or prolonged caregiving for elderly/diseased family members may also yield substantial 
psychophysiological reactivity. 
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Because the studies described in this thesis are larger than any previous study and 
have the added advantage of being performed under ecologically valid conditions they 
provide the research community with the best estimates of the genetic architecture of 
cardiac autonomic control to date. As it stands, we conclude that individual differences 
in sympathetic and parasympathetic influences on cardiac electrical activity are best 
explained by invoking only two sources of variance, additive genetic influences and 
unique environmental influences. The additive genetic variance varies between different 
markers, across the different times of day, and across the different pursuits of daily life, 
but the average of all reported ambulatory RSA heritabilities throughout this thesis was 
49% and for PEP it was 38%. 
The long-term association between ANS (re)activity and inflammatory and metabolic risk
Inflammatory processes and metabolic disturbances have both been associated 
with cardiovascular disease, and both have been associated with ANS functioning. 
Although evidence for a deleterious role of ANS functioning characterized by a shift 
in sympathovagal balance to sympathetic dominance in increased inflammatory and 
metabolic risk has previously been found in both directions, bidirectional influences 
between ANS functioning and both risk profiles has never been researched in one study 
before. The study described in chapter 7 was also the first to include reactivity to real-
life stress, captured as work-related ANS activity versus leisure time ANS activity in the 
evening, as a factor. 
Our results point to an unidirectional association of higher ambulatory resting 
heart rate paired to exaggerated cardiac sympathetic reactivity with higher inflammatory 
risk at follow-up. Exaggerated cardiac sympathetic reactivity did also precede higher 
metabolic risk measured 4.6 years later. Conversely, inflammatory and metabolic risk were 
not associated with ANS functioning measured 5.4 years later. With this study we show 
that both higher baseline heart rate and large sympathetic responsivity to work-related 
challenges can make one prone to develop cardiovascular problems in future. Multiple 
short-term stress experiences or stress that is experienced chronically may both be at 
the basis of these associations. Since the reactivity measure that was incorporated in this 
study pertains to work and recovery from work-related activity (evening leisure time), it 
may be noteworthy that considerable variation in the experience of work stress between 
individuals exists. Vrijkotte, van Doornen, & de Geus (Vrijkotte et al., 2000) studied this 
topic and found that individuals that experienced high imbalance at work (a combination 
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of high effort and low reward) had higher heart rates at work and directly after work, a 
higher systolic blood pressure during work and leisure time, and lower 24-h vagal tone 
on work days and a non-workday. Individuals that experienced high overcommitment 
(inability to unwind from work), on the other hand, showed a general pattern of shorter 
PEP during work and leisure time periods across workdays and the non-workday. In 
addition, smaller absolute sleep-wake differences and decreased PEP variability were 
observed in individuals experiencing high overcommitment, possibly pointing to down-
regulation of cardiac beta-receptors by chronic cardiac SNS activity (Vrijkotte et al., 2004). 
These results illustrate that certain coping styles or personality profiles may give rise to 
a particular ANS reactivity profiles that may compromise physical health in the long run. 
Future directions
Having established that the regulation of cardiac autonomic control can largely be 
explained by genetic variation, it becomes important to characterize the actual causal 
variants responsible for this heritability. As already outlined in the introductory chapter, 
the first steps have been undertaken towards this aim. Many candidate gene association 
studies have been conducted and even a few single-cohort GWA studies. The yield of 
these attempts has, perhaps not surprisingly, been modest. Cardiac autonomic activity is 
a complex phenotype, and only a very small percentage of the total genetic variance is 
expected to be explained by a single genetic variant. Instead, lots of variants with very 
small effects may be at play. In addition, structural variation and rare variants could be 
of importance to ANS traits in comparable ways as they are to other traits (Eichler et al., 
2010; Manolio et al., 2009). For future research, the key lies in expanding the sample 
sizes of the gene finding efforts, preferably by pooling across many studies in meta-
analysis and by taking a hypothesis-free stance, i.e. by focusing on a GWA approach 
rather than a candidate gene approach. This is exactly what is currently being done by 
the Genetic Variance in Heart Rate Variability (VgHRV) consortium, in an attempt to detect 
the genetic variants causing individual differences in resting RSA. A major concern that 
this consortium is facing is that the various studies to be pooled did not always use the 
same metric to quantify RSA. In that regard, our finding that future gene finding studies 
can safely pool studies that have assessed RSA and RMSSD or RMSSD and SDNN to gain 
power is very reassuring. 
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A major component missing from the current ANS data set is self-reported emotional 
state during the ambulatory recording. There are clear links between ANS functioning and 
emotion although a one-to-one mapping of emotional state on ANS remains very complex 
(Kreibig, 2010). Previous research found that people that have a genetic vulnerability to 
develop anxiety and/or depression showed more negative affect in response to stress 
in daily life compared to people who did not have this genetic vulnerability (Gunthert 
et al., 2007; Wichers et al., 2007; Wichers et al., 2008). These findings point to gene-
environment interaction effects that may also be reflected in ANS functioning. 
Emotional state can be assessed in several ways and at several levels. It was only 
until few decades ago that emotional state was solely assessed by means of classical 
questionnaires, the focus of which is on past experience and current beliefs built on that 
experience. This makes the outcomes of questionnaires inevitably prone to retrospective 
bias. Although this may be a good thing for some purposes, for instance in clinical 
practice where focus lies on the participants’ beliefs or mental representations of certain 
experiences, it may not be a good thing in other instances when one is interested in co-
occurring states of multiple modes (i.e. mood, physiology, and behavior). For this reason, 
emotional state is increasingly measured by Ecological Momentary Assessment (EMA) 
procedures that repeatedly assess e.g. mood at various (random) times of the day using 
tablets or smartphones (Conner & Barrett, 2012; Fahrenberg et al., 2007). The idea that 
two different constructs are measured by EMA and by questionnaires is emphasized even 
more by studies that found only moderate correlations between outcomes of real-time 
mood assessment and retrospective questionnaires measuring the same phenomena 
(Ebner-Priemer & Trull, 2009b). 
This discrepancy between momentary and recalled symptoms may also explain why 
research linking the physiological state to mood or personality assessed by retrospective 
questionnaire has been rather inconclusive (Conner & Barrett, 2012). Emotional states 
assessed by EMA in real-life settings may be more strongly correlated to ANS activity than 
questionnaire-based measures of anxiety and depression symptoms to laboratory based 
physiology. Support for this notion comes from studies that found ambulatory levels of 
cardiovascular parameters (BP, HR, HRV) to be more strongly associated to momentary 
self-report measures compared with the classical retrospective self-reports (Bhattacharyya, 
Whitehead, Rakhit, & Steptoe, 2008; Kamarck et al., 2005). In ANS Study 1 and 2 we used 
a paper-and-pencil diary to mainly record posture and (physical) activity at the expense 
of detailed emotional state measurement. The current-day more advanced assessment 
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methods were simply not available. We deliberately kept the protocol identical in Study 2 
as we needed to balance the comparability of data across waves against the advantages 
of the newly available technology. Future research, however, would do well to replace 
the paper dairies for applications on a smart phone. Such apps can accommodate many 
types of self-reported data collection, including the assessment of momentary mood 
(Trull & Ebner-Priemer, 2013). Data obtained from these assessments is ‘on the spot’ 
and has great potential to help us gain more insight in the complex interplay between 
our ambulatory behavioral state and our ambulatory ANS functioning. This thesis clearly 
confirmed that ambulatory ANS functioning plays a major role in our long-term health. 

Chapter 9 
Nederlandse samenvatting: 
Oorzaken en gevolgen van 
individuele verschillen in ambulant 
gemeten autonome zenuwstelsel 
activiteit (dutch summary) 
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Hart- en vaatziekten zijn een van de belangrijkste doodsoorzaken in Westerse landen. 
Ze vormen een verzamelnaam voor een groep aandoeningen betreffende het hart 
(bijvoorbeeld hartfalen, hartritmestoornissen), de vaten (bijvoorbeeld aneurysma, 
slagaderverkalking), maar ook een beroerte wordt tot de hart- en vaatziekten gerekend. 
De ontstaanswijze van deze aandoeningen is vaak heterogeen waar veel verschillende 
factoren in meer of mindere mate aan bij kunnen dragen. Hierbij kan men denken aan 
demografische factoren als sekse en leeftijd, maar ook sociaal-economische klasse, 
levensstijl (roken, alcoholgebruik, voeding), psychologische factoren (angst, stress, 
depressie), een bepaalde genetische aanleg, en mogelijk een samenspel tussen deze 
factoren (Brotman et al., 2007; Brotman et al, 2005). Voordat hart- en vaatziekten tot 
uiting komen, zijn er vaak wel al waarschuwingssignalen of condities aanwezig die 
vooraf kunnen gaan aan het ontstaan van de aandoening, of die hier een bij-product 
van zijn. Voorbeelden hiervan zijn het metabool syndroom dat gekenmerkt wordt 
door obesitas, hypertensie, hyperlipidemie, en hyperglycemie (Bayturan et al., 2010), 
inflammatie (Danesh et al., 2008), een coagulatie/fibrinolyse imbalans (Libby & Theroux, 
2005), een verminderde hartslagvariabiliteit (Dekker et al., 1997; Dekker et al., 2000), 
en een verhoogde hartslag (Fox et al., 2007). Al deze lichamelijke risicofactoren worden 
beïnvloed door de activiteit van het autonoom zenuwstelsel.
Het autonoom zenuwstelsel is verantwoordelijk voor onze homeostase en coördineert 
daartoe verschillende lichaamsfuncties die het lichaam beschermen tegen veranderingen 
in de interne of externe omgeving (bijvoorbeeld door fysieke inspanning, een verandering 
van lichaamshouding, voedselinname, of een bloeding). Het autonoom zenuwstelsel 
bestaat uit het parasympathische zenuwstelsel en het sympathische zenuwstelsel. Het 
sympathische zenuwstelsel wordt ook wel het ‘vecht-of-vlucht’ systeem genoemd; het 
maakt het lichaam klaar om in actie te komen. Het zorgt er onder meer voor dat de hartslag, 
ademhaling, hartcontractiliteit en bloeddruk omhoog gaan, dat de luchtpijptakken zich 
verwijden, de zweetproductie op gang komt, dat er epinefrine (een stimulerende stof) 
wordt vrijgegeven en dat er bloed naar de spieren wordt gestuurd. Het parasympathische 
zenuwstelsel daarentegen zorgt voor het behoud van het lichaam door de opname van 
voedingsstoffen te promoten en te zorgen dat het lichaam zich ontdoet van afvalstoffen. 
Deze tak van het autonoom zenuwstelsel wordt ook wel het ‘rust-en-verteer’ systeem 
genoemd. Het verlaagt de hartslag en verhoogt de hartslagvariabiliteit, de pupillen 
worden kleiner, en de maag en speekselklieren worden gestimuleerd. Beide takken van 
het autonoom zenuwstelsel origineren in het brein en projecteren naar verschillende 
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gebieden in het lichaam, waaronder het hart. Voor het onderzoek in dit proefschrift zijn 
24-uurs opnamen van het hart gemaakt. Er zijn continue electrocardiogram (ECG) en 
impedantiecardiogram (ICG) signalen verzameld in meer dan 1300 tweelingen en hun 
familieleden. Deze metingen vonden plaats op een representatieve doordeweekse dag. 
Uit het ECG hebben we de hartslag bepaald. Hartslag zelf is echter het resultaat van een 
onbekende mix van sympathische en parasympathische invloeden op het hart. Om goed 
onderscheid te kunnen maken tussen deze twee systemen, hebben we naast hartslag 
ook hartslagvariabiliteit, als maat voor de parasympathische aansturing van het hart, 
berekend. Hier zijn verschillende maten voor, maar aan de basis van het concept liggen 
de periodieke veranderingen in de tijdsintervallen tussen opeenvolgende hartslagen. Als 
maat voor de sympathische aansturing van het hart hebben we de pre-ejectieperiode 
(PEP) bepaald en hebben we in hoofdstuk 5 ook de T-golf amplitude (TWA) uit het ECG 
onder de loep genomen. De PEP is het tijdsinterval tussen de aanvang van de elektrische 
prikkel die het hart doet samenknijpen en het openen van de linker hartklep. 
Onderzoeksvragen
Eerder onderzoek heeft al aangetoond dat er grote individuele verschillen bestaan in 
de activiteit van het autonoom zenuwstelsel in rust (Berntson et al.1994; Berntson et al., 
2008; Cacioppo et al., 1994; Grossman & Kollai, 1993; Light et al., 1998; Salomon et 
al., 2000) en dat deze versterkt worden door stress opgewekt in een laboratorium (de 
Geus et al., 2007; Houtveen et al., 2002; Lucini et al., 2002; Wang et al., 2009), maar ook 
door aanhoudende psychosociale stress (Riese et al., 2000; Vrijkotte et al., 2004). Het 
is echter onduidelijk in hoeverre een laboratorium situatie een ware reflectie biedt van 
de werkelijke wereld, want dat is waar we uiteindelijk in geïnteresseerd zijn. Meten we 
wel dezelfde soort lichaamsreacties in het laboratorium als in het echte leven? Er zijn al 
belangrijke stappen gezet in het ambulante, of veldonderzoek, vaak nog gestructureerd 
met een vooraf geplande stressor en rustmeting, maar ook ongestructureerd al dan niet 
met inachtneming van de verschillende dagdelen. Laatstgenoemd onderzoeksterrein is 
een nog grotendeels onontgonnen gebied waar een grote uitdaging ligt in de volgende 
vraagstellingen: Hoe kunnen we het beste structuur aanbrengen in ongestructureerde 
24-uurs ambulante hartmetingen? Of met andere woorden, hoe kunnen we rust en stress 
condities definiëren zonder dat er een vooraf geplande stressor plaatsvindt tijdens de 
meting? Kunnen we deze condities ook gebruiken voor toekomstig stress-onderzoek? 
Wat is de invloed van genen en omgeving op verschillende fysiologische risicofactoren 
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voor hart- en vaatziekten, gemeten in het dagelijks leven? Zien we de invloed van genen 
in ambulante stress-situaties toenemen ten opzichte van een rustperiode, net als in het 
laboratorium? Hebben de ambulante rust- en stress condities predicerende waarde voor 
(cardiovasculaire) gezondheid op de lange termijn? En omgekeerd, zijn bloedmarkers 
gerelateerd aan de metabole en inflammatoire toestand voorspellend voor ambulante 
autonome zenuwstelsel (re)activiteit op een later moment? Dit zijn de hoofdvragen 
van het onderzoek dat wordt beschreven in dit proefschrift. Voor ik de belangrijkste 
bevindingen van dit onderzoek zal bespreken, wil ik eerst kort ingaan op de rationale 
achter het tweelingonderzoek.
Tweelingonderzoek
Het onderzoek beschreven in dit proefschrift is uitgevoerd bij tweelingen en hun 
familieleden die ingeschreven staan bij het Nederlands Tweelingen Register (NTR). Door 
onderzoek bij tweelingen uit te voeren kunnen we uitzoeken in hoeverre een bepaalde 
eigenschap wordt bepaald door genen en in welke mate door de omgeving. Aan de 
basis van het klassieke tweelingonderzoek ligt de wetenschap dat eeneiige (monozygote, 
of MZ) tweelingen nagenoeg 100% van hun genetische materiaal met elkaar delen en 
twee-eiige (dizygote, of DZ) tweelingen 50%. Door bepaalde eigenschappen van grote 
groepen MZ en DZ tweelingen met elkaar te vergelijken, kunnen we erachter komen of MZ 
tweelingen meer op elkaar lijken dan DZ tweelingen wat betreft de gemeten eigenschap. 
Als dat zo is, dan wijst dit erop dat genen (deels) van invloed zijn op het tot uiting komen 
van de eigenschap. Lijken de tweelingen meer op elkaar dan op basis van genetische 
invloeden kan worden verklaard, dan duidt dit op invloeden van een gedeelde omgeving. 
Hierbij kan gedacht worden aan de dagelijkse leefomgeving die gedeeld wordt tussen de 
tweelingen die hen op elkaar kan doen lijken, bijvoorbeeld het gezin. Als laatste is er nog 
de rol van de unieke omgeving, zoals het woord uniek al impliceert gaat dit om factoren 
die uniek zijn voor het individu. Met andere woorden omgevingsinvloeden die niet 
gedeeld worden door familieleden, zoals eigen vrienden. De erfelijkheid wordt voorts 
berekend door de proportie van de variatie die aan genetische factoren toegeschreven 
kan worden te delen door de totale variatie die de eigenschap laat zien.
Het klassieke tweelingmodel kan nog verder uitgebreid worden door naast 
tweelingen ook familieleden van tweelingen in het onderzoek te betrekken (bijvoorbeeld 
broers, zussen, ouders, of partners). Dit wordt dan ook een ‘uitgebreide tweelingstudie’ 
genoemd. De voornaamste reden waarom dit gedaan wordt is om de studie krachtiger 
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te maken zodat we beter onderscheid kunnen maken tussen de genetische en 
omgevingsinvloeden die gedeeld worden binnen een familie. Een uitbreiding van het 
klassieke model met ouders of partners maakt het ook mogelijk nog andere effecten te 
onderzoeken zoals gelijkenissen tussen partners (is er partnerselectie of gaan partners 
over de tijd meer op elkaar lijken doordat ze een omgeving delen) of culturele transmissie 
(Boomsma et al., 2002; Falconer & Mackay, 1996).
Naast een uitbreiding van het tweelingmodel met meer familieleden, kan het model 
ook uitgebreid worden wat betreft het aantal eigenschappen dat gemodelleerd wordt. 
Dit is interessant wanneer men wil onderzoeken op welke manier de eigenschappen met 
elkaar samenhangen. Zoals ook in dit proefschrift gedaan wordt kan dat bijvoorbeeld 
toegepast worden wanneer men geïnteresseerd is in de vraag in hoeverre dezelfde genen 
betrokken zijn bij verschillende maten voor eenzelfde eigenschap (hartslagvariabiliteit), of 
wanneer men de genetische samenhang en/of of het optreden van nieuwe genetische 
invloeden over herhaalde metingen wil onderzoeken (metingen van dezelfde eigenschap 
op verschillende hartslagniveaus, of tijdens rust en stress momenten).
Erfelijkheid van de parasympathische aansturing van het hart
In hoofdstuk 3 hebben we de erfelijkheid van de drie meest gebruikte maten voor 
hartslagvariabiliteit onderzocht in de grootste dataset met 24-uurs ambulante metingen 
tot nu toe (RMSSD, SDNN, en pvRSA). De erfelijkheid in deze studie werd geschat 
rond de 50%. Hiermee bevestigen we eerdere tweelingstudies, maar vonden daarbij 
ook dat de schattingen van gelijke orde waren voor alle drie parameters over drie 
verschillende condities (hartslagvariabiliteit gemeten tijdens slaap, uitsluitend zittende 
activiteiten overdag, en tijdens lichte niet-zittende fysieke activiteit overdag). Met deze 
studie toonden we ook aan dat ongeveer 50% van de samenhang tussen de drie maten 
voor hartslagvariabiliteit door genetische factoren verklaard kan worden. Ook vonden 
we dat de genetische overlap, of correlatie, tussen de drie hartslagvariabiliteit maten 
erg hoog was. Dit betekent dat nagenoeg dezelfde genen ten grondslag liggen aan 
de verschillende hartslagvariabiliteit maten en dit heeft belangrijke implicaties voor 
toekomstig onderzoek dat tracht de daadwerkelijke genen te vinden die hierbij betrokken 
zijn. Voor dit type onderzoek zijn enorm grote datasets nodig. Een trend op dit vlak is 
dat onderzoeksgroepen over de hele wereld steeds vaker de krachten bundelen door 
datasets samen te voegen om zo tot grotere aantallen te komen en meta-analyses te 
doen over deze samengevoegde datasets. De drie hartslagvariabiliteitmaten die we in 
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deze studie hebben onderzocht kunnen nu dus ook met een gerust hart samengevoegd 
worden omdat we verwachten dat de genetische architectuur vrijwel gelijk is. 
Erfelijkheid van de sympathische aansturing van het hart
Om op niet-invasieve manier de sympathische aansturing van het hart te meten wordt 
vooral gebruikt gemaakt van systole tijdsintervallen, met de PEP als eerste keuze (de 
Geus et al., 2015). In hoofdstuk 4 wordt de erfelijkheid van de PEP geschat tussen de 22 
en 45%. Recent onderzoek door onze groep heeft echter laten zien dat de TWA tijdens 
de repolarisatie fase goed gebruikt kan worden als extra indicator van de sympathische 
aansturing van het hart (van Lien et al., 2015). In hoofdstuk 5 van dit proefschrift laten we 
zien dat deze maat gemiddeld tot hoog erfelijk is (58 tot 72%). Dat deze maat, net als de 
PEP significante erfelijkheid laat zien, geeft dat extra ondersteuning aan het idee dat de 
sympathische aansturing van het hart onderhevig is aan genetische invloeden.
Manieren om de ongestructureerde ambulante hartmetingen in betekenisvolle condities 
op te delen
In hoofdstuk 4 hebben we met behulp van de activiteitendagboeken die de deelnemers 
gedurende de meetdag bijhielden en de bewegingsmeter die ingebouwd is in de VU-
AMS hartmeter, twee ambulante rust- en vier ambulante stresscondities geëxtraheerd 
voor elke deelnemer. Voor de rustcondities hebben we de gemiddelde hartactiviteit 
tijdens slaap en in de vrije tijd berekend. De eerste stressconditie was de gemiddelde 
hartactiviteit over de gehele wakkere periode. Als tweede hebben we de gemiddelde 
activiteit tijdens een werkdag berekend. Deze laatste conditie hebben we ook nog 
een keer berekend maar dan alleen voor zittende activiteiten op het werk. Als laatste 
hebben we nog de periodes met de hoogste hartslag tijdens zittende activiteiten op 
het werk geselecteerd die optelden tot minstens een half uur en daar de mediaan van 
genomen. Op basis van deze condities hebben we verschillende maten voor ambulante 
reactiviteit samengesteld die berekend werden door het absolute verschil tussen de 
rust- en stressconditie te berekenen voor de verschillende autonome maten (hartslag, 
hartslagvariabiliteit en de PEP).
De bruikbaarheid van deze maten als zijnde ‘real-life’ reactiviteitsmaten hebben we 
getest door de betrouwbaarheid, temporele stabiliteit en de erfelijkheid te onderzoeken. 
We vonden dat de maten betrouwbaar gemeten konden worden en een gemiddelde 
tot hoge temporele stabiliteit lieten zien over een periode van drie jaar. Deze temporele 
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stabiliteit konden we in kaart brengen omdat een deel van de deelnemers twee keer 
mee heeft gedaan met het onderzoek. Hierdoor konden we de hartprestatie in de 
verschillende condities correleren met de hartprestatie in dezelfde condities drie en een 
half jaar later. Tot slot vonden we dat de meeste ambulante reactiviteit maten erfelijk 
waren; de schattingen lagen tussen de 16 en 47%. Het bleek dat de erfelijkheid van 
reactiviteit gemeten in het dagelijks leven grotendeels verklaard kon worden doordat er 
nieuwe genetische variatie in het spel kwam bij een hogere ten opzichte van een lagere 
mate van interactie met de psychosociale omgeving. De conclusie van deze studie is dan 
ook dat reactiviteit in het dagelijks leven goed en betrouwbaar gemeten kan worden en 
dat hiermee andere genetische informatie wordt blootgelegd dan die wordt gevonden 
tijdens rustmetingen in het laboratorium of standaard klinische ECG metingen.
In hoofdstuk 5 hebben we een andere benadering gekozen om de 24-uurs metingen 
te organiseren. In plaats van de dag op te delen in homogene periodes gebaseerd op 
fysieke activiteit en psychosociale omstandigheden, gebruikten we voor deze studie een 
fysiologisch criterium om homogeniteit te creëren in de ambulante signalen. In deze 
studie richtten we ons volledig op geselecteerde delen van het 24-uurs ECG zodanig dat 
alle ECGs werden gemiddeld van hartslagen met eenzelfde duur. De aanname was dat 
alle hartslagen met eenzelfde duur (dat wil zeggen bij eenzelfde hartfrequentie) eenzelfde 
fysiologische toestand representeren. Er werden drie toestanden geselecteerd: hartslagen 
bij een lage hartfrequentie (1 Hz, 60 slagen per minuut), hartslagen bij een gemiddelde 
frequentie (1.3 Hz, 78 slagen per minuut), en hartslagen bij een hoge frequentie (1.6 Hz, 
96 slagen per minuut). Hiervoor werd een speciaal ‘beat binning’ algoritme ontwikkeld. 
Vervolgens hebben we de erfelijkheid van vier klinisch relevante repolarisatie (TpTe, QT, 
en TWA) en depolarisatie (QRS) parameters geschat per frequentie.
We hebben deze schattingen vergeleken met de erfelijkheidsschattingen van 
dezelfde parameters onttrokken uit een typisch 10 seconde durend rust-ECG op 1.12 Hz 
(67 slagen per minuut), zoals vaak gebruikt wordt in de klinische praktijk. We vonden een 
gemiddelde tot hoge erfelijkheid voor alle parameters (TpTe: 52 tot 63%, QT: 34 tot 69%, 
TWA: 55 tot 72%, en QRS: 32 tot 42%). De erfelijkheidsschattingen voor het klinische 
rust-ECG waren in het algemeen lager dan die gebaseerd op het frequentiespecifieke 
ambulante ECG. Dit verschil was zelfs significant voor QT en TWA wanneer het rust-ECG 
vergeleken werd met het gemiddelde ECG in de laagste hartfrequentie. Ook hebben 
we de genetische correlatie tussen de verschillende hartslagfrequenties binnen elke 
parameter onderzocht. We vonden dat deze correlatie erg hoog was, wat suggereert 
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dat de genetische factoren die een rol spelen bij grotere fysieke activiteit niet significant 
anders zijn dan de genen die actief zijn tijdens rustigere periodes gekenmerkt door 
een lagere hartfrequentie. Voor QT en TWA nam de erfelijkheidsschatting echter wel 
af met een toenemende hartslag. Deze resultaten impliceren dat het goed mogelijk is 
ongestructureerde ECG metingen te organiseren op basis van hartslagfrequentie. Daarbij 
toont dit onderzoek aan dat de parameters vastgesteld door middel van deze benadering 
misschien zelfs beter gebruikt kunnen worden voor genetische studies dan het typische 
klinische rust-ECG. 
Tot slot hebben we in dit zelfde onderzoek nog de genetische overlap tussen de 
verschillende repolarisatieparameters onderzocht. Alhoewel de correlatie tussen de 
verschillende repolarisatieparameters vooral door genen verklaard kon worden, was de 
overlap tussen de genetische factoren die de parameters beïnvloedden niet zo groot. 
Dit suggereert dat elke onderzochte repolarisatieparameter unieke genetische informatie 
met zich meedraagt met betrekking tot de repolarisatiefase en dat er informatie wordt 
gemist wanneer slechts een of een deel van deze parameters onder de loep wordt 
genomen. 
Erfelijkheid van inflammatoire markers
In hoofdstuk 6 hebben we de erfelijkheid van een ander cardiovasculair risicocluster 
onderzocht: inflammatie. De inflammatoire respons wordt in gang gezet door de pro-
inflammatoire cytokines Tumor Necrosis Factor-alpha (TNF-α) en Interleukin(IL)-1 (Tracey, 
2002). De inflammatoire cascade wordt verder gestimuleerd door de productie van IL-6 
welke op haar beurt de acute fase respons stimuleert. Deze respons wordt gekenmerkt 
door de synthese van C-Reactive Protein (CRP) en fibrinogeen (Gabay, 2006; Gabay 
& Kushner, 1999; Packard & Libby, 2008). Eerder onderzoek heeft aangetoond dat 
verhoogde TNF-α, IL-6, CRP en fibrinogeen niveaus geassocieerd zijn met onder meer 
een toegenomen risico op hart- en vaatziekten (Cesari et al., 2003; Danesh et al., 2008; 
Danesh et al., 2004; Humphries et al., 2007; Libby & Theroux, 2005; Packard & Libby, 
2008; Woods et al., 2000). Eerder onderzoek heeft ook aangetoond dat de manifestatie 
van deze markers deels door genetische factoren verklaard kan worden. Echter, de variatie 
in de erfelijkheidsschattingen die tot op heden zijn gevonden is erg groot. Daarbij zijn 
de schattingen, met een paar uitzonderingen daargelaten, gebaseerd op relatief kleine 
groepen (~ 400) tweelingen (de Lange, et al., 2001; de Lange et al., 2006; de Maat et al., 
2004; Grunnet et al., 2006; Jermendy et al., 2011; MacGregor et al., 2004; Rahman et al., 
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2009; Reed et al., 1994; Sas et al., 2012; Su et al., 2008; Su et al., 2009a; Su et al., 2009b; 
Wessel et al., 2007; Wang et al., 2011; Worns et al., 2006). Voor deze studie hebben we 
gebruik gemaakt van data die verzameld is tijdens een grote biobank studie, uitgevoerd 
door het NTR. Aan dit project hebben naast tweelingen en hun broers en zussen ook 
andere familieleden, waaronder de ouders van tweelingen, deelgenomen. 
Het toevoegen van familieleden van tweelingen aan het onderzoek, maakt het 
mogelijk verder te differentiëren tussen additief genetische en non-additief genetische 
effecten en daarbij ook de gedeelde omgeving mee te modeleren (in het klassieke 
tweeling model dient op basis van de tweelingcorrelaties gekozen te worden tussen 
het modeleren van ofwel additief genetische effecten ofwel de gedeelde omgeving). 
Het toevoegen van ouders aan een tweelingstudie, maakt het verder mogelijk ook de 
mogelijke effecten van partnerselectie te onderzoeken. De immuun-parameters die we 
hebben onderzocht waren de cytokines TNF-α en IL-6 en de acute fase reactanten CRP 
en fibrinogeen. In totaal hebben er 3,534 tweelingen, 1,568 broers en zussen, en 2,227 
ouders van tweelingen uit 3,095 families meegenomen in de analyses voor deze studie. 
Dit maakt deze studie het meest omvangrijk in zijn soort tot nu toe. 
We vonden dat de pro-inflammatoire markers gemiddeld erfelijk waren, schattingen 
kwamen uit op 39%, 21%, 45%, en 46% voor TNF-α, IL-6, CRP en fibrinogeen, respectievelijk. 
Daarbij vonden we dat een substantieel deel van de genetische variatie in TNF-α, CRP 
en fibrinogeen non-additief van aard was terwijl de erfelijkheid van IL-6 volledig toe te 
schrijven was aan additief genetische effecten. Invloeden van een gedeelde omgeving 
bleken voor geen enkele immuunmarker significant. Ook vonden we geen bewijs dat 
partnerselectie een prominente rol speelt in de manifestatie van de onderzochte markers. 
We concluderen dat deze grote studie duidelijke erfelijkheidsschattingen neerzet welke 
gebruikt kunnen worden als referentie voor toekomstige genoom-wijde associatie 
studies die trachten de daadwerkelijke genen te vinden die verantwoordelijk zijn voor de 
manifestatie van deze markers. 
Wederkerige associatie tussen sympathische en parasympatische (re)activiteit  
en de inflammatoire en metabole risicoprofielen?
In hoofdstuk 7 onderzochten we de lange termijn relatie tussen sympathische en para-
sympathische zenuwstelsel (re)activiteit en de inflammatoire en metabole risico profielen. 
In het verleden zijn zowel een verschuiving in autonome balans van sympathische 
dominantie en een overdreven autonome reactiviteit op stress geassocieerd met een 
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verhoogd cardiovasculair risico. Eerder onderzoek wijst op parallele autonome effecten 
op de metabole en inflammatoire risicoprofielen die deels verantwoordelijk zijn voor dit 
risico. Deze eerdere studies waren echter vaak cross-sectioneel van aard en uitgevoerd 
in het laboratorium of in een kliniek. In het onderzoek beschreven in dit hoofdstuk testen 
we de bidirectionele lange termijn associatie tussen autonome zenuwstelsel activiteit 
en reactiviteit en inflammatoir en metabool risico in twee onafhankelijke prospectieve 
studies. We hebben inflammatoire en metabole risiscoscores berekend door de Z-scores 
van een aantal van de belangrijkste markers van de pro-inflammatoire (TNF-α, IL-6, CRP 
en fibrinogeen) en metabole (middelomtrek, body mass index, glucose, triglyceride, 
low-density cholesterol, en high-density cholesterol levels) toestand bij elkaar op te 
tellen. Deze markers zijn bepaald tijdens de eerder genoemde biobank studie. De 
dataverzameling van de 24-uurs ambulante autonome zenuwstelsel activiteit vond vijf 
jaar voor en vijf jaar na de biobank studie plaats. Op basis van de resultaten beschreven 
in hoofdstuk 4, hebben we de hartslag, RSA, en PEP tijdens slaap en in de vrije tijd 
als rustlevels meegenomen, samen met de reactiviteitsmaat (werk_zittend – vrije tijd) 
die het minst onderhevig was aan vertekening door houding en/of fysieke activiteit. 
We vonden dat een hogere rusthartslag in de vrije tijd gekoppeld met een verhoogde 
sympathische reactiviteit geassocieerd waren met hoger inflammatoir risico vijf jaar later. 
Ook werd gevonden dat een hogere sympathische reactiviteit geassocieerd was met een 
verhoogd metabool risico vijf jaar later. Een ongunstig metabool of inflammatoir profiel 
had omgekeerd geen nadelig effect op autonome zenuwstelsel (re)activiteit vijf jaar later. 
Uit deze studie concluderen we dat er slechts unidirectionele causale effecten zijn van 
een verhoogde rusthartslag en sympathische reactiviteit op inflammatoir risico. Ook zijn 
er slechts unidirectionele effecten van sympathische reactiviteit op metabool risico.
Conclusies
De studies die beschreven staan in dit proefschrift zetten duidelijke numerieke erfelijk-
heidsschattingen neer wat betreft de regulatie van autonome controle over het hart 
gemeten in het dagelijks leven. Gebleken is dat individuele verschillen in sympathische en 
parasympathische invloeden op de elektrische activiteit van het hart het beste verklaard 
kunnen worden door twee typen variantie: additieve genetische invloeden en unieke 
omgevingsinvloeden. De additieve genetische variantie varieert voor de verschillende 
markers, over de verschillende dagdelen, en over de verschillende bezigheden in het 
dagelijks leven. We hebben aangetoond dat er verschillende manieren zijn om data 
 Nederlandse samenvatting 193
9
van ongestructureerde ambulante hartregistraties dusdanig te organiseren zodat deze 
gebruikt kunnen worden voor (klinisch) psychofysiologisch onderzoek. We vonden dat 
genetische invloeden over het algemeen toenemen tijdens stress en dit lijkt vooral te 
komen doordat er andere genen actief worden bij lichaamsreacties op psychosociale 
gebeurtenissen in het dagelijks leven. Dit patroon wordt ook wel gezien bij reacties op 
typische stress taken die vaak in laboratoria worden gebruikt, maar niet altijd en veel 
minder sterk. Tot slot is met dit proefschrift aangetoond dat het functioneren van het 
autonoom zenuwstelsel ook op de lange termijn een belangrijke rol speelt in onze 
gezondheid.
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Invitation letter and brochure
NEDERLANDS TWEELINGEN REGISTER (NTR) 
 
FACULTEIT DER PSYCHOLOGIE EN PEDAGOGIEK 
Biologische Psychologie 
BEZOEKADRES 
Van der Boechorststraat 1 
Kamer 2B-35 
1081 BT Amsterdam 
POSTADRES 
Van der Boechorststraat 1 
1081 BT Amsterdam 
WWW.FPP.VU.NL  
  
DATUM ONS KENMERK UW BRIEF VAN UW KENMERK 
 NETAMB3-082010/b1       
E-MAIL TELEFOON FAX BIJLAGE(N) 
m.neijts@.vu.nl 020 5982537 020 598 8832 Informatiefolder 
   
Betreft: Uitnodiging Familieonderzoek naar lichamelijke en geestelijke gezondheid 
 
   
Geachte heer, mevrouw ……., 
 
U ontvangt deze brief omdat wij u graag willen uitnodigen voor bovengenoemd onderzoek. In de afgelopen 
jaren hebben u en een aantal van uw familieleden meegedaan met (vragenlijst)onderzoek van het 
Nederlands Tweelingen Register (NTR). Uw medewerking hieraan was van zeer groot belang.  
 
Het onderzoek waar wij u nu voor uitnodigen is in 1997 begonnen en inmiddels hebben reeds 800 tweelingen 
en hun familieleden hieraan meegewerkt. Bij dit onderzoek zullen wij u thuis bezoeken om een korte 
vragenlijst met u door te nemen en u een hartactiemeter om te doen. Hiermee zal uw hartactie gedurende 24 
uur gemeten worden. Verder zal de onderzoeker uw bloeddruk meten. Ook wordt u gevraagd een aantal 
maal op een watje te kauwen voor de verzameling van speekselhormonen. Meer informatie over het 
onderzoek en de metingen, vindt u in de bijgaande folder.  
 
Binnen één tot twee weken nadat u deze brief heeft ontvangen, zullen wij telefonisch contact met u opnemen 
om verdere uitleg te geven en om een afspraak met u te maken. Uw persoonlijke hartslaggegevens met een 
korte toelichting worden u kort na de metingen toegestuurd. Wij hopen op uw medewerking. 
 
Met vriendelijke groet, namens het onderzoeksteam, 
 
Drs. Melanie Neijts  
Dr. Gonneke Willemsen 
Prof. dr. Eco de Geus  
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Achtergrond 
 
In 1991 is in Nederland een langlopend tweeling-familieonderzoek gestart naar de geestelijke en 
lichamelijke gezondheid. Bij dit onderzoek wordt gebruik gemaakt van het Nederlands 
Tweelingen Register (NTR) dat in 1987 is opgericht aan de Vrije Universiteit in Amsterdam. Met 
behulp van vragenlijsten en soms ook interviews wordt informatie verzameld over de geestelijke 
gezondheid. De lichamelijke gezondheid wordt gemeten door bloed- en speekselonderzoek, door 
bloeddrukonderzoek, of door onderzoek waarbij de hartfunctie wordt gemeten met elektrodes op 
de borst. De aansturing van het hart is rechtstreeks van belang voor hart- en vaatziekten. 
Daarnaast zijn er aanwijzingen dat de aansturing van het hart gekoppeld is aan het 
immuunsysteem. In dit onderzoek willen wij de aansturing van het hart verder onderzoeken en 
daarvoor vragen wij uw medewerking.  
 
Resultaten tot nu toe 
 
Wij hebben al kunnen aantonen dat veel aspecten van de lichamelijke gezondheid deels bepaald 
worden door familiale aanleg. Voor een groot deel komt dat omdat familieleden hun erfelijk 
materiaal delen. Bij bloeddruk, hartslag, cholesterol en de bloedsuikerspiegel blijkt deze erfelijke 
invloed zelfs van zeer groot belang. Het afgelopen jaar zijn variaties in een aantal genen 
gevonden die deze erfelijke invloeden verklaren. Deze genen zijn mede dankzij onderzoek van 
het NTR opgespoord. Dit helpt ons verder om te begrijpen hoe het mechanisme van erfelijke 
invloed op hart- en vaatziekten werkt.  
 
Waarom bent u belangrijk voor dit nieuwe onderzoek? 
 
Tussen 2004 en 2008 heeft u meegedaan aan onderzoek van het NTR, waarbij u thuis bent 
bezocht door onze medewerkers, die bloed bij u hebben afgenomen. In het nieuwe onderzoek 
willen we de gegevens uit dit eerdere onderzoek koppelen aan metingen van bloeddruk en 
hartfunctie. Omdat u deel uitmaakt van een tweelingfamilie kunnen we het totale belang van 
erfelijke aanleg op bloeddruk en hartfunctie in kaart brengen. Daarvoor wordt gebruik gemaakt 
van de metingen bij eeneiige en twee-eiige tweelingen en hun broers of zussen. Voor dit deel 
van het onderzoek wordt gekeken naar de overeenkomsten tussen familieleden.  
Waarschijnlijk heeft u in het verleden ook aan het vragenlijstonderzoek van het NTR 
meegedaan. Daarin werd gevraagd naar stressvolle gebeurtenissen, gevoelens van angst en 
depressie maar ook geluk en tevredenheid. In dit nieuwe onderzoek zullen we ook kijken in 
welke mate het effect van erfelijke aanleg afhangt van uw geestelijke gezondheid, nu en in het 
verleden. 
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Wat houdt het onderzoek in? 
 
U hoeft voor het onderzoek niet naar de VU te komen, wij komen naar u. Enkele dagen voor het 
thuisbezoek krijgt u van ons een vragenlijst en materiaal voor het afnemen van speeksel 
thuisgestuurd. Op de dag van het onderzoek komen we u 's ochtends thuis bezoeken op een 
datum en tijd die u het beste schikt. Het bezoek neemt 30-40 minuten van uw tijd in beslag. U 
krijgt dan een hartmeter om. Via zeven meetelektroden, die met plakkertjes op de rug en borst 
bevestigd zijn, worden de aansturing en de samentrekkingskracht van het hart gemeten. Wij 
stellen u een aantal vragen over uw gezondheid. Tevens meten we de bloeddruk in rust en 
tijdens een kort computertestje. Daarna vragen we u om de hartmeter gedurende de verdere 
dag en de nacht om te houden tot aan de volgende morgen. De meter is daarvoor speciaal 
ontworpen aan de Vrije Universiteit. Hij is klein, kan onder de kleding worden gedragen en levert 
weinig hinder op bij dagelijkse werkzaamheden.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De VU AMS hartactiemeter bij een  
verpleegkundige tijdens het werk 
 
Omdat de hartactie kan veranderen als gevolg van veranderingen in activiteit, houding en 
stemming, vragen wij u om tijdens de meetdag een dagboekje bij te houden. De ochtend van de 
meetdag, vlak voor het slapen gaan en de ochtend erna neemt u wat speeksel af. Dit gebeurt 
door even op een watje te kauwen dat u daarna in een bijgeleverd buisje doet. De volgende dag 
kunt u zelf de hartmeter afdoen en deze samen met de buisjes in een retourenvelop 
terugsturen. Binnen enkele weken na het onderzoek ontvangt u een overzicht van uw 
hartslaggegevens.  
 
Eerder hebben al ruim 800 personen uit families, ingeschreven bij het Nederlands Tweelingen 
Register, meegedaan aan dit soort onderzoek. In totaal zullen ongeveer 1300 mensen aan dit 
onderzoek deelnemen. Door hun èn uw medewerking krijgen we meer kennis over het verband 
tussen lichamelijke en geestelijke gezondheid en over de reden waarom mensen daarin van 
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elkaar verschillen. We hopen dat die kennis zal bijdragen aan een betere gezondheid van 
iedereen. 
Vertrouwelijkheid 
 
Alle persoonlijke gegevens worden strikt vertrouwelijk behandeld en gecodeerd verwerkt bij een 
wetenschappelijke rapportage.  
 
Vrijwilligheid van deelname 
 
Deelname is vrijwillig en u kunt zich op elk moment, ook na ondertekening van het 
toestemmingsformulier, zonder opgave van redenen uit het onderzoek terugtrekken. 
 
Meer informatie 
 
Voor praktische informatie kunt u te allen tijde contact opnemen met de uitvoerend 
onderzoeker: drs. Melanie Neijts. 
Verdere informatie over de wetenschappelijke achtergrond van de studie wordt desgevraagd 
verstrekt door: prof. dr. Eco de Geus of dr. Gonneke Willemsen.  
Wilt u informatie over dit onderzoek inwinnen bij een onafhankelijk arts, dan is dr. Richard 
Ijzerman, tel. 020-4440533, bereid uw vragen te beantwoorden.  
 
Dit onderzoek is door de Medisch Ethische Toetsingscommissie van het VU Medisch Centrum 
aangeduid als een onderzoek zonder risico, waarvoor een vrijstelling van verzekering is 
afgegeven. 
 
Vrije Universiteit Amsterdam 
Biologische Psychologie  
T.a.v. drs. M. Neijts 
Van der Boechorststraat 1 
1081 BT Amsterdam 
Tel. 020 5988787 
 
U kunt ook een kijkje nemen op onze website: http://www.tweelingenregister.org onder 
“Onderzoek.”  
 
© Vrije Universiteit Amsterdam / NTRAMB3-082010    
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Confirmation letter
NEDERLANDS TWEELINGEN REGISTER (NTR) 
 
FACULTEIT DER PSYCHOLOGIE EN PEDAGOGIEK 
Biologische Psychologie 
BEZOEKADRES 
Van der Boechorststraat 1 
Kamer 2B-35 
1081 BT Amsterdam 
POSTADRES 
Van der Boechorststraat 1 
1081 BT Amsterdam 
WWW.FPP.VU.NL  
  
DATUM ONS KENMERK UW BRIEF VAN UW KENMERK 
 NETAMB3-062010/b2       
E-MAIL TELEFOON FAX BIJLAGE(N) 
m.neijts@vu.nl 020 5982537 
 
020 598 8832 3 
   
Betreft: Bevestiging deelname familieonderzoek naar lichamelijke en geestelijke gezondheid 
 
Geachte heer, mevrouw ……., 
 
Hierbij sturen wij de bevestiging van de afspraak die we telefonisch hebben gemaakt voor de ambulante 
meting. De afspraak zal plaatsvinden op: 
 
Datum:  ……..………………………  Tijd:  ……………………………..   
(Het bezoek zal ongeveer 45 minuten duren)  
 
Bij deze brief is het volgende gevoegd: 
 
1. Een toestemmingsformulier. Dit formulier wordt gebruikt om uw deelname aan de studie te bevestigen. Wilt u 
het invullen zodat de onderzoeker het mee kan nemen na het bezoek?  
2. Een vragenlijst. Het zou fijn zijn als u deze ingevuld hebt voor wij bij u langskomen zodat wij deze meteen 
mee terug kunnen nemen. Het duurt ongeveer 15 minuten om deze in te vullen. 
3. Materialen voor de speekselverzameling. Er moeten 2 verzamelingen op de ochtend vóór het bezoek worden 
gedaan. Wij hebben hiervoor twee buisjes met watjes en een instructie meegestuurd. Leest u deze de avond 
van tevoren alstublieft goed door.  
 
Omdat hartslag en bloeddruk beïnvloed worden door inspanning en alcoholgebruik, willen wij u vragen om de 
dag voor de meting niet te sporten en de avond voor de meting geen of slechts weinig alcohol te gebruiken. 
Als u medicijnen (inclusief de pil) gebruikt, wilt u deze dan klaarleggen voor wij bij u langskomen? 
Wij komen met de auto naar u toe en doen ons uiterste best om op het afgesproken tijdstip bij u aanwezig te 
zijn. Mocht dit door files of om een andere reden niet mogelijk zijn, dan laten wij u dit vanzelfsprekend zo 
spoedig mogelijk weten. Mocht u zelf onverhoopt verhinderd zijn op de afgesproken datum, zou u ons dit dan 
zo snel mogelijk willen laten weten? Wij zijn te bereiken op 020-5982537 of 06-50698826. Bedankt voor uw 
deelname! Wij zien ernaar uit u te bezoeken. 
 
Met vriendelijke groet, 
Melanie Neijts 
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Toestemmingsformulier (Informed Consent) 
 
Familieonderzoek naar lichamelijke en geestelijke gezondheid 
 
 
- Ik bevestig dat ik de informatiefolder voor de proefpersoon (kenmerk NTRAMB3-
082010) heb gelezen en ik begrijp de informatie. Ik heb voldoende tijd gehad om 
over mijn deelname na te denken en ben in de gelegenheid geweest om vragen te 
stellen. Deze vragen zijn naar tevredenheid beantwoord. 
 
- Ik geef toestemming voor deelname aan bovengenoemd medisch-wetenschappelijk 
onderzoek. 
 
- Ik weet dat mijn deelname geheel vrijwillig is en dat ik mijn toestemming op ieder 
moment kan intrekken zonder dat ik daarvoor een reden hoef op te geven. Mijn 
gegevens zullen dan, als ik dat wil, worden vernietigd. 
 
- Ik geef toestemming om de gegevens te verwerken voor doeleinden zoals beschreven 
in de informatiefolder met kenmerk NTRAMB3-082010. 
 
- Ik ga ermee akkoord dat de gegevens uit het huidige onderzoek gekoppeld mogen 
worden aan gegevens die eerder van mij verzameld zijn, zoals erfelijk materiaal, 
resultaten van de bloedmonsters en/of de vragenlijsten. 
 
 
 
 
 
Voornaam    ………………………………………………………………………………  man / vrouw 
 
Achternaam  ……………………………………………………………………………… 
 
Adres   ……………………………………………………………………………… 
 
   ……………………………………………………………………………… 
 
Telefoonnr  ……………………………………………………………………………… 
 
Geboortedatum ……………………………………………………………………………… 
 
 
 
Handtekening           Datum 
 
 
 
………………………………………………………………………………………………………………………………………………………. 
                                                          
 Doorhalen wat niet van toepassing is 
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Instructions saliva collection
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Speekselverzameling 
 
Er zijn in totaal 5 momenten waarop speekselverzamelingen plaatsvinden. De eerste 2 
speekselverzamelingen vinden plaats op de ochtend dat de onderzoeker bij u langskomt. U krijgt 
daarom alvast een instructie en een setje wattenrolletjes meegestuurd.  
 
Het is de bedoeling dat u direct na het wakker worden, terwijl u nog in bed ligt, èn 30 minuten 
daarna speeksel verzamelt. Wilt u de avond van te voren de buisjes bij uw bed, bijvoorbeeld op het 
nachtkastje, klaarleggen? Wij willen u verder vragen in het onderstaande schema in te vullen hoe laat 
u het speeksel hebt verzameld. Dit is belangrijk omdat de hoeveelheid van het hormoon ook 
afhankelijk is van het tijdstip op de dag. 
 
Het is belangrijk dat u een half uur van tevoren niet eet of drinkt. Een glas water mag wel. Wij willen u 
dus ook vragen te wachten met het ontbijt tot u de 2 speekselverzamelingen hebt gedaan. Verder is 
het belangrijk dat u niet vlak voor de speekselverzameling uw tanden poetst (zo vermijdt u dat het 
speeksel met bloed wordt vermengd). In de ruimte voor opmerkingen kunt u aangeven als er iets niet 
helemaal goed is gegaan of als zich misschien een uitzonderlijk voorval heeft voorgedaan.  
 
Instructie 
 
 U draait de dop van de buis en haalt het wattenrolletje eruit. 
 U legt het wattenrolletje in uw mond gedurende 1 minuut. Het is belangrijk dat het 
wattenrolletje goed doordrenkt wordt. U kunt dit bevorderen door niet te slikken en licht op 
het wattenrolletje te kauwen. 
 Stop het wattenrolletje na 1 minuut terug in het plastic hulsje in de juiste buis en draai de dop 
erop. 
 Vul in onderstaand schema de tijd van de speekselverzameling in. 
 
Buisje Verzamelmoment Tijd 
1. Ontwaken In bed, direct na het wakker 
worden, op de dag dat de 
onderzoeker bij u langskomt 
 
….. uur ….. min 
2. Ontwaken +30 30 minuten na het wakker 
worden 
 
….. uur ….. min 
Opmerkingen 
 
 
 
 
 
 
Op de buisjes staat aangegeven welke u eerst gebruikt (1. Ontwaken) en welke daarna (2. Ontwaken 
+ 30). Er wordt een reserve buisje meegestuurd, mocht er iets misgaan. De onderzoeker zal de 
buisjes na het bezoek meenemen. 
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Appendix V
Health and lifestyle interview
 
 
Interview 
 
Familieonderzoek naar lichamelijke en 
geestelijke gezondheid 
 
 
 
 
 
- In te vullen door de testleider -  
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Meten van taille en heupomtrek 
 
 
Algemeen 
 
We gebruiken een centimeter van 1,5 meter lang. De centimeter wordt om het lichaam getrokken, zodat deze goed 
aansluit (niet te los en niet te strak). De taille omtrek wordt op de blote huid gemeten. De heupomtrek over de broek. 
Zorg dat de centimeter parallel loopt op buik- en rugzijde. Omtrek is opgeschreven op een halve cm nauwkeurig.  
 
Taille 
 
De taille wordt gemeten op het smalste punt van het middel. Dit punt ligt net boven de navel.  
 
Heupomtrek 
 
De heupomtrek wordt gemeten op het breedste punt van de heupen. Als hulpmiddel: dit is het punt waar je de 
heupkom goed kunt voelen. 
 
 
 
 
Plakken VU-AMS elektrodes 
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Identificatie door proefleider 
Voornaam?                                                                             Sekse? M / V 
Geboortedatum?                         
□  Testleider: Checken informed consent / speekselverzameling 1 en 2 + instructie met ingevulde tijden / vragenlijst 1 / supplement 
□  Testleider: Voorstellen + uitleg metingen 
□  Testleider: Navraag medicatie: zie medicatiedoosjes 
 
Merknaam  Substantienaam  Dosis / hoe vaak?  Reden  
 
………………………….. ………………………….. ………………………….. ………………………….. 
 
………………………….. ………………………….. ………………………….. ………………………….. 
 
………………………….. ………………………….. ………………………….. ………………………….. 
 
………………………….. ………………………….. ………………………….. ………………………….. 
 
 
□  Assistent: Aansluiten VU-AMS staand: noteren serienummer VU-AMS op dagboekje + tijdstip start (= einde) 24-uurs meting in DB  
□  Assistent: Vragen lengte, meten gewicht, omvang middel en heupomvang  
    Lengte        ……….. cm 
 
    Gewicht           ……….. kg 
    
    Omvang middel  ……….. cm 
    
    Heupomvang    ……….. cm  
 
□  Interview, rustig zitten 
 
Inventarisatie dag / beroep 
1. Wat voor dag is het? 
□  Vrije dag 
□  Werkdag (ook indien u huisvrouw / -man bent) 
□  U heeft momenteel geen werk 
□  Anders, namelijk …………………………………………. 
 
2. Wat voor soort werk doet u momenteel? (Meerdere antwoorden mogelijk) 
□  fulltime betaald werk: meer dan 32 uur per week, specificeer ………. 
□  parttime betaald werk: 12-32 uur per week, specificeer ………. 
□  parttime betaald werk: minder dan 12 uur per week, specificeer ………. 
□  scholier / student 
□  werkeloos, sinds ………. (jaartal) 
□  huisman / huisvrouw, sinds ………. (jaartal) 
□  arbeidsongeschikt ………. (jaartal) 
□   anders, namelijk ………. 
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IN GEVAL VAN WERK 
3. Werkt u in ploegendiensten? Zo ja, hoe zien uw diensten er uit? 
□  Nee, geen ploegendiensten 
□  Ja, ik werk in ploegendiensten. Toelichting: ………………………………………….  
 
4. Hoeveelste werkdag in een rij is dit? 
 
5. Wat is uw beroep? (Gedetailleerd weergeven, ook: leidinggevende functie of niet?) 
 
 
6. Heeft u een zelfstandig beroep? 
□  Ja, geheel zelfstandig: eigen bedrijf of vrij beroep 
□  Gedeeltelijk zelfstandig, toelichting: …………………………………………. 
□  Niet zelfstandig / loondienst 
□  Vrijwilligerswerk 
□  Nooit gewerkt 
7. Wat is uw hoogst genoten opleiding welke u met een diploma hebt afgerond?  
 
Hoe lang duurde deze opleiding? ………. jaar 
 
En betrof dit: 
□  Lager onderwijs  
□  Middelbaar onderwijs (mavo, lbo, vmbo)  
□  Hoger middelbaar onderwijs (havo / vwo, mbo) 
□  Hoger onderwijs (universiteit, hoger niet-universitair, hbo, BaMa) 
□  Anders, namelijk: ……………………….. 
 
Gezondheid 
8. Voelt u zich gezond? 
□  Ja, ik voel me gezond > volgende vraag overslaan 
□  Normaal wel, maar vandaag niet 
□  Nee, ik voel me de laatste tijd niet gezond 
9. Kunt u aangeven waarom u zich niet gezond voelt? 
 
 
 
 
Inspanning 
10. Heeft u zich gisteren zwaar fysiek ingespannen? 
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Sport en beweging 
11. Doet u regelmatig aan sport of lichaamsbeweging? 
□  Nee > alleen volgende vraag overslaan  
□  Ja  
 
 
12. Zo ja, welke sport(en) beoefent u? En kunt u per sport aangeven hoe lang en hoe vaak u deze sport gemiddeld beoefent? 
 
Naam sport  Aantal jaar Aantal maanden  Aantal keer Gemiddelde tijd  
                                                                per jaar               per week per keer 
 
…………………………… ……………….. ………………………..  ………………… ………………… min 
 
…………………………… ……………….. ………………………..  ………………… ………………… min 
 
…………………………… ……………….. ………………………..  ………………… ………………… min 
 
…………………………… ……………….. ………………………..  ………………… ………………… min 
 
 
13. Hoeveel fietst u in een normale week?       ……….. uur en ……….. minuten per week 
 
14. Hoeveel wandelt u in een normale week?    ……….. uur en ……….. minuten per week 
 
Roken 
15. Heeft u ooit gerookt? 
□  Nee > sectie roken kan worden overgeslagen 
□  Een paar keer om te proberen > sectie roken kan worden overgeslagen  
□  Ja 
 
16. Hoeveel jaar rookt of rookte u in totaal?    ……….. jaar  
 
17. Hoe vaak rookt u nu? 
□  Ik ben gestopt met roken sinds …………………….. (mm/jjjj) 
□  Ik rook 1 keer per week of minder 
□  Ik rook meerdere keren per week, niet elke dag 
□  Ik rook 1 of meerdere malen per dag 
 
18. Hoeveel keer heeft u serieus geprobeerd met roken te stoppen?      ……….. keer  
 
 
19. Wat rookt of rookte u? 
 
□  Sigaretten en shag, eventueel samen met sigaren, pijptabak etc. 
□  Uitsluitend sigaren of pijptabak > sectie roken kan verder worden overgeslagen 
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VOOR ROKERS EN EX-ROKERS 
 
20. Hoeveel sigaretten rookt(e) u gemiddeld per dag?                            ……….. sigaretten per dag 
 
 
Alcohol 
21. Hoe vaak drinkt u een alcoholische drank? (Inclusief de keren dat u slechts een kleine hoeveelheid, bijvoorbeeld een paar slokjes, 
drinkt). 
□  Ik drink geen alcohol 
□  1 keer per jaar of minder 
□  Aantal keren per jaar 
□  Ongeveer 1 keer per maand 
□  1 keer per week 
□  Aantal keren per week 
□  Dagelijks 
 
22. Hoeveel glazen alcohol drinkt u gemiddeld per week (inclusief weekend)? 
□  Minder dan 1 glas 
□  1-5 glazen per week 
□  6-10 glazen per week 
□  11-15 glazen per week 
□  16-20 glazen per week 
□  21-40 glazen per week 
□  Meer dan 40 glazen per week 
 
Nachtrust 
 
23. Hoe laat bent u vanochtend opgestaan?     ……….. uur ……….. minuten 
24. Is dit ook uw normale tijd van opstaan? 
□  Ja 
□  Nee, normaal sta ik op om             ……….. uur ……….. minuten 
 
Familie- / gezinssituatie 
25. Hebt u nu een duurzame relatie? 
□  Nee 
□  Ja, niet samenwonend 
□  Ja, samenwonend / gehuwd 
 
26. Hoe lang hebt u een relatie met uw partner? ………. jaar en ………. maanden  
 
27. Bent u eerder getrouwd geweest / hebt u eerder een duurzame relatie gehad (samengewoond / getrouwd)? 
□  Nee 
□  Ja, deze verbintenis is geëindigd in een scheiding / verbroken sinds (jaartal) ……….. 
□  Ja, deze verbintenis is geëindigd door overlijden partner, sinds (jaartal) ……….  
□  Ja, anders, namelijk ………. 
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28. Hebt u kinderen? Zo ja, hoeveel? 
□  Nee 
□  Ja, ik heb ………. biologische kinderen  
□  Ja, ik heb ………. niet-biologische kinderen 
 
29. Wilt u voor uw kinderen aangeven wat hun geboortedatum en geslacht is? 
30. Hoeveel kinderen wonen er op dit moment bij u thuis? 
 
Biologisch / niet-biologisch             Geboortedatum   Geslacht  Thuiswonend ja / nee 
 
…………………………………………  ………. - ………. - ……………….. ……….  ………. 
 
…………………………………………  ………. - ………. - ……………….. ……….  ………. 
 
…………………………………………  ………. - ………. - ……………….. ……….  ………. 
 
…………………………………………  ………. - ………. - ……………….. ……….  ………. 
 
 
ALLEEN VOOR VROUWEN 
Menstruatie 
31. Enkele vragen met betrekking tot de menstruele cyclus. 
Is uw menstruele cyclus regelmatig? 
□  Ja 
□  Nee onregelmatig 
□  Menopauze 
□  Anders, nl. …………………………………………… 
 
32. Wat is gemiddeld het aantal dagen tussen twee menstruaties?     ……….. dagen 
 
33. Wat was de eerste dag van uw laatste menstruatie?    ……………………….. (dd/mm/jjjj) 
34. Gebruikt u anticonceptie? 
□  Ja, nl. ………………………………. (pil / spiraaltje / pessarium / injecties / etc.) 
    Van het merk: ………………………………………………..  
□  Nee 
IN GEVAL VAN MENOPAUZE 
35. Komt de onregelmatigheid van uw menstruatie mogelijk door het begin van de menopauze? 
□  Ja 
□  Nee 
 
36. Hoe lang geleden was uw laatste menstruatie?      ……….. jaar en ……….. maanden 
 
37. Weet u de eerste dag van uw laatste menstruatie nog? Zo ja, Welke dag was dat?  
□  Ja, dat was ……………………….. (dd/mm/jjjj) 
□  Nee 
 
38. Gebruikt u hormoon vervangende middelen? Zo ja, welke medicatie gebruikt u? 
□  Ja, nl. ………………………………………………………… 
□  Nee 
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□  Invullen vragenlijst 2 
□  Stroop / Serial Subtraction 
 
Bloeddruk SBP DBP HR  Tijd (uu:mm) 
 
Rust 1 
 
 
 
   
Start vragenlijst 2  
 
 
Rust 2 
 
 
 
   
Eind vragenlijst 2  
 
 
Stroop 
 
 
 
   
Start Stroop 
 
 
 
SS 
 
 
   
Eind SS 
 
 
 
 
 
Toelichten 
□  Folder overheid 
□  Dagboekje 
□  Retour sturen spullen 
 
Meenemen   
□  Getekende Informed Consent 
□  Cortisol samples 1 en 2 
□  Instructie speekselverzameling met ingevulde tijden van verzameling 1 en 2 
□  Vragenlijst 1 (met supplement) en 2 
 
□  Handtekening op formulier proefpersoonvergoeding  
 
Opmerkingen 
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Stroop  
Volgorde van de 
juiste kleuren 
 
Nr Kleur Fout 
1 Blauw  
2 Geel  
3 Groen  
4 Geel  
5 Rood  
6 Blauw  
7 Rood  
8 Geel  
9 Rood   
10 Blauw  
11 Groen  
12 Geel  
13 Groen  
14 Groen  
15 Rood  
16 Groen  
17 Blauw  
18 Groen  
19 Geel  
20 Geel  
21 Rood  
22 Rood  
23 Geel  
24 Blauw  
25 Groen   
26 Rood  
27 Blauw  
28 Groen  
29 Rood  
30 Geel  
31 Groen  
32 Groen  
33 Geel  
34 Groen  
35 Geel  
36 Blauw  
37 Blauw  
38 Groen  
39 Rood   
40 Geel   
41 Rood  
42 Groen  
43 Geel  
44 Rood  
45 Groen  
46 Rood  
47 Blauw  
48 Groen  
49 Blauw  
50 Groen  
51 Geel  
52 Groen  
53 Groen  
54 Groen  
55 Rood  
56 Geel  
57 Groen  
58 Groen  
59 Geel  
60 Groen  
61 Geel  
62 Geel  
63 Groen  
64 Geel  
65 Rood  
66 Blauw  
67 Rood  
68 Geel  
69 Rood  
70 Blauw  
71 Groen  
72 Geel  
73 Groen  
74 Groen  
75 Blauw  
76 Geel  
77 Groen  
78 Geel  
79 Rood  
80 Blauw  
81 Rood  
82 Geel  
83 Rood  
84 Blauw  
85 Groen  
86 Geel  
87 Groen  
88 Groen  
89 Rood  
90 Groen  
91 Blauw  
92 Groen  
93 Geel  
94 Geel  
95 Rood  
96 Rood  
97 Geel  
98 Blauw  
99 Groen  
 
Aantal fouten: ……… 
 
 
 
 
 
 
 
Serial Subtraction 
2 min terugtellen in 
stappen van 7 vanaf 
1263  
 
Nr Count Fout 
1 1256  
2 1249  
3 1242  
4 1235  
5 1228  
6 1221  
7 1214  
8 1207  
9 1200  
10 1193  
11 1186  
12 1179  
13 1172  
14 1165  
15 1158  
16 1151  
17 1144  
18 1137  
19 1130  
20 1123  
21 1116  
22 1109  
23 1102  
24 1095  
25 1088  
26 1081  
27 1074  
28 1067  
29 1060  
30 1053  
31 1046  
32 1039  
33 1032  
34 1025  
35 1018  
36 1011  
37 1004  
38 997  
39 990  
40 983  
41 976  
42 969  
43 962  
44 955  
45 948  
46 941  
47 934  
48 927  
49 920  
50 913  
51 906  
52 899  
53 892  
54 885  
55 878  
56 871  
57 864  
58 857  
59 850  
60 843  
61 836  
62 829  
63 822  
64 815  
65 808  
66 801  
67 794  
68 787  
69 780  
70 773  
71 766  
72 759  
73 752  
74 745  
75 738  
76 731  
77 724  
78 717  
79 710  
80 703  
81 696  
82 689  
83 682  
84 675  
85 668  
86 661  
87 654  
88 647  
89 640  
90 633  
91 626  
92 619  
93 612  
94 605  
95 598  
 
 
Aantal fouten: ……… 
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Appendix VI
Activity diary
 
 
Dagboekje 
 
Familieonderzoek naar lichamelijke en 
geestelijke gezondheid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STICKER 
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1. Wat wordt er van u verwacht? 
 
De hartactiemeter 
 
U krijgt de meter ’s ochtends aan het begin van de (werk)dag bevestigd. Als de meter eenmaal gestart is, 
hoeft u er verder niets aan te doen; u kunt uw dagelijkse activiteiten gewoon verrichten. Graag zouden wij 
zien dat u gedurende de meetdag geen extreem fysieke inspanning verricht en niet teveel alcohol drinkt. 
Gelieve de hartactiemeter 24 uur, dag en nacht, om te houden. Wanneer de hartactiemeter is 
aangesloten, knippert er een groen lampje. 
Als het lampje langzaam knippert (2-3 maal per 10 seconden), is alles in orde en wordt de hartactie 
gemeten. Als het lampje snel knippert, is dit meestal een teken dat een van de elektrodes heeft 
losgelaten. In dat geval, willen wij u vragen de elektrodes te controleren en opnieuw vast te maken.  
 
 
 
 
 
Invullen van het activiteitendagboek 
 
De gemeten biologische signalen (zoals de hartslag) worden beïnvloed door lichamelijke activiteit en 
lichaamshouding. Om de gegevens goed te kunnen interpreteren is het noodzakelijk een nauwkeurig beeld 
te hebben van uw activiteiten. Daarom vragen we u tijdens de ambulante metingen elk uur een 
activiteitendagboek in te vullen.   
 
1. U vult eerst in het dagboekje de begin- en eindtijd in. 
2. Vervolgens vult u, op volgorde van tijd, in wat u sinds de vorige keer hebt gedaan. Van belang hierbij is 
dat u naast het soort activiteit ook de verandering in houding vermeldt. Als u bijvoorbeeld eerst aan tafel 
hebt gezeten en vervolgens een tijdje hebt gestaan, schrijft u dit dan op. Ook willen wij graag weten of u 
in gezelschap van mensen was of alleen. Probeer het dagboek elk uur in te vullen.  
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Voorbeeld dagboekje 
 
Tijd  
Van 7 uur 15 min  
Tot 8 uur 15 min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
 
Kastje werd omgehangen, gestaan en gegeten (thuis). Onderzoeker was 7.30 weg, rondgelopen, 
ontbijt klaargezet. Alleen ontbeten, zittend (thuis). Daarna beetje opgeruimd en katten eten 
gegeven. Om 8 uur naar buiten met vuilnis (lopen en staan). Daarna ongeveer 20 minuten 
naar het werk gefietst. 
 
 
 
Tijd 
Van 8 uur 15 min  
Tot 9 uur 15 min 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner, etc.), locatie (werk, thuis, etc.) 
 
Aangekomen op werk, computer aan gezet (zittend), koffie gehaald (gelopen), gekletst met 
collega’s (staand). 9.00 uur aan het werk. PC werk (alleen) zittend. 
 
 
 
 
 
Tijd 
Van 9 uur 15 min  
Tot   10 uur 15 min 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner, etc.), locatie (werk, thuis, etc.) 
 
Vergadering met collega’s zittend, hevige discussies (op werk). Daarna zitten achter PC 
(alleen). 2 keer opgestaan om naar printer te lopen 
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2. Dag 1 
 
Ochtend 
 
Ontbijt … uur … min 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere 
personen (collega, partner, etc.), locatie (werk, thuis, 
etc.) 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
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Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere 
personen (collega, partner, etc.), locatie (werk, 
thuis, etc.) 
 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere 
personen (collega, partner, etc.), locatie (werk, thuis, 
etc.) 
 
 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere 
personen (collega, partner, etc.), locatie (werk, thuis, 
etc.) 
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Middag 
 
Lunch … uur … min 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere 
personen (collega, partner, etc.), locatie (werk, thuis, 
etc.) 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
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Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere 
personen (collega, partner, etc.), locatie (werk, thuis, 
etc.) 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
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Avond 
 
Avondeten … uur … min 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere 
personen (collega, partner, etc.), locatie (werk, thuis, 
etc.) 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
 
 
Vanavond om 22.30uur, of daarvoor als u eerder gaat slapen, gaat u weer speeksel verzamelen. 
Wilt u ervoor zorgen dat u een half uur van tevoren niets meer eet of drinkt (behalve een glas 
water)? Vergeet u niet in te vullen hoe laat u het speeksel verzamelt? 
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Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen 
(collega, partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
Tijd  
Van ….. uur …min  
Tot ….. uur …min 
Vul in: activiteit, houding, aanwezigheid andere personen (collega, 
partner, etc.), locatie (werk, thuis, etc.) 
 
 
 
 
 
 
Speekselverzameling 3 
(3. Avond) 
22.30 uur òf 
voor het slapen 
gaan als dit 
eerder is 
 
Werkelijke tijd: 
 
….. uur ….. min 
 
 
 
Wilt u voor u gaat slapen nog de POMS stemmingsvragenlijst op de volgende pagina invullen? 
 
En denkt u er aan de 2 laatste buisjes voor de speekselverzameling alvast op uw nachtkastje 
klaar te leggen voor morgenvroeg, als u wakker wordt? 
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POMS Stemmingsvragenlijst 
 
De woorden in de lijst hieronder beschrijven stemmingen of gevoelstoestanden. Lees ieder woord nauwkeurig 
en kruis dan aan hoe u zich vandaag voelde. Denk niet te lang na over uw antwoord. Het gaat om uw eerste 
indruk. Er bestaan geen foute antwoorden. Elk antwoord is goed, als het maar uw eigen stemming weergeeft. 
Sla geen woord over. 
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1. Neerslachtig □ □ □ □ □ 20. Ongelukkig □ □ □ □ □ 
2. Slecht gehumeurd □ □ □ □ □ 21. Woedend □ □ □ □ □ 
3. Uitgeput □ □ □ □ □ 22. Lusteloos □ □ □ □ □ 
4. Actief □ □ □ □ □ 23. Vol energie □ □ □ □ □ 
5. Zenuwachtig □ □ □ □ □ 24. Rusteloos □ □ □ □ □ 
6. Hulpeloos □ □ □ □ □ 25. Onwaardig □ □ □ □ □ 
7. Geërgerd  □ □ □ □ □ 26. Knorrig □ □ □ □ □ 
8. Helder □ □ □ □ □ 27. Doodop □ □ □ □ □ 
9. Paniekerig □ □ □ □ □ 28. Schuldig □ □ □ □ □ 
10. Droevig □ □ □ □ □ 29. Opgeruimd □ □ □ □ □ 
11. Vriendelijk □ □ □ □ □ 30. Angstig □ □ □ □ □ 
12. Opstandig □ □ □ □ □ 31. Droefgeestig □ □ □ □ □ 
13. Vermoeid □ □ □ □ □ 32. Kwaad □ □ □ □ □ 
14. Levendig □ □ □ □ □ 33. Afgemat □ □ □ □ □ 
15. Gespannen □ □ □ □ □ 34. Onzeker □ □ □ □ □ 
16. Eenzaam □ □ □ □ □ 35. Wanhopig □ □ □ □ □ 
17. Bezorgd □ □ □ □ □ 36. Behulpzaam □ □ □ □ □ 
18. Verbitterd □ □ □ □ □ 37. Ontmoedigd □ □ □ □ □ 
19. Aan het eind van mijn 
krachten 
□ □ □ □ □ 38. Mopperend □ □ □ □ □ 
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3. Dag 2 
 
Ochtend 
 
Wilt u als u wakker wordt, terwijl u nog in bed ligt, speekselverzameling 4 doen? En vult u dan 
in onderstaand schema in hoe laat u dit heeft gedaan? 
 
 
Speekselverzameling 4 
(4. Ontwaken) 
Wakker worden  
(in bed) 
Werkelijke tijd: 
 
….. uur ….. min 
 
Om de hartactiemeter uit te zetten, houdt u het knopje bovenaan het kastje 5 seconden 
ingedrukt. Daarna mag u de hartactiemeter afdoen en de batterijen er uit halen. Over 30 
minuten vragen we u voor de laatste keer speeksel te verzamelen. Denkt u er aan dat u in de 
tussentijd niets eet of drinkt (behalve een glas water)? Wacht u alstublieft ook nog even met 
het poetsen van uw tanden? U mag ondertussen de laatste vragen invullen. Ze staan hieronder. 
 
Slaapkwaliteit 
 
Hieronder volgen 15 uitspraken over de kwaliteit van uw slaap. Het gaat er om dat u aangeeft of de 
uitspraak van toepassing is op uw slaap zoals die de afgelopen nacht was. De uitspraken lijken soms op 
elkaar, maar zijn nooit hetzelfde. Beantwoord alstublieft elke vraag. 
 
 Ja Nee 
1. Ik heb geen oog dicht gedaan □ □ 
2. Ik had, nadat ik wakker geworden was, moeite weer in slaap te vallen □ □ 
3. Ik ben tijdens de slaapperiode opgestaan □ □ 
4. Ik vind dat ik heel slecht geslapen heb □ □ 
5. Ik sliep makkelijk in □ □ 
6. Ik sliep niet langer dan 5 uur □ □ 
7. Ik lag langer dan een half uur wakker □ □ 
8. Ik ben meerdere malen wakker geworden □ □ 
9. Ik lag erg te woelen □ □ 
10. Ik vind dat ik goed geslapen heb □ □ 
11. Ik heb naar mijn gevoel maar een paar uur geslapen □ □ 
12. Ik had, nadat ik was opgestaan, een moe gevoel □ □ 
13. Ik ben naar mijn gevoel slaap tekort gekomen □ □ 
14. Ik voelde me, nadat ik was opgestaan, goed uitgerust □ □ 
15. Heeft u vannacht slechter geslapen als gevolg van de hartslagmetingen? □ □ 
16. Hoe laat ging u naar bed?    uur    min  
17. Hoe laat stond u op?    uur    min 
 
Speekselverzameling 5 
(5. Ontwaken + 30) 
30 min na het 
wakker worden  
 
Werkelijke tijd: 
 
….. uur ….. min 
 
 
Ontbijt … uur ... min 
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4. Einde van het onderzoek 
 
Het onderzoek is afgelopen! Wij willen u zeer hartelijk bedanken voor uw medewerking en inzet. Als laatste  
willen wij u vragen onderstaande spullen naar ons terug te sturen. U heeft daarvoor een grote bubbeltjes- 
envelop gekregen waar het goede adres al op staat. Let u goed op dat u alles in de envelop doet:  
 
□  Hartactiemeter  
□  Elektroden           
□  Beschermhoes hartactiemeter + draagriem  
□   Batterijen     
□  3 buisjes met wattenrolletjes van de speekselverzameling 
□  Dagboekje     
Als u de vragenlijsten nog niet heeft meegegeven aan de onderzoeker:     
□  Vragenlijst 1      
□  Vragenlijst 2 
 
Een postzegel plakken is niet nodig, dit betaalt de VU (u stuurt de spullen terug naar ons antwoordnummer). 
Helaas is de envelop net wat te dik om door de brievenbus te kunnen. Wij willen u daarom vriendelijk  
verzoeken deze: 
 
□  Af te geven / in de postbak te deponeren bij een postkantoor bij u in de buurt  
□  TNT Post is tegenwoordig ook steeds vaker gevestigd in winkels als supermarkten, boekhandels,  
    tabakszaken en drogisterijen. Vaak kunt u ook daar een postbak of -zak vinden waar u grotere pakketten  
    kunt posten         
□  Indien mogelijk, kunt u de envelop afgeven bij de postafdeling van uw werk 
 
U krijgt van ons binnen enkele weken, nadat wij uw gegevens hebben verwerkt, een uitdraai van uw hartslag  
en bloeddruk thuisgestuurd. Als dank voor uw deelname, sturen wij een cadeaubon van EUR 10,- mee. 
 
Als u nog vragen of opmerkingen heeft, kunt u deze op de volgende pagina kwijt. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Naam onderzoeker / contactpersoon: …………………………………………………………………………………………………………. 
 
Telefoonnummer: 020-5982537 òf 06-50698826  
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Thank you letter and annotated review of the recording
NEDERLANDS TWEELINGEN REGISTER (NTR) 
 
FACULTEIT DER PSYCHOLOGIE EN PEDAGOGIEK 
Biologische Psychologie 
BEZOEKADRES 
Van der Boechorststraat 1 
Kamer 2B-35 
1081 BT Amsterdam 
POSTADRES 
Van der Boechorststraat 1 
1081 BT Amsterdam 
WWW.FPP.VU.NL  
  
DATUM ONS KENMERK UW BRIEF VAN UW KENMERK 
 NETAMB3-062010/b5       
E-MAIL TELEFOON FAX BIJLAGE(N) 
m.neijts@vu.nl 020 5982537 020 598 8832 uitdraai hartslag 
cadeaubon 
 
   
 
Geachte heer , mevrouw, 
 
 
Wij zijn onlangs bij u op bezoek geweest in het kader van het familieonderzoek naar lichamelijke en 
geestelijke gezondheid. Tijdens dat bezoek hebben wij uw bloeddruk gemeten en kreeg u een hartactiemeter 
om, die u tot de volgende ochtend omhield. Zoals beloofd ontvangt u van ons hierbij een uitdraai van uw 
resultaten met een korte toelichting. 
 
Als blijk van dank voor uw deelname voegen wij tevens een cadeaubon van EUR 10,- bij.  
 
Via de NTR website wwww.tweelingenregister.org kunt u op de hoogte blijven van de ontwikkelingen binnen 
dit onderzoek. De knop “Onderzoek” aan de linkerkant van de site brengt u op een pagina waarop ook dit 
onderzoek vermeld wordt.  
 
Wij willen u bij deze hartelijk danken voor uw bijdrage aan het onderzoek van het Nederlands Tweelingen 
Register. 
 
 
Met vriendelijke groet, namens het onderzoeksteam, 
 
 
 
 
Drs. Melanie Neijts 
Prof. dr. Eco de Geus 
Dr. Gonneke Willemsen 
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Uw persoonlijke gegevens 
 
De hartactiemeter die u tijdens ons bezoek om kreeg en dat u tot de volgende ochtend omhield, 
registreerde ondermeer uw hartslag en de hoeveelheid lichaamsbeweging.  
Door de bewegingsregistratie te combineren met de gegevens uit uw dagboekje konden we de 
gemiddelde hartslag tijdens verschillende bezigheden bepalen. Hieronder ziet u deze gegevens 
weergegeven. Aan de linkerkant ziet u de verschillende bezigheden gedurende de meetperiode. In het 
balkje daarnaast ziet u uw gemiddelde hartslag voor iedere bezigheid. Deze wordt tevens aangegeven 
door de lengte van de balk. 
 
Een uitleg van de categorieën kunt u vinden op onze website www.tweelingenregister.org door via de 
knop 'Onderzoek' aan de linkerkant naar de lijst met NTR onderzoeken te gaan. Onder 'TITEL 
ONDERZOEK' ziet u deze studie, ‘Familieonderzoek naar lichamelijke en geestelijke gezondheid,‘ staan. 
 
Op de achterzijde vindt u een grafiek die uw hartslag en beweging weergeeft over de gehele periode dat 
u de hartactiemeter om had. Bovenaan in de figuur staan de gegevens voor de eerste helft van de 
meetperiode, onderaan de gegevens voor de tweede helft van de meetperiode.  
 
Naast de hartactiviteit hebben wij tijdens het bezoek een aantal keer uw bloeddruk gemeten. Bloeddruk 
wordt altijd weergegeven door twee waarden: de bovendruk en de onderdruk. Deze waarden worden 
uitgedrukt in millimeters kwikdruk (mm Hg).  
 
Uw gemiddelde bloeddruk over de metingen was … /… mm Hg. 
 
Een bloeddruk wordt als verhoogd beschouwd als de bovendruk hoger is dan 160 mm Hg en/of de 
onderdruk hoger is dan 95 mm Hg.  
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List of abbreviations 
266 List of abbreviations
-2LL Minus twice the logarithm of the likelihood
ACh Acetylcholine
AIC Akaike’s information criterion
ANS Autonomic nervous system
BMI Body mass index
BRS Baroreflex sensitivity
CN Cranial nerve
CRP C-reactive protein
CVD Cardiovascular disease
DOS Dizygotic opposite-sex
DZ Dizygotic
dZ/dt Change in thoracic impedance
E Epinephrine
ECG Electrocardiogram
EF Ejection fraction
GSKL Groningse slaap kwaliteit lijst
GWAS Genome wide association study
HDL-cholesterol High-density lipoprotein cholesterol
HF High frequency
HR  Heart rate
HRV Heart rate variability
IBI Interbeat interval
ICG Impedance cardiogram
IML Intermediolateral
IL-6 Interleukin-6
LDL-cholesterol Low-density lipoprotein cholesterol
LF Low frequency
LF/HF The ratio of low to high frequency power
MSNA Muscle sympathetic nerve activity
MZ Monozygotic
NE Norepinephrine
nsSCR Nonspecific skin conductance responses
NTR Netherlands twin register
NTS Nucleus of the solitary tract
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PEP Pre-ejection period
POMS Profile of mood states
PNS Parasympathetic nervous system
pvRSA Respiratory sinus arrhythmia derived by peak-valley estimation
RMSSD  Root mean square of differences between valid, successive interbeat 
intervals
RSA Respiratory sinus arrhythmia 
RVLM Rostral ventrolateral medulla
SA Sinoatrial
SBP Systolic blood pressure
SCL Skin conductance level
SCR Skin conductance response
SDNN Standard deviation of all valid interbeat intervals
SEM Structural equation modeling
SES Socioeconomic status
SNP Single nucleotide polymorphism
SNS Sympathetic nervous system
SVR Systemic Vascular Resistance
TNF-α Tumor necrosis factor-alpha
TP Total power
TWA T-wave amplitude
ULF Ultra low frequency
VLF Very low frequency
VU-AMS VU university ambulatory monitoring system
Z Thoracic impedance
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274 Dankwoord
Klaar! Althans, voor zover dit mogelijk is binnen de zich voortdurend aan ontwikkeling 
onderhevig zijnde wetenschap. Maar, dit project is nu afgesloten en wat was het een 
groot project en wat waren er veel mensen bij betrokken! Graag zou ik dit proefschrift 
dan ook willen besluiten de mensen te bedanken die mee hebben geholpen aan de 
totstandkoming ervan.
Allereerst grote dank aan alle tweelingen en hun familieleden voor hun trouwe 
deelname aan het doorlopende onderzoek van het Nederlands Tweelingen Register en 
in het bijzonder natuurlijk de deelnemers aan deze studie. Ik zou kunnen zeggen zonder 
deelnemers geen onderzoek wat een waarheid als een koe is, maar dan zou ik jullie 
bijdrage nog tekort doen. De fijne onthalen, jullie interesse, inzet en welwillendheid mee 
te werken was vaak hartverwarmend. 
Dan wil ik graag mijn promotor en copromotor bedanken. Eco, bedankt voor je 
wijsheid, doortastendheid en humor. Je enthousiasme is aanstekelijk; een werkbespreking 
stapte ik vaak weer vol goede moed en met veel nieuwe inzichten en ideeën rijker weer uit. 
Ondanks je enorme takenpakket bij zowel de VU als het VUmc, wist jij altijd binnen afzienbare 
tijd mijn vragen te beantwoorden of mijn stukken van commentaar te voorzien. Ik heb 
enorm veel van je kunnen leren tijdens mijn promotietraject. Gonneke, van jou heb ik ook 
zoveel mogen leren tijdens mijn aanstelling bij de VU. Je stond altijd voor me klaar tijdens 
elke fase van het traject. Altijd kon ik bij je langskomen en bood je een luisterend oor. Als 
ik door de bomen het bos even niet meer zag, kwam jij met een helder stappenplan. Als ik 
vastliep met een script, maakte jij tijd om het samen door te lopen. Dank voor jouw begrip, 
geduld en support. Dorret, ook jou wil ik expliciet bedanken voor de mooie ervaringen die 
ik op heb mogen doen tijdens mijn aanstelling bij de afdeling Biologische Psychologie. Ik 
ben je heel dankbaar dat ik de kans heb gekregen zoveel over onderzoek en methoden te 
leren en te werken in zo’n dynamische en gemotiveerde onderzoeksgroep.
Ik wil de leden van de leescommissie bedanken voor het lezen en beoordelen van 
mijn proefschrift: prof. dr. Huizink, dr. Ijzerman, dr. Kupper, prof. dr. Snieder, en dr. Tiemeier. 
Ook alle (ex-)collega’s, mede-AIO’s, en collega’s van het secretariaat zou ik hartelijk 
willen bedanken voor de afgelopen tijd. In het bijzonder ook mijn (ex)kamergenootjes: 
Tinca, Inge, Laura, Michelle, en Fiona. En natuurlijk Suzanne: jij bent bijna van het begin 
tot het eind mijn kamergenoot geweest en ik heb ook jouw traject van heel dichtbij mogen 
aanschouwen. Voor jou nu ook de laatste loodjes!! Rene, Ineke, en Nienke, de mede-AMS 
AIO’s ook jullie wil ik nog even speciaal bedanken voor de fijne samenwerking. Rene 
wij gaan het langste terug; het was een hele belevenis samen met jou bij de practica 
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voor Psychophysiology te assisteren. Er was altijd leven in de brouwerij en we hebben 
samen heel wat afgelachen. Dit stokje werd vorig jaar overgedragen aan Ineke. Het is 
bewonderenswaardig met hoeveel gemak jij dit overgenomen hebt, naast dat je het zo 
druk hebt met de dataverzameling voor je eigen project. Respect! 
Ik wil graag nog bedanken mijn onderzoeksassistenten Lena en Rianne; wat waren 
we een goed team en wat hebben we samen veel meegemaakt in die twee jaar data-
verzameling. Door weer en wind en in alle vroegte hebben we bijna 600 huisbezoeken 
afgelegd, gewapend met een tray red bull, flessen bar le duc citroen en een doos napo-
leons. Ook wil ik graag alle stagiaires bedanken die mee hebben geholpen aan dit 
project: Amber, Elisabeth, Eline, Hester, Kirsten en Naomi. Door jullie inzet hebben we 
nog even extra gas kunnen geven.
De TD: Cor, Evert, Jarik, Rob, Daan en Menaka. Ik weet niet wat ik zonder jullie 
had gemoeten. Jullie stonden altijd met en raad en daad voor ons klaar als we tegen 
software of hardware problemen aanliepen. Samenwerken met jullie was een feest door 
jullie enorme drive en gastvrijheid; ook de keukendeur stond altijd open voor een lekker 
kopje koffie met koek wat na die vroege ritten zeer welkom was! Rene, Marwin en Marco: 
bedankt voor jullie fantastische ICT support. Jullie kwamen altijd direct voor me in actie 
als er problemen waren, zelfs in de tijd van de rode computers. Klasse!
Jenny en Laili, wat ontzettend fijn dat jullie mijn paranimfen willen zijn. Jenny, jou 
heb ik leren kennen bij BioPsy. We zijn in eerste instantie min of meer meteen aan elkaar 
gekoppeld toen ik twee maanden na aanvang van mijn aanstelling een kamer in Boulder 
met je ging delen. Gelukkig bleek dat wel een goede match; ik heb je leren kennen als 
een lief en oprecht persoon, barstensvol met leuke ideeën. Ik vind het fijn dat jij mij bij 
wilt staan! Laili, wij kennen elkaar van onze studie Psychologie en hebben lief en leed 
met elkaar gedeeld. Ik vind het heel speciaal dat ik ook dit met jou kan delen. Dan wil ik 
nog bedanken mijn andere lieve Maastricht-vrienden Michiel, Casper en Tessa. Allemaal 
verschillende kanten op gegaan, letterlijk en figuurlijk, maar ik geniet nog steeds van 
onze get togethers. En natuurlijk Aafke, jouw steun betekent heel veel voor mij. Ik vind 
het heel bijzonder dat we zo veel levensfases later nog steeds zo betrokken zijn bij elkaar. 
Als laatste mijn familie en in het bijzonder mijn vader Peter en broertje Bram. Dank 
voor jullie onvoorwaardelijke steun en geloof in mij. Mama, wat had ik dit graag ook met 
jou willen delen, ik weet zeker dat je het fantastisch had gevonden! En tot slot, Dennis.. ik 
ben heel blij dat ik jou heb leren kennen en wil je bedanken voor alle liefde, vertrouwen 
en steun. Ik hoop dat we samen nog veel mooie momenten gaan beleven!

